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INTRODUCTION 
Viruses are obligate parasites intimately associated with 
host cells which may be components of tissues, organs, or whole 
organisms. Viruses may also exist in single individual cells 
such as circulating blood cells, in independently living cells 
such as bacteria or protozoa, or in artificially cultured cells, 
tissues, or organs. It is difficult to discuss viruses as 
separate or independent entities inasmuch as they grow or 
reproduce only within living cells, and the existence of viruses 
outside of these living cells is only a temporary or transitory 
state between their existence in living host cells. 
The subject of this dissertation is a discussion of some 
of the interactions of the group of agents known as the bovine 
viral diarrhea (BVD) viruses with host cells. Included in this 
study are not only the effects of viral agents on host cells 
which usually result in pathology or a disease process, but 
also the effects of passages in different cells on properties 
and characteristics of viral agents themselves. Modifications 
of these viral agents may be expressed as different types of 
cytopathology which are produced in host cells, serological 
properties such as neutralization titers or immunofluorescence, 
or as clinical expression of disease in susceptible animals. 
Bovine viral diarrhea is a syndrome in cattle produced by 
a filterable virus or group of viruses, and which is the result 
of rather complex Interactions among the viral agents and the 
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host cells of affected animals. Some of the virus-host inter­
actions involved in this syndrome have been studied and are 
described in this dissertation. 
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REVIEW OF LITERATUBE 
Bovine Viral Diarrhea as a Disease 
Olafson et al. (1) in 19^6 were the first to describe the 
effects of a newly recognized contagious and transmissible 
disease agent of cattle as producing ulcers and necrosis of 
mucous membranes of the lips, cheeks, tongue, pharynx, and 
esophagus, as well as hemorrhages in various tissues. Olafson 
and Eickard (2), after additional observations, attributed this 
to a filterable virus which they called virus diarrhea of 
cattle. 
Ramsey and Chivers (3) in 1953 described the pathological 
picture of Iowa cattle affected with a mucosal disease of 
unknown etiology. For the next 4 or 5 years, a controversy 
existed as to whether or not the disease entities known as 
virus diarrhea and as mucosal disease were separate diseases, 
or were one and the same disease. One of the chief drawbacks 
to establishing identifying criteria for the agents producing 
these two syndromes was the lack of an ^  vitro assay system. 
For many years research on bovine viral diarrhea was impeded by 
the fact that all the isolated agents were noncytopathogenic in 
cell and tissue cultures (4), however, Lee and Gillespie (5) 
had maintained the New York-1 (NY-1) strain of viral diarrhea 
virus for 20 consecutive passages in bovine embryonic skin-
muscle tissue prepared in roller tubes by the plasma-clot 
method and for 15 further transfers in embryonic bovine kidney 
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cortex cells prepared by trypsinization. Multiplication of 
this virus was not associated with conspicuous cytopathic 
effects (CPE) on cells, but virus was maintained at 10^ to 10? 
levels in fluid from these tissue cultures. Virulence of this 
passaged virus did not abate as shown by assays in susceptible 
calves. 
Gillespie and Baker (6) maintained the Indiana strain 46 
(IND-46) BVD virus for 26 serial passages in tissue cultures 
in a manner similar to that described for NÏ-1 strain. The 
IND-46 strain, also, did not produce CPE, and remained infec­
tive for calves after 26 tissue culture passages. The NÏ-1 and 
IND-46 strains cross-immunized calves. 
Underdahl et al. (7) isolated and cultivated in embryonic 
bovine kidney (EBK) cells, a cytopathogenic agent from tissues 
of cattle with mucosal disease. They stated that although this 
viral agent was isolated from lesions of cattle having mucosal 
disease, the evidence presented did not prove it to be the 
causative agent of the disease. 
Gillespie et (8) isolated a cytopathogenic virus, 
designated Oregon C24V, from the spleen of a calf from Oregon 
with signs of illness and lesions indicating the disease, viral 
diarrhea. The isolation of a cytopathogenic strain of viral 
diarrhea virus made possible the use of serology to study 
various strains of viruses and their homologous antisera. With 
this new tool, Gillespie et (9) showed antigenic relation­
ships between strains of viral diarrhea virus and those of 
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mucosal disease when compared by neutralization tests. They 
pointed out that according to rules of nomenclature priority, 
Olafson's (2) name of the disease "virus diarrhea" after the 
most prominent signs of illness in animals should take preced­
ence over "mucosal disease," which described a prominent lesion 
of the syndrome (3). Earlier, Lee and Gillespie (5) had already 
mentioned the so-called "virus diarrhea-mucosal disease complex" 
of cattle. An international committee (10) investigating anti­
genic relationships of some of the viruses isolated from this 
disease syndrome, from the United States, Great Britain, and 
West Germany adopted this terminology to describe such agents. 
Thomson and Savan (11) concluded from their studies on out­
breaks of viral diarrhea and mucosal disease; "that there were 
not two diseases, but one, and that according to priority 
should be called virus diarrhea." 
Effects of BVD Agents on Hosts and Host Cells 
The main features characterizing the BVD syndrome of 
cattle have already been mentioned briefly (1). Other salient 
features appearing in the whole animal affected by this syn­
drome as described by Ramsey and Chivers (3) are fever, 
anorexia, profuse salivation, depression, dehydration, a foul-
smelling mucopurulent nasal discharge, and constant or inter­
mittent watery diarrhea sometimes mixed with blood. The main 
organ and tissue changes are hyperemia, hemorrhages, erosions. 
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ulcerations and necrosis of the mucosa of the alimentary canal 
from lips to anus. 
Gross pathology and histopathology of the disease have 
been described in great detail by Ramsey (12), Lesions of the 
mucosa of the alimentary canal and the lamina epithelia are 
primarily erosive, ulcerative and cystic. Necrosis of the 
lymphoid tissue of the intestine, lymph nodes and spleen fre­
quently occur. 
A study of the comparative pathology and clinical responses 
produced by a number of selected agents of the BVD complex was 
published by Tyler and Ramsey (13) .• This study described some 
of the jja vivo relationships among several isolants including 
Sanders, Merrell, National Animal Disease Laboratory (NADL), 
North Dakota (BMD), Nebraska (C-1) and Indiana (IND-46) agents. 
An interesting commentary on this work is that both the gross 
pathology and the histological and cellular studies reveal 
similarities among the pathological changes produced by the 
Sanders, Merrell, IND-46 and NADL agents. The first 3 viruses 
are noncytopathogenic agents in cell culture systems, while the 
latter agent produces a rapid and easily recognized CPE in 
EBK cells (14). 
The cytopathology of the C24V strain of the BVD virus in 
cell cultures has been briefly described by Gillespie et al. 
(8), and in much more detail by Hansen et al. (15). These 
latter researchers compared the histological changes found in 
sections from cattle infected with 2 Swedish strains, Farsen 
7 
406 and 417, with the cytopathological changes seen in calf-
kidney cell cultures inoculated with either of these 2 strains 
or with the Oregon C24V strain of BVD virus. The major cell 
lesion encountered in both histological sections and cell 
cultures consisted of shrinking and karyopyknosis. Additionally, 
the C24V strain caused extensive vacuolization of the cytoplasm 
of infected cell cultures, a feature also described by 
Gillespie et al. (8). 
Pernelius and Ritchie (l6) have described and illustrated 
the type of CPE occurring in NADL-infected EBK cells as pri­
marily formation of pyknotic nuclei, rounding of cells, and 
early detachment of most of the cells from the monolayer. Cyto­
pathological changes in culture cells infected by C24V consisted 
chiefly of formation of vacuoles of varying sizes in the cyto­
plasm, pyknotic nuclei which were often eccentric, and rounding 
of some of the cells followed by detachment from the monolayer. 
The CPE alone were not sufficient criteria for identification 
or characterization of BVD viruses, because noncytopathogenic 
strains such as CG-1220 produced little or no CPE in infected 
cell cultures. 
Characteristics of BVD Agents 
The Oregon C24V agent of the BVD disease syndrome was 
reported by Hermodsson and Dinter (1?) to be an RNA-contalning 
lipo-virus with a size of approximately 40 m^ as estimated by 
filtration data^ Spherical particles with diameters of about 
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40 mji were observed In electron micrographs of ultra-thin sec­
tions of virus pellets prepared from infective tissue culture. 
These authors admitted, however, that since the titer of the 
tissue culture fluid never exceeded 10^'? TCID^Q/ml, the con­
centration of virus in the pellet was too low to permit identi­
fication of the particles as the BVD virus. The sedimentation 
coefficient of the C24V strain of BVD virus was estimated to 
be approximately 80-90 S by centrifugation in a Spinco Model L 
centrifuge. 
Gutekunst (18) presented data to show that both NADL and 
Oregon C24V viruses readily passed through 220 m)i and 100 ngi 
Millipore filters, a small fraction (approximately .01^) passed 
the 50 nifi filter, and no infective material passed the 10 mp 
filter. These data indicated a virus size of between 50 and 
100 m]û, excluding any adsorption or electrostatic forces 
possibly preventing filtration of particles. 
Taylor et al. (19) reported that the C24V strain of BVD 
virus passed through both cellulose and asbestos filters with 
an average porosity of 100 mji, but would not pass through 
filters with an average porosity of 50 mp using either system. 
Pritchard (20) published a chromium shadowed electron 
micrograph (supplied by Kniazeff) of a preparation of BVD 
virus-like particles, 35 to 55 in diameter, roughly spheri­
cal in form, and infective for cell cultures. 
The structure of BVD virus, strain BVDMJ was studied by 
Dutta et al. (21) by use of negative staining techniques. 
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Infective tissue culture fluids were pelleted by ultracentrl-
fugatlon, then further purified by G-75 Sephadex-gel filtration. 
They reported the virus to be spherical in shape with a diameter 
of 75 to 85 m]!. The central core was enveloped and the outer 
coat covered with surface projections 7-8 m)i in length and with 
a bulbous appearance at their distal ends. The virus appeared 
to have helical symmetry and thus could be classified in the 
myxovirus group. 
Ditchfleld and Doane (22) studied 2 BVD viruses, the 
Oregon C24V strain, and the Ontario MC A strain by negative 
staining of cryostat sections of infected tissue culture cells. 
They reported that the size of the virion varies from I50 to 
250 myi, and all particles are studded with periodic projec­
tions of 10 mp. in length. The internal component is in the 
form of a helix which possesses a diameter of 18 m;i. Because 
of these properties, the authors suggest that the virus should 
be considered a member of the myxovirus group, 
Diderholm and Dinter (23) reported cold phenol extraction 
of infectious ENA from BVD virus. The titer of the intact 
virus was approximately 6 log units higher than the titer of 
its RNA (8.3 and 1.9 log PFU/ml respectively). These authors 
infer that these results preclude a myxovirus classification 
because myxovlruses are refractory to extraction of Infectious 
nucleic acid (24). 
The C24V strain of BVD virus was shown by Dlnter (25) to 
be sensitive to the lipid solvents ether, chloroform, and 
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desoxycholate, as well as somewhat sensitive to trypsin. These 
sensitivities indicate that the virion has a lipo-protein coat. 
Ether and chloroform sensitivities of BYD viruses have also 
been reported by other workers (17» 18, 22). 
A single contrary finding that the Oregon C24V strain of 
BVD viruses Is ether-stable was reported by Taylor et §d. (19). 
On the basis of size, lack of hemadsorption, and ether stability, 
these authors suggested that BVD agents could be classified as 
adenoviruses rather than myxovlruses which are also In a similar 
size range. 
Gillespie et al. (26) state: 
"Because virus diarrhea virus of cattle is ether 
susceptible. It would not currently be classified 
as an enterovirus even though its clinical name 
may Imply that it should fall into this classi­
fication." 
Some authors (2?) have mistakenly called these viruses "entero­
viruses", a class reserved for a distinct and separate group of 
viruses with characteristics quite different from those of the 
BVD group of viruses. 
Dlnter (25) considers BVD and hog cholera (EC) viruses to 
be related to group B arboviruses because of similarities of 
size, type of nucleic acid, and susceptibility to lipid sol­
vents and trypsin. However, evidence of arthropod spread of 
these viruses, a criterion for arbovirus classification, seems 
to be lacking for both BVD and HC viruses. 
Burkl (28) pointed out that equine arteritis (EA) and 
human hepatitis (HH) viruses share common physiochemlcal 
11 
properties with BVD and HC viruses. Inasmuch as no insect 
vectors are involved, none of these viruses could be considered 
to be arboviruses, and the name proposed by McLean (29). 
"hemovirus" would be appropriate for classifying all 4 of these 
viruses into a single group, according to Burki. 
Horzinek (30) reported that buoyant densities of BVD 
viruses are lower than 1.18 g/ml (cited as a personal communi­
cation of preliminary results from Hafez). She also reports 
buoyant densities of HC viruses between 1.15 and 1,20 g/ml, 
with a peak at I.l6 g/ml as measured by cesium chloride density 
gradient centrifugation. The high lipid content of these two 
viral groups account for their low densities; proteins alone 
have densities of about I.30 g/ml. 
Several groups of researchers have shown antigenic rela­
tionships between BVD and HC viruses by animal protection 
tests (27, 31) by agar gel diffusion studies (32, 33), by 
immunofluorescence (34), by fixation of complement (35). and 
by cross neutralization tests (25). It is quite likely that 
all of these antigenic relationships are mediated by common 
soluble antigens produced by HC and BVD viruses. 
BVD Viral Detection Systems 
Systems for detecting noncytopathogenic BVD viruses have 
been described. They are based on the principle that infection 
of cells in cultures with noncytopathogenic BVD virus inter­
feres with subsequent infection of these cells with a 
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cytopathogenic virus. Kniazeff and McClain (36) developed such 
a system for detecting and titrating interfering BVD viruses by 
a plaque-reduction technique employing the vesicular stomatitis 
(VS) virus as the challenge virus. Gillespie et a^, (37) 
described a similar system in which the cytopathogenic strain 
of BVD virus. New York C60F was used as the indicator virus 
instead of the VS virus. Detection of noncytopathogenic 
strains, therefore, became possible without the use of expen­
sive calves. A further adaptation of this interference test 
led to successful serological comparisons of both noncytopatho­
genic and cytopathogenic strains of BVD viruses. Gutekunst and 
Malmqulst (35) modified the interference detection and neutrali­
zation methods of Gillespie et by employing the NADL strain 
as the challenge virus. 
The END method (exaltation of Newcastle disease virus) 
which was originally developed to detect hog cholera viruses, 
was successfully applied to the detection and measurement of 
several noncytopathogenic BVD strains by Inaba et al. (38). 
Fernelius (14) described a method for detecting and titrat­
ing noncytopathogenic BVD agents in cell culture systems by 
immunofluorescence. Cytopathogenic and. noncytopathogenic 
viruses cross-reacted with fluoresceln-conjugated serum globu­
lins produced against either group of viruses, but the fluores­
cence was more intense in the homologous system. 
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Immunological and Serological Relationships 
Among Strains of BVD Viruses 
A number of conflicting reports concerning serological 
and immunological relationships of the various isolants and/or 
strains of BVL viruses are in the literature. Methodology, 
viral contaminants, misdiagnoses, and inadequate descriptions 
and characterizations account for much of the confusion. 
Olafson and Rickard (2) found that one attack of viral 
diarrhea conferred a solid immunity to cattle. On the other 
hand, Pritchard et al. (39) reported that 
" . . .  r e c o v e r y  f r o m  m u c o s a l  d i s e a s e  d o e s  n o t  c o n f e r  
resistance to a subsequent challenge with either 
virus diarrhea—New York or virus diarrhea—Indiana. 
. . . The results of these studies suggest that 
immunological differences may exist between (sic) 
the three diseases." 
Later, this group (40) reported: 
"Cross-protection tests conducted with virus diar­
rhea—New York Indicated that the two diseases were 
different—at least immunologically. Animals that 
had recovered from virus diarrhea—New York developed 
virus diarrhea—Indiana when challenged with that 
agent and vice versa. Recovery from virus diarrhea— 
Indiana, on the other hand, resulted in immunity to a 
subsequent challenge with the same agent." 
Tyler and Ramsey (13) reported in I965 that all calves 
initially inoculated with Sanders, Merrell, IND-46, or NADL 
agents were shown to be immune when challenged with any one of 
the other agents. 
Gillespie et al. (8) compared C24V and NY-1 strains of BVD 
viruses by direct and interference neutralization methods. In 
reciprocal cross-immunity tests, Oregon C24V immunized against 
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itself and against NI-1, and NY-1 inmiunized against itself and 
Oregon C24V. 
The relationship between a serum neutralization test and 
Immunity to viral diarrhea was examined by Robson et (41) 
to determine whether the serological test could be used as a 
substitute for direct challenge in studies of the efficacy of 
a modified live-virus vaccine. The neutralization test was 
foundT to be at least 95^ accurate and usable as a substitute 
for direct animal challenge. Coggins (42) further standard­
ized this neutralization test to a greater degree of reliabil­
ity by instituting better controls of variables. 
Gillespie et (9) reported that when the cytopatho-
genic strain of BVD virus, Oregon C24V, was compared with 2 
noncytopathogenic strains, NY-1 and IND-46, by cross-immunity 
tests in cattle and by neutralization tests, all 3 strains 
proved to be similar. Four other cytopathogenlc strains desig­
nated as "viral diarrhea" agents and 1 cytopathogenlc strain 
called a "mucosal disease" virus showed antigenic relationships 
when compared by the neutralization test. These tests were 
conducted by neutralization of log dilutions of each virus by 
a single dilution of an antl-C24V serum from a convalescent 
calf. Antigenic differences among the viruses compared were 
based on a neutralization index derived from differences 
between viral titers obtained with and without antiserum. 
Inspection of their data revealed widely varying indices (vari­
ations over approximately 3 logs) which suggests antigenic 
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differences among the 6 viruses titrated by the single anti­
serum. 
Kniazeff et (10) concluded that even though neutrali­
zation tests, conducted against the C24V virus with antisera 
from worldwide outbreaks of disease diagnosed as either viral 
diarrhea or mucosal disease, indicated an antigenic relation­
ship between the C24V, BVD virus and viral diarrhea-mucosal 
disease viruses from various parts of the world, the extent of 
this relationship was not revealed by the study. Furthermore, 
the findings did not imply that all the agents involved as 
causative factors in the viral diarrhea-mucosal disease complex 
are identical or are related. 
Dinter et (43) stated that Swedish strains of BVD 
viruses are also antigenically closely related to the American 
Strain C24V. 
Inaba et aj. (38) reported that cross-neutralization tests 
by this method showed that a noncytopathogenic virus was anti­
genically identical with the cytopathogenic Oregon CZkV strain, 
Gutekunst and Malmquist (35) compared complement-fixing 
(CP) and serum-neutralizing (SN) antibodies produced against 
cytopathogenic NADL and noncytopathogenic CG-1220 viruses. The 
CP antibody responses in calves infected respectively with 
either virus were similar; whereas, SN antibody responses indi­
cated strain specificity in reciprocal cross-neutralization 
tests. 
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Pernelius (14) compared cytopathogenic and noncytopatho-
genlc BVD viruses by SN and FA methods. Neutralization titers 
of sera against both groups were compared for both groups of 
viruses. Results of cross-reactions agreed with the results of 
immunofluorescence tests and suggested that although common 
antigens occur in the various strains of BVD viruses, distinct 
antigenic differences among strains were also present. These 
results agreed with those of Gutekunst (18) who reported a 
similar neutralization study. Kahrs (44) disagreed with these 
results. By use of qualitative virus-neutralization tests with 
Oregon C24V and NADL strains of BVD virus on sera of cattle 
before and after vaccination with a live-virus vaccine prepared 
from C24V, he found these 2 strains to be serologically identi­
cal in 240 of 242 tests. However, much lower neutralization 
titers were involved than in studies described above (14, 18). 
Other Hosts Naturally Affected by BVD 
In India, Pande and Krishnamurthy (45) and Chandrasekharan 
and Balasubramaniam (46) described an outbreak of BVD among 
buffaloes and their calves vaccinated previously against rinder­
pest. Only buffalo calves were susceptible; adult buffaloes, 
bovine calves, sheep and goats were refractory. 
In North Dakota, Richards et al. (4?) observed clinical 
symptoms resembling BVD among white-tailed deer and mule deer. 
The disease was experimentally transmitted from deer to deer, 
deer to antelope by means of infected splenic tissues, and from 
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an Infected cow to white-tailed deer, one of which died of 
typical symptoms and lesions of BVD. 
Romvary (48) diagnosed BVD among roe living in a wild 
reservation adjacent to a state cattle farm where the disease 
had previously caused severe losses among the calves. He 
reported Isolating a noncytopathogenic strain of BVD virus, 
which, when injected intravenously, elicited experimental BVD 
in a young calf. The identity of the isolant from the roe was 
confirmed serologically by neutralization of Oregon C24V BVD 
virus with paired sera from experimentally infected calves. 
Sheffy et al. (31) inoculated pigs with Oregon C24V and 
NÏ-1 strains of BVD viruses. These pigs developed an average 
antibody neutralization titer of 1:2? against BVD virus 28 days 
after Inoculation but showed no titer against EC virus. Inocu­
lation of these pigs with HC virus produced titers against EC 
and boosted the BVD neutralizing titers. Control animals given 
EC virus died. From this evidence, these authors concluded 
that BVD virus protects pigs against lethal doses of HC virus. 
Beckenhauer ^  al. (2?) protected swine against HC by 
inoculations with the C24V strain of BVD virus. The virus did 
not spread from inoculated to control swine, and upon serial 
passage in swine it eventually disappeared. 
Attempts to Adapt Bovine Viral Diarrhea Viruses 
to Hosts Other Than Bovine Animais 
In order to study pathogenesis of BVD at the cellular, 
tissue, and organ level, the use of smaller and less expensive 
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laboratory animals would provide obvious advantages over the 
use of cattle. Attempts have been made by many research groups 
to propagate causative agents of BVD in other animals. Olafson 
et al. (1) failed to produce recognizable symptoms of disease 
in mice, rabbits, guinea pigs, sheep, and 10-day-old chick 
embryos after injecting splenic material from infected calves. 
Olafson and Rickard (2) attempted cultivation of BVD virus by 
serial passages of infectious splenic material in chicken 
embryos. However, material from the chorioallantoic and amni­
otic membranes of embryonated eggs from the seventh passage 
proved to be noninfectious when inoculated into heifers. 
Jarrett (49) reported over 100 experimental transmissions 
of mucosal disease in calves by IP, IV, Intra-epithelial 
(tongue and mucous membranes of the lips) with spleen, blood, 
and feces from affected animals; this same material failed to 
infect sheep, goats, rabbits, guinea pigs, and mice (adult and 
suckling). 
Schipper et aJ. (50) were unsuccessful in their attempts 
to transmit the agent of mucosal disease to guinea pigs, 
rabbits, hamsters, white mice, white rats, young chicks, chick 
embryos, sheep, and swine; intramuscular administration of 
blood from typical cases of bovine mucosal disease into sus­
ceptible cattle produced only a mild form of disease. 
Baker et (51) attempted, but failed, to infect 
embryonated eggs, guinea pigs, pigs, dogs, cats, goats, sheep, 
and mice with the NÏ-1 strain of BVD material in the form of 
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a saline suspension of spleen from an Infected calf. These 
workers did, however, succeed in transferring this NY-1 strain 
of BVD to rabbits by 3 alternate calf-to-rabbit passages of 
splenic material, followed by 75 rabbit-to-rabbit successive 
passages. The virus became modified after serial passages in 
rabbits so that inoculation of susceptible calves in the 75th 
transfer produced a slight leukopenia and a temperature ele­
vation that lasted 1 day only. This modified virus immunized 
against fully virulent virus. 
Taylor et (19) failed to propagate the Oregon C24V 
strain of BVD after 2 successive passages in embryonated eggs; 
in suckling mice after 3 successive passages by intracranial, 
oral, or intraperitoneal routes; or after 3 serial passages in 
rat fetuses inoculated utero. Successful propagation of 
C2^V, however, was accomplished after 3 serial passages in lamb 
fetuses ^  utero. Recovery of the virus from all 3 passages 
was indicative that the virus had propagated in the latter 
experimental host. 
Growth of BVD Viruses in Non-Bovine 
Cell Cultures and in Cell Lines 
Growth or non-growth of BVD viruses in various intact 
animals has been reviewed in the previous section. Several 
researchers have Investigated the growth and propagation of 
these viruses in cell cultures of various origins. 
Shope (52) has remarked on the affinity of BVD viruses for 
cells of the reticuloendothelial system, although these viruses 
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can Induce CPE on many other primary bovine cell cultures. He 
also reported that deer endocardial cells and ovine kidney 
cells, but not ovine or porcine endocardial cells were suscep­
tible to BVD viruses. 
Madin and Darby (53) developed an established cell line 
derived from adult bovine kidney (MDBK) which has been used in 
studies of replication and plaque assay of BVD viruses (5^). 
Kalk and Hetrick (55) established 2 bovine lymph node cell 
culture lines (BLN-l and BLN-2) from lymphoid tissue of normal 
adult cattle. These cell cultures have undergone 52 and 29 
passages respectively and of 51 viruses tested, 32 produced CPE 
in these cells. Among the viruses listed as producing cyto-
pathic changes is a BVD virus, the strain not specified. 
A new cell line, EBTr, originated by trypsinization of an 
embryonal bovine trachea, was established by Kniazeff et al. 
(56) by serial subpassaglng without an attempt to maintain 
ploidy. Plaque assays of BVD virus showed that plaquing effi­
ciency was high at the 5th passage level, declined markedly at 
the 10th and 15th passage, and returned to 5th passage level in 
the 20th to 40th passage cells. These fluctuations could not 
be correlated with chromosomal or morphological cell changes. 
Diderholm and Dinter (57) propagated and titrated the C24V 
strain of BVD virus in bovine cells which had been previously 
transformed by the SV 40 virus. Transformed cell lines were 
derived from bovine embryonic lungs or subcutaneous tissue of 
calves. These cell lines proved to be more stable on passages 
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than non-transformed cells, and although the transformed cells 
still contained infectious SV 40 virus, no mutual effects were 
observed between this virus and BVD virus. 
Malmquist, Fernelius and Gutekunst (58) adapted the NADL 
strain of BVD virus to primary (PK) and a subculturable cell 
line (PK-I5 or CCL-33) of swine kidney cell cultures. The 
adaptation process was followed by comparative titrations in 
EBK and PK cultures and by immunofluorescence. The authors 
believed that the NADL virus propagated in PK or PK-I5 cells 
may have wide applications. In addition to its use as an indi­
cator for titrations of hog cholera virus in cell cultures by 
the interference method (36, 37), there was evidence that the 
virus had become so attenuated for cattle that it no longer 
produced undesirable reactions and could, therefore, be con­
sidered as a possible candidate for a live-virus vaccine. 
Heterogeneity of Immunological Systems 
Serum proteins with the electrophoretic mobility of gamma­
globulin have not only distinct physico-chemical and immuno­
logical characteristics, but are also heterogeneous according 
to criteria of size, time of formation, and type of serological 
response. In the ultracentrifuge, gamma-globulin is resolved 
into 2 classes of protein which differ in molecular size and 
are referred to as 7 S and 19 S fractions (59)• Sequential 
formation of heavy (I9 S) antibody and of light (7 S) antibody 
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in the sera of several host animals in response to a number of 
antigens has been described by a number of investigators. 
Benedict et (60) described a primary response in 
chickens immunized with bovine serum albumin to consist chiefly 
of macroglobulins (19 S), or electrophoretically fast-moving 
gamma-globulins; secondary response sera consisted mainly of 
slow-moving gamma-globulins or 7 8 globulins, Uhr and Finkel-
stein (6l) injected fix 174 bacteriophage into guinea pigs and 
observed early formation of rapidly sedimenting 19 S antibody 
molecules, and later synthesis of slowly sedimenting 7 S 
molecules. 
Bauer et al. (62) determined the sequence of synthesis of 
19 S macroglobulin and 7 S globulin antibodies in rabbits after 
immunization with T 2 phage, various proteins, erythrocytes, 
bacteria, and "0" and "H" antigens of Salmonella typhosa. The 
primary response to these antigens, with the exception of the 
"0" antigen, was the early synthesis of 19 S globulin antibody, 
and the later synthesis of 7 S globulin antibody. The primary 
response to the "0" antigen consisted of only a macroglobulin. 
Shulman et al. (63) have shown that rabbits produce 
different size antibodies according to the route of injection 
of a human serum albumin antigen; these antibodies, heavy and 
light, differ in hemagglutinating activity per unit of antigen-
binding capacity. These workers also reported a complete lack 
of precipitating antibody in gel diffusion plates with the 
heavy antibody fraction of their system. Other workers. 
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however, have reported precipitins in the 19 S fraction as 
expressed by the use of agar double-diffusion techniques 
(61, 64). 
Bauer (65) has shown that the production of heavy and light 
antibodies is not dependent upon different antigenic deter­
minants because both types of antibody can be produced in the 
same rabbit in response to a small haptenic group. 
Murphy et al. (66) showed that complement-fixing antibody 
activity was associated with bovine macroglobulin (V-IM) rather 
than with the 7 S V-globulin component of bovine serum. 
Sequential Development of Viral Antigen 
in Host Cells 
Sequential development of viral antigen in cell cultures 
as measured by immunofluorescence has been the subject of study 
in many virus-cell culture systems. Investigations on the many 
virus-cell systems are so numerous and extensive that only 
selected examples will be cited here. 
Measles virus was one of the first agents studied by an 
immunofluorescent technique. Enders (6?) reported cytoplasmic 
localization of viral antigen. Baker et al. (68) later reported 
the observation of intracytoplasmic and intranuclear inclusions 
by both immunofluorescence and electron microscopy. Happ 
et al. (69) observed early fluorescence as perinuclear, which 
later spread to the nucleus, especially to the nucleolus. 
Lebrun (70) studied the development of herpes simplex 
virus in tissue cultures, chick embryos, and mouse brains by 
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means of the fluorescent antibody (FA) technique. In cell 
cultures of human epidermoid carcinoma, viral antigen appeared 
as intranuclear granules 24 hr after Injection; 48 hr after 
injection, nuclear staining decreased and granular cytoplasmic 
staining appeared, the reverse of the order of appearance of 
fluorescence reported for measles virus. 
Sokolov and Parfanovich (71) reported fluorescing specific 
rabies virus antigen in the nucleoli and on the nuclear mem­
brane of sheep embryo kidney cells 24 hr after inoculation, in 
nuclei as granular agglomerates and cytoplasmic inclusions 
after 48 hr, and as homogeneous specific fluorescence of the 
whole cytoplasm in a majority of cells after 5 days. 
Pope and Rowe (72) detected nuclear fluorescence in each 
of 5 mammalian cell lines transformed by SV 40 virus. Their 
FA system consisted of fluorescein-labeled serum from hamsters 
with SV 40 tumors. Other workers (73) studying the SV 40 virus 
reported that fluorescing antigen appeared in the nucleus of 
cell cultures at 18 hr, reached a peak at 38 hr, after which 
nuclear antigen decreased and a cytoplasmic fluorescing stage 
occurred. Nuclear fluorescence was also reported in cells from 
monkey kidney, human embryo kidney, and hamster kidney cells by 
Levinthal and Shein (74). 
Reda, Rott, and Schafer (75) used FA techniques to differ­
entiate between the G antigen and the HA antigen of Newcastle 
disease (ND) virus. After staining with G-antigen antibody in 
chick or KB cells, distinct fluorescing foci were observed 
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around the nucleus at about 3 hr after inoculation. These foci 
Increased In size and brightness, sometimes forming a "corona" 
or "halo" around the nucleus. The HA antigen was always more 
uniformly distributed over the cytoplasm In all cell systems 
examined and became detectable by the FA technique shortly 
after the G antigen had appeared. 
The mode of intracellular development of equine rhino-
pneumonltis virus, a DNA-containing herpesvirus, was studied 
by Ishizaki et al. (76) by a FA technique to elucidate the 
sequential development of viral (V) antigen and soluble (S) 
antigen. During the latent period, S antigen was first detected 
and developed exclusively in the nucleus, whereas, V antigen 
appeared in the cytoplasm with increase in intracellular infec-
tivity. As viral multiplication proceeded, the whole cell was 
filled with both antigens, followed by the disappearance of 
antigenic materials from the cells except at the terminal stage 
of Infection. 
By an immunofluorescent method, ND virus S and V antigens 
were shown by Zhdanov et al. (77) to be synthesized in the 
cytoplasm of cell cultures. In some instances, S antigen was 
also found in the nucleoli of cultured cells. 
Solorzano (78) reported in I963 that the viral antigens of 
hog cholera first appeared in the nuclei of infected tissue 
culture cells and later was present in the whole cell. Stair 
et al. (79) stated that fluorescence must be found in the cyto­
plasm or nucleus of individual cells, taken from Infected 
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swine, to be a valid indicator of HC viral antigen. Also, in 
discussing immunofluorescent microscopy as a tool to diagnose 
HC, Sirbu et al. (80) observed fluorescence mainly in the cyto­
plasm and sometimes in the nucleus of occasional cells from 
lymph node impressions, 60 hr after experimental infection. 
Some groups have reported cytoplasmic fluorescence in HC-
infected cells with no mention of nuclear fluorescence (34, 81). 
Mengeling et aJ. (82) and Carbrey et al. (83) have reported 
only cytoplasmic staining of HC virus-infected cells. Neither 
group observed nuclear staining. 
Solorzano (78) who first reported both nuclear and cyto­
plasmic fluorescent staining of HC virus-infected cells, 
reversed his opinion in a later report (84), by stating that a 
positive reaction of HC virus, in a PA diagnostic test employ­
ing the PK-15 cell line, consists of bright cytoplasmic fluo­
rescence sharply contrasting with uninfected cells in the 
monolayer. Also, it was reported that the NADL or C24V strains 
of BVD viruses when Inoculated into the PK-15 cell system and 
examined by the FA test did not yield positive tests, whereas 
bovine kidney primary cell cultures similarly treated were 
positive. When the NADL strain was adapted to the PK-15 cell 
line by Malmqulst ejt al. (58), specific fluorescence was 
observed. 
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Fluorescent Antibody Tracing of Viral Infections 
in Tissues of Infected Animals 
Immunofluorescent tracing of viral infections of cells and 
tissues in affected animals has proved to be a powerful tool 
for detecting and identifying sites of infection within the 
Infected animal, Maestrone and Coffin {85) detected ND virus 
in sections and smears of experimentally infected embryonating 
eggs and chicks by means of a FA procedure. Viral antigen was 
detected in epithelial cells of the larynx and vascular walls 
4 days before visible signs of illness in chicks appeared and 
2 days before viremia through egg inoculation could be demon­
strated, 
Hobbs and Mascoli (86) demonstrated reovirus Infection in 
lungs of mice devoid of clinical illness by means of FA stain­
ing of frozen sections of mouse lungs. 
Baratawidjaja et al. (87) showed that during the stage of 
viremia, viral antigen was demonstrable by means of immunofluo­
rescence in the leukocytes of peripheral blood of experimental 
animals infected with vaccinia, lymphocytic choriomeningitis 
and rabies viruses. 
Gratzek et ad. (88) employed a FA antibody-tracing tech­
nique to reconstruct a scheme of pathogenesis of infectious 
bovine rhinotracheitis virus in calves. The portal of entry 
and initial site of virus replication was the tonsil; later, 
the distribution of viral antigen was widespread throughout the 
animal with a tendency to accumulate in lymphoid—tissues. 
28 
Several workers have used the technique of double-staining 
by PA followed by chromatic dyes on identical areas of tissue 
sections of virus-infected animals. Among such studies is one 
by Vainio et al. (89) who used this procedure to show that the 
in vitro distribution of the VS virus in fetal mouse kidney 
closely corresponds with that of the histologically observed 
viral lesions. 
Porter et al, (90), in studies on Aleutian disease of 
mink, used a combination of FA and hemotoxylin and eosin stains 
to show that areas of fibrinoid necrosis of arteries corres­
ponded closely with areas which stained with fluorescent anti-
mink gamma-globulin. 
Woods et ad. (91) demonstrated specific viral antigen in 
the cytoplasm of tissue culture cells by an indirect FA test. 
They employed the same reagents to demonstrate discrete foci 
of fluorescent cells in heart and skeletal muscle of an infant 
which died from a rubella infection. 
Soluble Antigen in Virus-Cell Systems 
The "soluble" antigen (SA) of influenza viruses was first 
so designated in 1937 by Hoyle and Fairbrother (92). Lennette 
and Horsfall (93) reported this SA to be 10 mp in size, and 
develops in the body only after infection. It is valuable in 
complement-fixation (CF) tests in diagnostic work, as it 
specifically identifies the type of virus involved in an infec­
tion. 
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In 1947, Henle aJ. (94) described 2 complement-fixing 
antigens in mumps virus: soluble (S) antigen and viral (V) 
antigen. The S antigen was smaller than the virus particle and 
was found in tissue where the virus was actively multiplying, 
whereas the V antigen was a property of the virus particle 
itself, Cuadrado (95) tested mumps immune sera by a modified 
agar gel diffusion method against concentrated soluble and 
viral antigens, and showed a reaction only against the soluble 
antigen. 
Neurath (96) characterized soluble antigens from cells 
infected with rabies virus, but failed to determine whether the 
soluble antigens have different or identical antigenic sites, 
whether and how they are related to the complete virion, and 
whether they are precursors or subunits synthesized in excess, 
or breakdown products of the virus. 
Wilcox and Ginsberg (97) added proflavine at different 
times during the growth cycle of type 5 adenovirus in HeLa 
cells. Viral synthesis could be suppressed early, but soluble 
antigen synthesis was less sensitive to this chemical, indi­
cating that synthesis of soluble antigens began prior to the 
first appearance of newly synthesized virus. This observation 
is compatible with the hypothesis that the soluble antigens may 
represent virus subunits or precursor materials. Easel et al. 
(98) used pooled SA preparations from adenovirus types 1, 2, 
and 4 to immunize human volunteers against adenovirus infection. 
These workers showed that it is possible to induce homotypic 
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and heterotypic neutralizing antibody in man by utilization of 
selected and partially purified noninfectious adenovirus sol­
uble antigens. Norby (99) purified the soluble antigens of 
adenovirus, type 3. by zone centrifugation. The particles 
carrying group-specific CF antigen activity had a sedimentation 
constant of 13 S. Their ultrastructure was tubular with a 
length of 70-80 A, an inner diameter of 20-30 A, and an outer 
diameter of 80-90 A. 
Gutekunst and Malmquist (100) described a method of pre­
paring SA from BVD-infected cells. They showed that this 
antigen formed precipitin lines in agar double diffusion 
systems employing both BVD and EC antisera. These same workers 
(35) used these SA preparations to follow production of neu­
tralizing and CF antibodies in BVD-infected calves. In a 
characterization study of BVD soluble antigens, Gutekunst and 
Malmquist (101) showed that SA was detectable in infected cell 
cultures by a CF test prior to the appearance of infectious 
virus, but the release of infective virus into the extracellu­
lar fluid was concomitant with the release of SA. Evidence was 
presented that SA associated with BVD virus was present intra-
cellularly at 3 hr postinoculâtion. A decline in intracellular 
SA after 12 hr, with a concomitant rise in cell-associated 
virus suggested that some SA was incorporated into mature virus. 
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MATERIALS AND METHODS 
BVD Viruses Used 
NADL strain 
The cytopathogenic strain NADL was isolated in January 
1962 by Gutekunst and Malmquist (100) from a clinical case of 
BVD occurring in the National Animal Disease Laboratory 
Holstein-Friesian herd. This strain was characterized by 
Gutekunst (18), and has been maintained at -75 C since its 
isolation as original infected tissues and as various passages 
in EBK cells. Various EBK cell passages were used for differ­
ent experiments in this work and are so designated when the 
passage number is pertinent to the experiment. 
C24V strain 
The cytopathogenic strain, C24V, which produces a dis­
tinctive type of vacuolization in susceptible EBK cells, and 
which was isolated by Gillespie et al. (8) from Oregon cattle, 
was supplied in I96I by Kniazeff, University of Florida, as a 
9th EBK passage and has been also maintained at -75 C and 
passaged as needed. 
CG-1220 strain 
A noncytopathogenic BVD virus, CG-1220, isolated from 
Iowa cattle in April I962 by Gutekunst and Malmquist (35) was 
used as the type-strain of noncytopathogenic virus. Original 
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Infectious buffy coats, autopsy material and various EBK pas­
sages of this virus have been stored at -75 C and cultured as 
needed, 
Sanders strain (SAN) 
The Sanders noncytopathogenic BVD agent which was origi­
nally isolated in Iowa from cattle with mucosal disease (102) 
was obtained in frozen whole defibrinated blood from Tyler 
(13), Department of Veterinary Pathology, Iowa State Univer­
sity. This BVD virus had to be passaged 8 times in EBK cells 
before an appreciable titer could be attained (14). 
West Virginia strain (WV-313) 
A noncytopathogenic BVD virus was isolated in November 
1966 by Lambert and Fernelius (unpublished report) at the 
National Animal Disease Laboratory from a blood sample from a 
cow which died from BVD in the dairy herd of the West Virginia 
University. This agent was maintained at -75 C as a 4th EBK 
cell passaged virus. 
Merrell strain (MER) 
The noncytopathogenic strain of BVD virus designated as 
the Merrell agent was Isolated in Indiana from a heifer 
affected with mucosal disease. This strain was procured from 
Gillette of the Department of Microbiology and Public Health, 
Purdue University in frozen whole defibrinated blood. This 
strain, as with the Sanders agent, had to be passaged in EBK 
cells several times before suitable titers were obtained (14). 
Indiana strain (IND-46) 
The IND-46 strain of noncytopathogenic BVD virus was iso­
lated in Indiana by Pritchard et al. (39) from a severe case of 
viral diarrhea occurring in a herd of shorthorn cattle. This 
agent was obtained in frozen whole defibrinated blood from 
Tyler, Department of Veterinary Pathology, Iowa State Univer­
sity, and was passaged 8 times in EBK cells to build up a 
suitable viral titer (14). 
New York strain (NY-1) 
The NY-1 strain of BVD virus, a noncytopathogenic virus, 
was isolated from the spleen of a young heifer in June 1948 by 
Baker e_t (51) • Samples of this virus were obtained from 
Gillette of Purdue University in frozen defibrinated bovine 
blood. Eight passages in EBK cells were necessary for obtain­
ing suitable titers of virus from these materials. 
In Vitro Host Cell Systems 
Primary EBK cells 
The chief cell culture system used throughout these 
studies was that derived from primary embryonic bovine kidneys 
(EBK). These cell cultures were provided by the National 
Animal Disease Laboratory's Central Research Services. Depend­
ing upon the type of experiment, cells were furnished as 
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monolayer cultures in racks of roller tubes, Leighton tubes 
containing coverslips, or in liter Blake bottles upon request. 
The general method of preparation of cell cultures was that of 
Younger (103) employing overnight trypsinization of cortical 
tissue from 6-9 month embryonic bovine kidneys. 
Initial growth medium for EBK cells consisted of Hanks' 
balanced salt solution (HBSS) containing 0.5^ lactalbumin 
hydrolyzate (LAH), 10% SPF calf serum (BVD-negative) plus 100 
units of penicillin and 0.1 mg of streptomycin per ml. After 
3 days at 37 C, the HBSS medium was decanted and changed to 
Earle's balanced salt solution (EBSS) containing 0,5% LAH, 10% 
SPF, calf serum and antibiotics. After another 3 days, main­
tenance medium was added to replace the 1st change of EBSS. 
This medium consisted of EBSS containing 0,5% LAH, 5% SPF calf 
serum, penicillin and streptomycin as above and 0.05 mg of 
kanamycln per ml to control possible contamination with myco­
plasma. 
PK-15 cell line 
An established porcine kidney cell line, PK-15 (54)^ sup­
plied by Cutter Laboratories, Berkeley, California, was employed 
for certain phases of this viral agent-host cell study. Cell 
cultures were prepared from serially passed stock by removing 
cell monolayers by a mixture consisting of equal parts of 0.2% 
^The PK-15 cell line has been also designated CCL 33 by 
the American Type Culture Collection (ATCC) Committee. 
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EDTA (Versene) and 0.25^ (1:300 activity) trypsin. Cultures 
were usually split 1—^k, i.e., cells from 1 monolayer culture 
were divided and dispensed into 4 cultures in the appropriate 
container. 
Growth media and conditions for PK-15 cells were essen­
tially the same as those described for the EBK cell system, 
except that growth times required for monolayer formation were 
shortened by 1/3 to 1/2. 
HaK^ cell line 
The HaK cell line was isolated from kidneys of 2 normal 
young adult male Syrian hamsters (5^). A 99th passage of this 
cell line was obtained from the ÀTCC. Cell cultures were 
divided 1—4 after trypsinization. 
Growth medium for HaK cells consisted of Eagle's minimal 
essential medium (MEM) made with HBSS, MEM-non-essential amino 
acid solution, glutamine, and 10% SPF calf serum. 
ERK-1 cell line 
2 The ERK-1 cell line originally emerged from a primary 
embryonic rabbit kidney culture (104) but was apparently con­
taminated with unidentified established human cells, possibly 
HeLa. By means of species-specific hemagglutination method, 
^The ATCC designation is COL 15. 
^ERK-1 cell line supplied as cell line #5850 by Difco 
Laboratories, Detroit, Michigan. 
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it was characterized as a pure human cell strain by Brand and 
Syverton (105). This cell line was presumed to be of rabbit 
origin when ordered, and even though it is a human cell line, 
it will be called ERK-1 in this dissertation. Cells were trans­
ferred 1—>-4 by trypsinization as described for PK-15 and HaK 
cells. 
The growth medium for ERK-1 cells consisted of EBSS, 0.5% 
LAH, and 10% SPF calf serum, 
LLC-RKi cell line 
The 212th passage of a strain of rabbit kidney cells, 
1 
LLC-RKj^ reported by Hull et al. (106) to have been carried in 
serial passage for 5 years was received from Dr. Hull, the 
Lilly Research Laboratories, Eli Lilly and Company, Indian­
apolis. Cell cultures were passaged 1—>-3 by trypsinization 
as described above. 
Cell culture medium consisted of mixture 199 with 1.12 g 
of NaHCO^/l and 5% horse serum. 
Assay Procedures 
Virus detection and measurement 
The presence of cytopathogenic viruses was determined by 
production of CPE in susceptible cells. Some of the viruses 
used in this study produced their own characteristic CPE and 
were easily detected by this means. 
^Presently available as cell strain TC-046 from Industrial 
Biological Laboratories, Rockville, Maryland. 
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Noncytopathogenic viruses were detected either by means of 
interference with the production of CPE by an indicator virus 
(35) or were detected by an immunofluorescence test employing 
fluorescein isothiocyanate-conjugated specific sera (14). 
Cytopathogenic viruses were quantitated by titrations of 
infectivity in susceptible cells by 10-fold serial dilutions in 
cold EBSS, then 0.2 ml of each dilution inoculated into each of 
4 cell monolayer cultures. 
These cultures were then incubated at 37 C and observed 
for the appearance of CPE. In certain screening tests, only a 
single EBK culture tube was inoculated per dilution of virus. 
Noncytopathogenic viruses were titrated by the interfer­
ence method consisting of a 72-hr incubation time of cultures 
prepared as above, followed by challenge with approximately 10^ 
CCID^q (cell culture Infective dose) of a cytopathogenic indi­
cator virus (NADL). Titration results were read in reverse of 
those obtained with cytopathogenic viruses, i.e., the absence 
of CPE with the indicator virus means that the noncytopatho­
genic virus is present. When multiple cultures per dilution 
were used to titrate a virus preparation, 50^ neutralization 
endpoints were calculated by the method of Reed and Muench 
(107). 
Adaptation of BVD Viruses to Cell Lines 
The NADL strain of BVD virus has been successfully adapted 
to the PK-15 cell line and to primary swine kidney cells (58), 
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so it may be possible to adapt the BVD viruses to cells other 
than bovine. 
One approach to adaptation of BVD viruses to laboratory 
animals is to first adapt the virus to cell cultures, lines and 
primary cells, derived from the homologous host to which the 
virus is to be adapted. 
Blind passages 
Cell lines HaK, ERK-1 and LLC-RKj_ were cultured in Leigh-
ton tubes (LT) containing coverslips in the appropriate culture 
media. Each of the cell lines was also carried in milk dilu­
tion bottle cultures so that cultures would be available to 
supply LT cultures continuously as passages of viruses pro­
gressed. When monolayers were formed on the coverslips, the 
growth medium was decanted and 0,2 ml of virus was placed 
directly on the coverslip and allowed to adsorb to the cells 
for 1 hour at 37 C. Fresh medium, in the amount of 1.2 ml per 
tube, was then added to inoculated cultures and incubation at 
37 C continued for 96 hr. Half of the LT cultures of each cell 
line was inoculated with the NADL strain of BVD virus which had 
been previously passaged 8 times in EBK cells followed by 23 
passages in PK-15 cells (58). This PK-I5 cell-adapted virus 
will '^e designated NADL-fK23 « The other half of the LT cultures 
was Inoculated with a 9th EBK passage of the Oregon C24V virus. 
The supernatant fluids were decanted at 48 and 96 hr and saved 
for future titrations for infectious virus. Coverslips were 
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acetone-fixed and saved for future observations after staining 
with specific BVD antiserum conjugates by a procedure previ­
ously described (34, 14). Both BVD viruses were passaged 10 
times in HaK and ERK-1 cell lines, and 5 times in the LK:-R% 
cell line. 
Attempts to establish infection by blind passages of 
these 2 BVD viruses in the 3 cell lines were unsuccessful, so a 
technique of cycling the viruses in non-susceptible and suscep­
tible cells was attempted. 
A 9th EBK-passaged C24V virus was serially passaged in 
PK-15 cells in an attempt to adapt this strain to the PK-15 
cell line as was earlier accomplished with the NADL strain (58). 
The same adaptation procedure was followed as described under 
"blind passages" except that assays for the presence of virus 
were made after each passage by both an FA method and a viral 
titration method employing both EBK and PK-I5 cell culture 
systems. This precaution was taken to detect any "inapparent" 
infection of cells in the event that no CPE were present. 
Employing dual cell assay systems both for titration of virus 
as expressed by CPE or by specific fluorescence was a precau­
tion that greatly contributed to knowledge of virus-cell 
interactions. 
Cyclic passages 
Because Baker and co-workers (51) had successfully 
adapted the NY-1 strain of BVD virus to rabbits by alternate 
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calf-to-rabbit passages, it seemed reasonable that similar 
cycles of passages of BVD viruses in susceptible and nonsuscep-
tible cells might also result in adaptation of BVD viruses to 
nonsusceptible cells. Cyclic passages of C24V and NADL viruses 
in ERK-1 and HaK cell lines were alternated with passages in 
susceptible cells, PK-I5 cells for NADL virus, and EBK cells 
for C24V virus. Briefly, the methods employed were to inocu­
late viral preparations consisting of supernatant culture fluid 
into cultures of cells having reached the monolayer stage. All 
cultures were prepared in Leighton tubes containing coverslips 
so that they could serve a dual purpose: that of providing the 
inoculum for the next passage and that of providing cells to 
stain by the FA or by a May-Griinwald-Giemsa (MGG) stain for any 
observable CPE. Fluids from cultures were harvested and 
assayed for viruses at approximately 72 hr and coverslip cul­
tures were fixed and stained by the appropriate method. 
In Vivo Host Cell Systems 
Bovine hosts 
The cattle employed in this work consisted of a wide 
variety of kinds and ages. Most were of the Holstein-Friesian 
breed, and many were produced under SPF conditions. Ages 
ranged from newborn calves to cattle several years of age, 
depending upon the type of agent-host interaction being investi­
gated. Some of the cattle were used cooperatively by the author 
and by Gutekunst and Malmquist to study different aspects of 
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BVD. Animals and treatments have been described by Gutelamst 
(18) and by Gutekunst and Malmquist (35)• Other cattle were 
those studied cooperatively by Lambert (108) and by Lambert and 
Fernelius (109). In the latter cooperative work, cattle were 
infected with BVD viruses by various routes and by varying 
doses, depending upon the nature and purpose of the experiment. 
Eight calves were given BVD virus on the day of birth, 1 was 
exposed on the 2nd day of life, and 2 were exposed when they 
were approximately 1 1/2 years of age. One 1 1/2-year-old bull 
and two 6-week-old calves were autopsied and their tissues 
processed as controls. 
At necropsy, blocks of tissue were removed from selected 
tissues and organs and processed as follows: smear impressions 
were made on 4 No. 1 coverslips; 2 coverslips were fixed in 
absolute acetone at -60 C for FA staining, and 2 were stained 
by the MGG method. Portions of each tissue were minced finely 
with scalpel or scissors, then ground in EBSS with sterile sand 
and a mortar and pestle. After tissue fragments had settled, 
the fluid portion was clarified by centrifugation or filtration 
and aliquots assayed for BVD virus by the prescribed method. 
In order to determine areas of infectivity by BVD viruses, 
certain tissues and organs which were positive by the PA smear 
impression test from 3 animals dying from BVD were frozen and 
sectioned with a cryostat microtome. A useful technique 
employed to study these tissue sections was to observe the 
identical area stained by both FA and MGG. This was 
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accomplished by first FA staining, photographing a certain area 
of a tissue, floating off the coverslip from the slide, restain-
ing the tissue by the MGG method, locating the same area by 
means of the microscope stage verniers, then re-photographing 
the area by light microscopy. 
Tissue sections stained with PA were also studied by phase 
fluorescence which will be described in a subsequent section. 
Bovine hosts were also used to produce anti-BVD sera to 
further study agent and host interactions. 
Rabbit hosts 
New Zealand White brood does were supplied by the Animal 
Services unit of NADL and bred so that 2 does would kindle at 
weekly intervals and neonatal rabbits would be available for 
BVD virus adaptation studies at periodic intervals. After 
parturition and a 3 to 4 week recovery period, the does were 
also utilized for rabbit passages of BVD viruses. Also, 6 
non-pregnant rabbits were used for viral passages. 
Passage of BVD viruses in neonatal and adult rabbits 
Attempts were made to propagate BVD viruses in neonatal 
(0 to 9-day-old) rabbits. 
Group #1 consisting of 6 rabbits was divided into 3 pairs 
and injected IP on the day of birth with 1 ml of the following 
viruses: (a) NADL (3rd passage in EBK cells, concentrated 
approximately 10-fold), (b) E-N-VIII virus (NADL-PK22 virus 
cycled 8 times in ERK-1 and PK-I5 cells), or with (c) E-C-VIII 
43 
(C24V virus cycled 8 times in ERK-1 and EBK cells). These neo­
natal rabbits were killed after 48 hr rather than at the end of 
the planned 5 days because they were abandoned by their mother. 
Blood, spleen, liver and intestinal tissues were removed and 
stored at -75 C. 
Group #2 consisting of 4 rabbits was injected IP on the 
2nd day of life with 1 ml each of; (a) NADL concentrate, 
(b) E-N-VIII, (c) E-C-VIII, or with (d) a 9th EBK-passaged C24V 
strain of BVD virus. These rabbits were killed at the end of 
5 days; tissues were removed and stored at -75 C. 
Group #3 consisting of 3 rabbits was injected IP at the 
age of 3 days with macerated thawed splenic material from the 
3 subgroups a, b and c of Group #1. 
Group #4 consisting of 4 rabbits was injected IP at the 
age of 2 days with 1 ml of splenic homogenate from each of the 
subgroups described in Group #2. 
Rabbits from Groups 3 &nd 4 were killed by ether after 5 
days and blood, spleen, liver, and intestinal tissues removed 
and stored at -75 G. At this point, all tissues from Groups 1, 
2, 3 and 4 were individually processed by thawing and making 
smear impressions on coverslips; 1 ml of blood was diluted with 
5 ml of HBSS; approximately 1 g of spleen, liver, and intesti­
nal tissue was macerated with sterile sand in 5 ml of HBSS, and 
EBK cell cultures were inoculated with these tissue suspensions. 
Tissue impression smears were stained with MGG stain and dupli­
cate smears were fixed with acetone for later FA observations. 
4-4 
At this time, the decision was made to discontinue "blind" 
passages of BVD viruses in neonatal rabbits and to attempt 
adaptation by cyclic passages from rabbit to cell culture to 
rabbit, etc. in a manner similar to that employed to adapt NADL 
and C24V viruses to HaK and EEK-1 cell cultures (reported 
above). 
Because Lambert (108) successfully Infected calves with 
the NADL strain of BVD virus by the oral route, the decision 
was made to try this method on rabbits. Seven 1-day-old rab­
bits from Group #5 were given orally, 1 ml each of virus 
preparations: (a) NADL concentrate, (b) C24V, (c) E-N-X (a 
10th cycled NADL-PK23 virus in EEK-1 and PK-I5 cells), (d) E-C-X 
(a 10th cycled C24V virus in EfiK-1 and EBK cells), (e) CG-1220 
(5th EBK passage), or (f) Sanders (3rd EBK passage). During a 
3 day observation period there were no signs of clinical BVD in 
any rabbit. They were autopsied and tissues cultured in EBK 
cells for virus, examined for cytopathology and for the pres­
ence of viral-induced antigen stainable by the PA method; the 
latter procedure is especially valuable to detect the presence 
of the noneytopathogenie viruses, CG-1220 and Sanders. To 
detect infected EBK_cells from rabbit-passaged viruses, it was 
sometimes necessary to subculture fluid from the cells through 
2 or 3 passages. 
At this stage, groups 6-9 either did not materialize 
because of non-pregnant does, or the newborn rabbits were eaten 
or abandoned by the mother. After an intermediate passage of 
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the viral cultures from Group #5 in EBK cells, six ^-day-old 
rabbits from Group #10 were orally inoculated with 1 ml of each 
virus. 
Group #11 consisted of only 2 rabbits so only the NADL and 
C24V cultures from rabbits 10a and 10b were inoculated into 
rabbits 11a and lib when they were 9 days old. 
No more pregnant does were available at this stage, so the 
adult does were used at this point to further propagate BVD 
viruses in rabbits. Some rabbits did not propagate viruses, so 
certain passages were terminated. All passages in adult rab­
bits consisted of cycling BVD viruses through EBK cell cultures, 
to rabbits, to cultures, etc. 
Guinea pig hosts 
Twelve 200-250 g guinea pigs were obtained from the Animal 
Services unit of NADL for the purpose of testing BVD agent-
guinea pig host cell interactions. 
Approximately 10^*^ CCID^q of a 3rd EBK-passaged NADL 
culture was given orally or intraperitoneally to each of 2 
groups of 4 guinea pigs. One animal from each group was sac­
rificed at 2, 4, 8 and l6 days. Each of the remaining 4 guinea 
pigs were given orally, 2 ml of a 5th EBK passage of 1 of the 
BVD viruses recovered from 4 different rabbits. Three of these 
viruses originated from the NADL strain and 1 from the C24V 
strain. These guinea pigs were sacrificed at k days PI. 
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No gross lesions or signs of disease were seen in any of 
the sacrificed guinea pigs at necropsy. Nevertheless, blood, 
spleen, liver, and intestinal samples were removed, ground in a 
mortar with sterile sand, and cultured for the presence of BVD 
virus in the same manner described for bovine and rabbit 
tissues. Smear impressions were stained and examined by the FA 
technique for evidence of BVD viral infection. 
Serological and Immunological Systems 
Serological and immunological methods such as neutraliza­
tion, precipitation and FA tests are useful tools to evaluate 
properties and possible modifications of strains of BVD viruses 
before and after cell or animal passages. Changes which are 
vital to the study of certain virus-cell interactions can be 
detected by means of these tests. 
Production of bovine anti-BVD sera 
A male calf (#5501) from a cow that was serologically 
negative for BVD antibodies was collected by the modified SPF 
technique described by Lambert (108). This calf was held in 
the NADL SPF unit until it was 5 months of age and was then 
transferred to the isolation unit of the Enteric Diseases of 
Cattle Project. Two days later, 15 ml of NADL strain of BVD 
containing approximately 10^ CCID^q administered orally. 
After a period of 6 weeks, a hyper-immunizing dose of 10 ml of 
the same concentration of NADL virus was injected intravenously. 
Neutralization titers were performed at weekly intervals and 
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and large amounts of serum were harvested from this animal when 
the titers reached levels greater than 1:5000. Several har­
vests of antisera were made from this animal up to 26 weeks PI, 
at which time a heterologous booster was given consisting of 
10 ml of a 2nd EBK-passaged C24V virus containing approximately 
106.8 cciD^o per ml. Following this heterologous booster, 
bleedings for serum were made at 30 and 33 weeks from the time 
of the original injection of NADL virus. 
A second male SPF calf (#5506) similarly obtained from a 
serologically negative dam was held in the SPF unit until 5 
months of age, then held in isolation in the Enteric Diseases 
of Cattle barn until 7 months of age, at which time it was 
given, intravenously, 10 ml of a 9th EBK-passaged C24V strain 
of BVD virus containing approximately 10^*-5 CCID^q per ml. 
After a period of 5 weeks, a hyperimmunizing dose, consisting 
of a 2nd EBK-passaged C24V virus containing approximately 
106.8 cciD^o per ml, was administered intravenously. Large 
quantities of high titered anti-C24V serum were harvested from 
this, animal during the next 10 weeks, at which time a heterolo­
gous booster of 10 ml of a 3rd EBK-passaged NADL virus contain­
ing 10? CCID^o per ml was given intravenously. Serum harvests 
were made at I6 and 24 weeks from the time of the original 
injection of C24V virus. 
A female SPF yearling calf (#5400) which was serologically 
negative for BVD antibodies was injected intravenously with 
10 ml of a 9th EBK-passaged CG-1220 strain of virus. The viral 
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titer of the inoculum as determined by the interference titra­
tion method was approximately 10-5"3 CCID^q per ml. Several 
liters of serum were collected at 3 weeks PI at which time, an 
intravenous booster injection was given. Large quantities of 
serum were also harvested at 10 weeks PI. 
A 2nd SPF yearling heifer (#5^09) was injected intrave­
nously with 10 ml of the Sanders strain of virus containing 
approximately 10^*^ CCID^q P^r ml as titrated by the interfer­
ence method. A similar booster Injection wa-s-given at 3 weeks, 
and serum harvests made at the same intervals as those given 
for animal #5^00 above. 
A small amount of serum was obtained from a Holstein cow 
(#205) which aborted at 5 1/2 months of pregnancy during an 
outbreak of BVD at West Virginia University. This anti-BVD 
serum was used in a limited number of cross-neutralization 
tests with known strains of BVD virus, and the WV-313 virus was 
tested against antisera from cattle immunized against known and 
identifiable strains of BVD viruses. 
Cross-neutralization tests with 
bovine anti-BVD sera 
Cross-neutralization tests were used to evaluate antigenic 
similarities or dissimilarities among the several strains of 
BVD viruses. The constant virus-varying serum method was 
employed in these tests. Sera were heat inactivated in a 56 C 
water bath for 30 min, then 2-fold or 4-fold dilutions of each 
serum were prepared in EBSS. After an equal volume of virus 
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(approximately 100 CCID^q per ml) was added, the virus-serum 
mixture was shaken by hand for 30 sec, then incubated at 37 C 
for 1 hr. Roller tube cultures of EBK cells were inoculated 
with 0.2 ml of the serum-virus mixture and endpoints were deter­
mined by the production of CPE after 4-7 days at 37 C. For 
screening tests, a single tube was employed, but for more 
definitive titrations, 4 or 5 cultures per dilution were used. 
Cross-neutralization tests employing noncytopathogenic viruses 
were conducted by the procedure Just described except that 
after 72 hr of incubation at 37 C, the fluid from each tube was 
removed. The cell layer was rinsed with 2 changes of EBSS then 
1 ml of EBSS containing approximately 10^ CCID^q of the chal­
lenge or indicator cytopathogenic NADL virus was added to each 
tube. If the noncytopathogenic virus is neutralized by the 
antiserum, the challenge virus produces CPE in the susceptible 
cells. If, on the other hand, the noncytopathogenic virus is 
not neutralized by the antiserum, the challenge virus produces 
CPE in that monolayer. These results are opposite from 
neutralizations of cytopathogenic viruses where excess serum 
neutralizes all the virus and no CPE is produced in higher con­
centrations of antiserum. As with viral titrations, neutrali­
zation titers for tests employing multiple roller tube cultures 
per dilution, the Heed and Muench (107) method of ^0% endpoints 
was used. 
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Agar double diffusion precipitin tests 
Precipitating antibodies in bovine and rabbit antisera 
were studied by reactions with homologous and heterologous 
soluble antigens (SA) derived from various BVD strains. Agar 
double diffusion tests employed were patterned after the method 
of Ouchterlony (110) and improved for contrast by the agar gel 
staining method of Glazier and Fernelius (ill). Soluble anti­
gens were produced from BVD viruses grown in cell cultures by 
a modification of the method described by Gutekunst and 
Malmqulst (101). 
A 1.5^ agar medium was prepared from 1,5 g of Difco Noble 
Agar in 50 ml of 0.15 ^ NaCl, 35 ml of 0.15 M Na2HP0ij., and 
15 ml of 0.15 M KH2P0i,,. After melting and cooling, 0.01^ Mer-
thlolate was added and 6 ml pipetted into 50 mm Petri dishes 
and allowed to gel. Six satellite wells surrounding a central 
well were cut with a #1 cork borer; wells were approximately 
3.5 mm in diameter and 2.5 mm apart. Four drops from a #26 
needle on a tuberculin syringe filled the wells to the desired 
depth with antiserum, or antigen. Agar plates containing 
antigen and antibody were incubated at room temperature, and 
the resulting lines of precipitation photographed at 24 to 72 
hr depending upon the optimal precipitation time for the test 
system. 
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Production of anti-cell and 
antl-BVD viral sera in rabbits 
Twelve New Zealand white male rabbits were used to pro­
duce anti-cell sera for virus-cell interaction studies. 
Because the BVD virus is an enveloped virus and since this 
envelope may be of host-cell origin, the following experiment 
was designed to test the effect of anti-cell sera on the BVD 
virus. Rabbits were injected IV with 0.5 ml of 1 of 4 cell 
antigen preparations on day 1; with 1,0 ml on days 4, 6, 13; 
after a 1^-day rest, rabbits were bled for early test sera and 
were given a 1,0 ml booster of the same antigens. At the end 
of 43 days all rabbits were exsanguinated. Cellular antigens 
given to groups of 3 rabbits each were: I. intact EBK cells, 
II. EBK cells freeze-thaw-treated 3 times, then sonicated for 
10 min in an ice bath, III, intact PK-I5 cells, and IV. PK-I5 
cells freeze-thaw-treated and sonicated as above. Rabbit anti-
sera were pooled according to treatments and used in neutrali­
zation tests with BVD viruses cultured in EBK or in PK-I5 cells. 
Anti-cell sera produced in rabbits were also tested for 
their ability to neutralize the following viruses grown in both 
EBK and PK-I5 cells; IBR, VSV, and vaccinia. Neutralization 
tests were also conducted with these anti-cell sera and 3 
bovine enteroviruses, obtained from Van Der Maaten (112). 
A hemagglutination inhibition test employing parainflu-
enza-3 (strain SF-4) was set up against the rabbit anti-cell 
sera to determine any possible antigenic relationship of 
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the anti-cell sera with the HA antigens on the surface of this 
myxovirus. 
In addition to production of anti-cell sera in rabbits, 
sera against several strains of BVD viruses were produced in 
rabbits by an immunization schedule identical with that used to 
produce the anti-cell sera. These rabbit sera were used in 
cross-neutralization, cross-precipitation, and in FA tests as 
controls on the anti-cell systems. 
Immunofluorescence as a tool to 
study virus-cell culture, virus-bovine, 
virus-rabbit, and virus-guinea pig systems 
The methods of preparing tissue smears and sections for 
FA staining have been described in earlier sections of this 
dissertation. The same method of FA staining described below 
applies to all slides or coverslips regardless of their method 
of preparation, whether smeared or sectioned, or whether they 
were primary or cell lines grown on coverslips in Leighton 
tubes. The cells or tissues were first rinsed in Dulbeccos 
phosphate buffered saline, pH 7.2, (PBS), air dried, then fixed 
in -60 C absolute acetone for 15-20 min. They were then placed 
in PBS for 5 min with gentle agitation then rinsed by 2 or 3 iip 
and down gentle motions in distilled water. Care was taken to 
prevent cells from peeling off the glass. Slides or coverslips 
were then air dried and either stained with FA conjugate immedi­
ately, or they were stored for various periods in the fixed, 
dry state in covered Petri dishes at 4 C. Storage for days, 
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weeks, months, and even years did not seem to affect the anti­
genic properties of cells and tissues prepared by this method. 
Several different fluorescein isothiocyanate conjugates 
were used in FA tests; their preparation has been described 
adequately in other reports (14, 16, 34, 82). Fluorescein-
labeled antisera were dropped onto cells either on slides or 
coverslips and incubated for JO min at 37 C, followed by the 
same rinsing procedure as used for acetone fixation. Cells 
were not allowed to dry at this point, but were immediately 
mounted with a 1:9 dilution of glycerin in PBS on slides or 
covered with coverslips, for coverslip and slide preparations 
respectively. Mounted preparations were usually stored at 4 C 
overnight before examination. 
The PA-stained preparations were observed with a Leitz 
Ortholux fluorescent microscope with a darkfield condenser, 
under oil, illuminated by an Osram lamp HBO-200, and with a 
primary BG-12 light filter and an OG-1 barrier filter. Photo­
micrographs were taken with a Leitz Orthomat automatic camera 
on Kodak TRI-X film with the camera setting at 50^ light-dark 
ratio and an ASA rating of 400. Kodak High Speed (HS) Ekta­
chrome film was employed where color photomicrographs were 
desired. 
Storage of mounted FA-stained cells for several months at 
4 C did not alter their staining characteristics. For some 
systems where specific antisera were not conjugated with fluo­
rescein for the direct test, an indirect method (l6) was 
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employed with fluorescein-conjugated specific globulins forming 
a "sandwich" between viral antigen, specific anti-viral unla­
beled globulins and fluorescein-labeled antiglobulin against 
the animal species from which the antiserum was obtained. Com­
plete details of both the direct and indirect tests have been 
published (113). 
Immuno-phase fluorescence 
Phase fluorescence is a useful technique to determine the 
depth or level of fluorescing material in a cell or tissue. It 
gives a 3rd dimensional proportion to cells and tissues which 
are stained with fluorescein and helps to determine whether 
fluorescing material is within a cell or merely on the surface 
of a cell. A Leitz fluorescence microscope was equipped with 
the necessary components to convert it to a phase system where 
dual lighting was employed, UV for exciting the fluorescent 
material, and tungsten brought into the UV beam by means of a 
45° piano-mirror set into a special mirror housing. An orange 
filter placed in front of the incandescent lamp in a holder 
slot gives a color contrast of orange to the greenish yellow of 
the fluorescing parts of the preparation. Photomicrographs are 
meaningful only when taken on color film, and HS Ektachrome was 
used for all phase-fluorescent studies. Tissue sections of 
BVD-infected calves were studied by this technique. 
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Heterogeneity Studies on BVD Viral Antibodies 
The present study was designed to establish serological 
properties of heavy (19 S) and light (7 S) serum globulin frac­
tions with regard to viral neutralizing, precipitating, and 
fluorescing antibodies from calves injected with BVD viral 
antigens. Sera produced against a cytopathogenic strain of BVD 
virus, a noncytopathogenic strain, and against a soluble 
antigen (SA) from BVD-infected cell culture systems were 
employed in this study. 
Paired antisera, an early and a late, from 4 SPF calves 
which had been inoculated and bled as described by Gutekunst 
and Malmquist (35) are identified in Table 1. Calf numbers 
corresponding to those assigned by these workers as well as 
NADL animal numbers are cross-referenced. All sera were heat 
inactivated prior to their use after removal from frozen 
storage. The BVD viruses employed in this study were the NADL 
and CG-1220 strains. The gamma-globulin fraction was sepa­
rated from the albumin and other serum components by the ammo­
nium sulfate precipitation method of Kendall (ll4J. Further 
separation of the gamma-globulins into 19 S and 7 S fractions 
was accomplished by an ultracentrifugal density-gradient 
method described by Kunkel (115). The gradient ranged from 
10 to 40^ chilled sucrose; 1 ml of gamma-globulin fraction of 
antiserum was gently stirred into the top layer of sucrose with 
the tip of a fine forceps, tubes were immediately placed in a 
swinging bucket rotor (SW-39L), and centrifuged for 18 hr at 
Table 1. Sera from calves identified as to source, treatment age and amount of 
BVD antigen administered 
Administration of antigen (Ag) Calf designation 
Serum 
no. 
Weeks 
PI Kind Schedule 
Total 
CCID^o Booster 
Total 
CCID^Q 
NADL 
no. 
Reference 
no.^ 
1 
2 
5 
20 
NADL-SA^ 
It 
3-weekly-ID 
II 
5x10^° 
II 
None 
NADL* 
None 
2x10? 
virus 
5132 3 
3 
4 
4 
13 
NADL 
II 
Si)ngle-IV 
II 
5x10^ 
11 
None 
IV-12 wks. 5x10^ 
5095 1 
5 
6 
5 
13 
NADL 
II 
5-daily IV 
II 
2x10? 
II 
None 
None 
None 
None 
5136 2 
7 
8 
7 
18 
CG-1220® 
II 
2-IV at 0&6 
wks. •• 
1x10? 
11 
None 
None 
None 
None 
5131 4 
^•Numbers assigned by Gutekunst and Malmquist (35) • 
^Chloroform-treated soluble antigen extracted from NADL-infected EBK cells. 
^Concentrated SA from cultures represents the growth of 5x10^ CCID^Q of 
NADL virus. 
^NADL live cytopathogenic virus given IV at 6 and 8 weeks. 
®Live noncytopathogenic BVD virus cultured in EBK cells. 
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35«000 rpm in a Spinco Model L ultracentrifuge. Two zones were 
visualized by light scattering of a thin beam of light passed 
through the bottom of the tube in a darkened room (Figure 1). 
The 2 zones consisting of light and heavy proteins were easily 
separated by means of a plastic syringe fitted with a 1 1/2 
inch No. 26 needle. The syringe was clamped firmly to a ring 
stand, and the upper fraction was carefully drawn off as the 
needle was slowly lowered in the tube, always keeping the 
needle tip just below the meniscus. The 2 globulin fractions 
were separated into 2 approximately equal volumes, placed in 
screw-cap vials and stored at -20 C until used. 
Antibody activity of whole sera, gamma-globulin fractions, 
7 S and 19 S fractions was determined by double agar diffusion 
precipitation, by immunofluorescence, and by neutralization 
techniques described earlier in this report. 
Studies on Sequential Development of Viral 
Antigen Within Infected Cells 
The NADL and C24V strains of BVD virus were cultured in 
primary EBK cells on coverslips in Leighton tubes in EBSS 
medium, and the NADL-PK2^ virus was cultured similarly in PK-15 
cells. A high multiplicity of virus per culture cell was 
employed as the inoculum in order to massively infect all the 
cells in the culture so that some degree of synchrony of viral 
antigen synthesis was obtained. The inoculum size employed was 
approximately 10^ CCID^Q/ml. 
Figure 1. Components of anti-BVD serum as shown by light-
scattering in centrifuge tube after sucrose density-
gradient ultracentrifugation 
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19S 
6o 
Viral cultures grown in cells on coverslips were processed 
as described above, then stained with NADL, CG-1220, or NADL-SA 
conjugates at sequential time periods of 6, 12, 18, 24, 30, 36, 
48, 54, 60, 72 and 96 hr PI. 
Observations for fluorescence and photomicrography tech­
niques were carried out in the same manner as described earlier 
in this section. 
Size and Density Studies on BVD Agents 
Size determinations on BVD viral 
agents by centrifugation-filtratlon 
Several centrifugation-filtration runs were made with 
NADL, C24V, Sanders, New York-1, Merrill, and Indiana-46 strains 
of BVD virus. The method employed was to filter pre-clarifled 
viral preparations through 220, 100, 50, and 10 m>i pore-sized 
Millipore filters in a Filterfuge tube (International Equipment 
Co.). These stainless steel tubes contain double filters in 
the event one breaks or leaks. Centrifugation time was 3-^ hr 
at 3300 rpm in a refrigerated International PR-2 centrifuge. 
Fluids collected in the bottom section of the centrifuge tubes 
were assayed for infective viruses by the previously outlined 
assay methods. 
Determinations of buoyant densities 
of BVD viruses by ultracentrifugation 
The ultracentrifuge is not only an indispensable tool for 
concentrating and purifying viruses, but is also a valuable aid 
in characterizing and determining physico-chemical properties 
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of viruses. Size and buoyant densities are 2 physical proper­
ties that affect sedimentation rates of viral particles in 
density gradients in the ultracentrifuge. In order to be able 
to predict conditions whereby quantities of BVD virus could be 
purified and concentrated for further characterization studies 
in the electron microscope, a number of preliminary experiments 
were conducted. 
Sedimentation rates of BVD virus were determined in regu­
lar growth medium which had been pre-clarified to remove cells 
or cellular debris. These sedimentation rates were determined 
in order to design experiments in which more precise measure-.. 
ments of size and density could be obtained. 
In an initial experiment, ^  ml of NADL virus was placed in 
polyallomer tubes, these were centrlfuged in the 8W-39L rotor 
at 40,000 rpm (IO5.OOO g) in a Beckman L-2 HV ultracentrifuge. 
Samples were removed at doubling time intervals ranging from 
30 min to 16 hr and the top half of each culture was withdrawn 
and assayed for infectious virus in EBK cells. Settling rates 
of BVD virus past the center of the tube were obtained from 
plots of logio CCID^q of virus against time of centrifugation. 
These sedimentation rate curves proved to be valuable for 
determining many conditions for centrifugation such as speed, 
type of rotor, volumes, etc. 
Buoyant density determinations involved 2 methods; first, 
a rate zonal centrifugation in which potassium tartrate layers 
varying from 55^ at the bottom of the tube to 1^% at the top 
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were layered with cultures of BVD virus and centrifuged for 
varying periods of time to determine approximate zones of 
equilibrium between the gradient and the infectious particles. 
These rate zonal centrifugations were repeated with sucrose 
gradients ranging from 55^ in the bottom to 5^ at the top of 
the tube. Rate zonal centrifugations of BVD viruses were also 
repeated with cesium chloride gradients ranging from 24^ on 
the bottom to lOX at the top of the tube. Second, density-
equilibrium centrifugation runs were made from results obtained 
from zonal centrifugations. These so-called isodensity or 
isopycnic centrifugations were carried out in the Beckman L-2 
HV with approximately 2 ^  of vacuum and at ^ -7 C. A modifica­
tion of the original method of Meselson, Stahl and Vinograd 
(ll6) was employed to determine equilibrium distributions of 
macromolecular material, including viruses, in a density 
gradient, itself at equilibrium. 
In addition to ultracentrifugation runs made with the 
SW 391^ rotor which holds 3 tubes each holding 4.5 ml, isoden­
sity and rate zonal runs were made with an SW-25.3 rotor 
holding 6 tubes, each having a volume of 16.5 ml. A sample 
rate zonal gradient arrangement is shown in Figure 2, A. This 
cellulose acetate tube contained CsCl pre-formed gradient as 
indicated on tube, D. Centrifugation time for rate zonal runs 
was usually 24-48 hr, and for isodensity runs 60-72 hr. An 
example of an isodensity equilibrium run is shown by tube C 
which contained 6.5 ml of 35^ CsCl plus 10 ml of concentrated 
Figure 2. Formation of density gradients for ultracentrifu-
gation of BVD viral preparations, and method of 
sampling 
A. Five concentrations of CsCl showing interfacial 
bands and BVD culture layered on top of the 
gradient 
B. Sampling template formed from a longitudinally 
split cellulose acetate tube showing 1 ml 
graduations 
C. CsCl and BVD viral culture mixed for an isopycnic 
run; illustrates how template fits on tube for 
sampling after run is completed 
D. Example of a rate zonal preparation, showing 
needle used to puncture bottom of tube for 
sampling procedure 
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NADL culture with a refractive index of 1.3^8? and a density 
of 1.156 g/ml. Collection of density gradient samples after 
centrifugation was accomplished by puncture of the bottom of 
the centrifuge tube with a 26-gauge needle and collection of 
drops into individual test tubes. Because of the variability 
of drop sizes according to hole size, density and viscosity of 
material passing through the hole, a calibrated template con­
sisting of a cutaway section of a cellulose acetate centrifuge 
tube, B, was held over the tube being sampled as shown by C, 
and the desired volumes, usually 0,5 ml. passing into the 
collection tube could be read directly from the level of the 
meniscus. 
Densities of the gradient fractions were read directly 
from standard curves plotted from densities for accurately 
weighed (weight/weight) concentrations of potassium tartrate, 
cesium chloride or sucrose from readings of refractive indices 
obtained with an Abbe 3I refractometer (Carl Zeiss Oberkocken, 
Germany). These plots were made from data taken from a hand­
book of chemistry and physics (11?) and refractive indices 
obtained from standard solutions by means of the refractometer, 
were fitted along the same axis as the per cent concentration 
(Figures 3. 4 and 5). 
Figure 3» Standard curve of w/w percentages of sucrose plotted 
against density; refractive indices were determined 
for the indicated percentages of sucrose by means of 
an Abbe refractometer 
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Figure 4. Standard curve plot of w/w percentages of potassium 
tartrate (KT) versus densities, with refractive 
indices determined for the indicated concentrations 
of KT 
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Figure 5' Standard curve for CsCl with w/w percentages corre­
sponding to refractive indices plotted against 
densities 
71 
% CsCI IN DISTILLED HjO 
0 10 20 30 40 50 60 70 
1.900 
1.800 
1.700 
1.600 
1.500 
1.400 
1.300 
1.200 
I.I 00 
1.3409 
1.3330 
1.3882 ' 
1.4044 
1.3608 
1.3736 1.3500 
REFRACTIVE INDEX 
72 
Concentration and Purification Techniques 
Ultracentrifugation to concentrate BVD virus 
Several different concentration and purification methods 
were employed in an attempt to both concentrate and eliminate 
cell fragments, serum components, and extraneous material which 
would interfere with visualization of BVD virus in the electron 
microscope. 
Early attempts to concentrate BVD virus, usually the NADL 
strain, consisted of high speed centrifugation, for example, 
40,000 rpm (106,000 g) for 2 hr in a Spinco Model L centrifuge, 
then resuspension of the pellet. This high speed centrifuga­
tion run was often followed by a simple purification step of 
filtration through a Millipore filter of 0.4^ )i pore size held 
in a Swinny syringe adapter. 
Later refinements of the early crude attempts at concen­
tration and purification of BVD virus consisted of a pre-centri­
fugation clarification run in an International PR-2 refrigerated 
centrifuge to eliminate cellular debris and aggregated mate­
rials. Centrifugation in an SW-39L rotor at 27,000 rpm for 
2 to 4 hr comprized the concentration step. Purification was 
again a Millipore filtration. 
The next attempt at concentration and purification of BVD 
virus consisted of a potassium tartrate (KT) density-gradient 
centrifugation. This procedure was described, in part, in the 
preceding section dealing with buoyant density determinations. 
The KT density-gradient tubes were made up by dissolving 55 S 
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of KT (K^CE^O^'l/Z H2O) in distilled water as a stock solution 
i55%)• From this concentration, appropriate dilutions were 
made consisting of 4^, 35» and 2^% solutions. These were all 
weight volume (w/v) solutions. One ml of each of these dilu­
tions was carefully layered on top of the concentration of 
higher density in 5 d cellulose acetate tubes. On top of the 
25^ concentration of KT was layered 0.5 ml of a concentrated 
preparation of NADL virus. This concentrate was produced by 
centrifuging 200 ml of NADL culture in the #40 rotor of a 
Model L Spinco centrifuge for 3 hr at 39,000 rpm, pelleting and 
discarding the supernatant fluid until the viral titer (CCID^g) 
was increased by approximately 3 logs. The KT gradient tubes 
were centrifuged in the 8W-39L rotor at 39»000 rpm (105,000 g) 
for 4 hr. After centrifugation, O.5 ml fractions were taken by 
micropipetting from the top of the tube. Viral assays were 
performed in EBK cells by the usual method. 
Another concentration of BVD virus was performed by a 
pre-clarification centrifugation run, pressure dialysis of 
525 ml of NADL virus for 2 days at 4 C at 5 lb of nitrogen 
pressure. A second clarification run, and centrifugation at 
30,000 rpm for 2 hr were carried out. 
The various preparations of BVD virus were assayed for 
virulence for EBK cell cultures and were examined in the 
electron microscope by methods to be described in a subsequent 
section. 
7^ 
Purification of BVD viruses by filtration 
through agar gel columns 
The principle involved in agar gel filtration is one of 
screening or of holding-back, by entrapment, small particles 
within the gel, while larger particles are allowed to flow 
between the porous gel particles. Since the introduction of 
the method for fractionating proteins on granulated agar gels 
by Poison (118), a number of workers have described methods of 
purifying viruses by separating them from cell protein con­
stituents, serum proteins, etc., which obscure the viral 
entities in a field under examination with the electron micro­
scope. Steere and Ackers (II9) separated tobacco mosaic virus 
from southern bean mosaic virus by means of chopped gelled agar 
sorted by sieving and packing into columns. Other workers 
(120) employed "pearl-condensed" agar which consisted of agar 
spheres. Agarose which has no charged groups has been employed 
by still other workers (121) in columns to separate particles 
of differing sizes. 
In a series of experiments, several batches of agar beads 
were prepared by a number of methods and with different concen­
trations of agar. After experimenting with several methods, 
the one chosen was: 150 ml of 1.5^ agar was poured into 6OO ml 
of mineral oil at 5^ C while stirring rapidly. When the mix­
ture reached 25 C it was Immersed in an ice bath and stirring 
was continued for 10 to I5 additional min. Beads were formed 
in the oil phase; the oil was separated by centrifugation. 
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washing with water, and finally by extraction with ethyl ether. 
The ether was removed by gentle heat and vacuum, which some­
times took 12 to 24 hr. If ether is not completely removed, a 
viral inactivation problem is present, because BVD virus is an 
ether-sensitive virus. The beads were sieved and the fraction 
between 40 and 80 mesh was used to pour columns. Several 
columns were poured and attempts to purify the BVD virus were 
made (separation of viral particles from cell fragments and 
cellular components) in order to get a "clean" preparation so 
that the virus could be recognized by electron microscopy. The 
method of assaying "purified" virus preparations was by means 
of cell culture assays which require that the virus be actively 
virulent and uncontaminated. 
Contamination was another problem—no matter how care­
fully everything was sterilized, columns, agar, buffer, mineral 
oil, glassware—a contamination of cultures occurred. Finally 
this was eliminated by Millipore filtration of eluted samples 
through an HA (0.45 filter with a Swinny syringe adaptor. 
Sheep red blood cells and hemoglobin were used as markers 
to give the "hold-up" volume and the trailing point of the 
viral material. Two or 3 "runs" through the columns led to 
predictions of particle retention based on particle size, also, 
predictions of flow rates or volumes in which to expect 
particles. These predictions, based on size values given by 
Rivers and Horsfall (122), are presented in Figure 6. A 
straight-line relationship of size to time of flow through the 
Figure 6. Predictions of the appearance of viral particles of 
various sizes in effluent from a 1.5^ agar bead 
column, based on passage of red blood cells and 
hemoglobin markers and on size data from Rivers and 
Horsfall (122) 
77 
10,000 
6 000 
4000 
2  0 0 0 -
200 
100 
60 
40 
20 
10 
I 
RICKETTSIA 
PSITTACOSIS 
MYCOPLASMA 
INFLUENZA 
RABBIT PAPILLOMA 
FOWL PLAGUE 
S I Z E  R A N G E  F O R  B V D  V I R U S  
POLIO VIRUS 
FOOT AND MOUTH 
HEMOGLOBIN 
EGG ALBUMIN 
J L J I I 1 I L 
6 7 8 9 1011 12 13 14 1516 1718 19 20 ' 22 ' 
21 23 
EFFLUENT(ml) 
78 
column was assumed because such a relationship has been shown 
for particles within narrower limits than those assumed. 
According to Steere^, agar and agarose spheres did not 
have the same internal geometry as did the agar or agarose 
"chips". Steere also stated that the concentration of agar or 
agarose needed for separating particles of the size predicted 
was Because of this information and the statement by 
Steere that agar and agarose were comparable as far as the per­
centage required to filter particulate material, i.e., 3^ agar 
compares to 3^ agarose, etc., experiments were set up to com­
pare spheres and chips. 
Three per cent agarose beads were prepared in mineral oil 
by the procedure outlined above for agar beads. Three per cent 
agarose chips were prepared as follows: Agarose was melted in 
the autoclave, allowed to cool, chopped in a Waring Blendor, 
then passed through a 40 mesh sieve with particle retention on 
an 80 mesh sieve. Physical structures of 3^ agarose beads and 
chips are shown in Figure 7. Columns were prepared from 
agarose beads and chips. A very high-titered BVD virus prepa­
ration was passed through these columns, and aliquots of fluid 
collected and assayed for virulence in cell cultures and 
examined in the electron microscope. 
Steere, R. L. , Plant Virology Laboratory, Crops Research 
Division, Beltsville, Maryland. Gel filtration for the puri­
fication of viruses. Private communication. 1964. 
Figure ?. Physical structure of 3^ agarose beads (A) and 
chips (B) stained with safranin (X600) 
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Genetron treatment as a purification 
method for BVD viruses 
The refrigerant Genetron^ (trifluorotrlchloroethane) has 
been used successfully to purify certain viral preparations. 
The efficacy of this chemical compound to separate and remove 
undesirable extraneous materials from BVD preparations was 
tested as follows; 30 ml of the NADL strain of BVD virus 
culture was mixed with 30 ml of Genetron in a 75 ml Sorvall 
Omnimix blendor unit. This container was lowered into an ice 
bath and mixed at high speed in cycles (15 sec on and 15 sec 
off) until the following desired mixing times were achieved: 
2, 4, 8, and l6 min. Assays of Genetron-treated and control 
virus preparations were made in EBK cells in the usual manner. 
Electron Microscopic Studies 
Negative staining technique 
Bovine viral diarrhea viruses were negatively stained by 
the method of Brenner and Home (123). This method was varied 
for different preparations, but in general, 2 drops of viral 
preparation were placed in the well of a spot plate with 
2 drops of 2% phosphotungstic acid (PTA), and 1 drop of a 
bovine serum albumin (BSA) solution. The BSA was added to 
overcome the hydrophobic properties of the carbon-filmed grids 
used as substrate to support the negatively-stained material. 
The mixture of virus, PTA and BSA was applied to carbon-coated 
1 
Allied Chemical Co., Industrial Chemicals Division, 
Morristown, New Jersey. 
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collodion films on copper grids by one of 2 methods: spraying 
with a vapor-nebulizer (Vaponefrin Co., Upper Darby, Penna.) 
or transfer of a loopful of material to the carbon-coated grid 
by bringing the loop over the grid and pressing the loop onto 
a piece of blotter paper beneath the grid. The latter method 
was handy for carrying out immuno-electron microscopy tech­
niques to be described in the following section. Negatively 
stained preparations were examined immediately with a Philips 
EM-200 electron microscope operated at 80 kv and with double 
condenser illumination. 
Immuno-electron microscopy 
The NADL strain of BVD which had been concentrated and 
partially purified by ultracentrifugation and filtration was 
incubated at room temperature with anti-NADL gamma-globulin 
conjugate which was prepared for FA work. This virus-serum 
reaction method was similar to that described by Bayer and 
Mannweiler (124) who used this technique to identify influenza 
virus particles. Minor variations of this direct immuno-
electron microscopy technique were used for different prepara­
tions, but the method in essence was to mix viral preparation, 
PTA and BSA as in the negative staining method, then add 2 or 
3 drops of high-titered, anti-BVD gamma-globulin and incubate 
the mixture from 30 min to an hr. This was done either on a 
grid with moisture removal by paper toweling, as described in 
the negative staining section, or the mixture was sprayed 
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directly onto carbon coated grids. Antigen-antibody prepara­
tions of BVD viruses were examined in the electron microscope 
as described for other negatively stained preparations. 
Ultra-thin section studies 
Cultures of BVD virus were grown on EBK cells in roller 
tubes in Earle's medium as described in an earlier section. At 
the end of 24, 48, and 72 hr of incubation, cells were removed 
by scraping with a sterile bacteriological loop. Contents of 
10 roller tubes were pooled for each time interval sample and 
2 ml of 2^ OsOjif, were added to 10 ml of cell suspension. This 
pre-fixed cell suspension was centrifuged at 800 rpm for 10 min 
to pack the cells, the supernatant fluid decanted, the pellet 
resuspended in 1,0 ml of Palade's (125) 1% OsO^ (pH 7.5) and 
allowed to stand at room temperature for 1 hr. Cells were 
sedimented again at 800 rpm, and embedded in 2% agar by a modi­
fied Kellenberger (126) technique. Agar blocks containing the 
osmium-fixed cells were chopped into cubes of 1 mm3 or less, 
placed in 1% OsO^ overnight at room temperature, dehydrated 
through a series of ethyl alcohol solutions and embedded in a 
divinyl crosslinked methacrylate monomer, described by Kushida 
(127). After the embedded capsules were polymerized at 50 C 
for 24 hr, they were trimmed, sectioned on an LKB microtome, 
mounted on grids and observed in the electron microscope. 
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Studies on Nucleic Acid of BVD Viruses 
Type of nucleic acid 
The type of nucleic acid possessed by the C24V strain of 
BVD virus was determined by Hermodsson and Dinter (1?) to be 
RNA by the use of 3 inhibitors of DM synthesis — <^iodo-deoxy-
uridine (lUDR), ^ -bromo-deozyuridine (BUDR), and ^-fluoro-
deoxyuridine (FUDR). By a similar technique, Gutekunst (18) 
determined that the NADL strain was an RNA virus, and Ditch-
field and Doane (22) found that the C24V and MAC A strains were 
RNA viruses. In order to determine the type of nucleic acid 
present in other strains of BVD viruses, and to exclude the 
possibility that DNA viruses such as adenoviruses were present 
as contaminants which could be responsible for the CPE in cell 
cultures, the following experiment was performed; Logj_o dilu­
tions of the BVD viruses C24V, NADL, WV-313, CG-1220, SAN, 
NY-1, MER, and IND-46 were made in EBSS medium. These dilu­
tions of virus were divided into 3 aliquots, the 1st serving 
as control cultures. To the 2nd portions, 50 jig of BUDR^/ml 
were added. The final 1/3 of the virus dilutions were cultured 
with 50 P-e of lUDR^/ml added to the culture medium. Similarly 
treated cultures of DNA viruses, vaccinia and bovine herpes­
virus, I BR served as DNA controls. Strain LCR-4 of the ECBO 
viruses, and the VS virus were cultured in lUDR and BUDR as 
RNA virus controls. 
^Nutritional Biochemicals Company, Cleveland, Ohio. 
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Infectlvlty of BVD viral nucleic acid 
À PK-I5 cell adapted NADL virus (NADL-PK22) was cultured 
in PK-I5 cells in two 1-liter Blake bottles. Four days after 
viral infection, cells were frozen and thawed 3 times to 
liberate intracellular virus. Cells were removed by centrifu-
gation at 2000 rpm for 30 min, Aliquots of culture were 
extracted twice with cold phenol by the method described by 
Bachrach (128). All samples contained .01^ EDTA, and 1 sample 
contained DEAE-dextran (30 p.g/ml) which binds to the RNA and 
protects it from cell or serum RNAse. Phenol was removed from 
the final aqueous phase by 5 extractions with ethyl ether, and 
the ether removed by bubbling nitrogen through the solution for 
30 min. Cells used to assay for infectious RNA were washed 3 
times with PBS to remove any serum RNAse originating from the 
growth medium. The following preparations were assayed for 
infectlvlty in cell cultures by diluting each sample in log 
dilutions ranging from 10"^ to 10"®: (a) RNA extract, (b) RNA 
extract + DEAE-dextran, (c) RNA extract + RNAse, (d) intact 
BVD virus + RNAse, (e) intact BVD virus only. The CPE produced 
in the PK-I5 cells were read at 4 and 7 days. 
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RESULTS 
Adaptation of BVD Viruses to Cell Lines 
Passage of NADL-PK23 and C2^V viruses in 
hamster kidney (HaK). embryonic rabbit kidney 
(EEK-1), and rabbit kidney (LLC-EKj) cell cultures 
"Blind" passages of NADL-PK2^ and C24V viruses in 3 cell 
lines were unsuccessful after the 1st passage, although 10 
successive passages were attempted in HaK and ERK-1 cells, and 
5 passages in LLC-RK^ cells. Fluorescent antibody and viral 
titrations in susceptible cells were both negative after the 
1st blind passage. 
Cyclic passages of C24V and NADL viruses in ERK-1 and HaK 
cell lines alternating with a passage in a susceptible cell 
(EBK for C24V and PK-I5 for NADL-PK23 virus) were successful as 
indicated by the FA method after 10 cyclic passages and also 
after 6 cyclic passages followed by 4 passages in ERK-1 or HaK 
cells only. The LLC-RK^ cell line was dropped early due to 
growth difficulties. Fluorescence of HaK and ERK-1 cells 
infected with NADL-PK23 and C24V viruses after cyclic passages 
is illustrated in Figure 8. The percentages of fluorescing 
cells increased with each subsequent passage much the same as 
those reported for NADL virus during adaptation to PK-I5 cells 
(58). Degree and extent of infectivity of HaK and ERK-1 cells 
by NADL and C24V strains of BVD virus as measured by the FA 
technique is given in Table 2. The intensity of fluorescence 
is a measure of the amount of viral-induced antigen produced 
Figure 8. Specific fluorescence of HaK and ERK-1 cells 
infected with the 7th cyclic passage of NADL-FK23 
or C24V strains of BVD virus (XIOOO) 
A. NADL-PK23 virus in HaK cells 
B. C24V virus in HaK cells 
C. NADL-PK23 virus in ERK-1 cells 
D. C24V virus in ERK-1 cells 
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Table 2. Fluorescence of HaK and ERK-1 cells infected by 
NjM)L-PK23 and C24V viruses 
Cell Cycle Average Intensity Percentage of 
line no. of fluorescence cells fluorescing 
NADL-PK21 C24V NADL-PK23 C24V 
HaK 1 + + 1-5 5-10 
3 ++ .++ 5-10 10-20 
5 ++ +++ 20-50 30-50 
7 ++ +++ 50-70 60-80 
9 +++ ++++ 90-100 90-100 
10 +++ ++++ 90-100 90-100 
ERK-1 2 + + 1-5 1-5 
if + ++ 5-10 10-15 
6 ++ +++ 10-20 20-30 
8 +++ ++++ 30-50 50-70 
10 ++++ ++++ 70-80 80-90 
in an Infected cell. The percentage of infected cells indi­
cates the number of cells attacked and infected by the virus 
during the adaptation process. Although parallel coverslips 
stained by the MGG method were carefully examined, no apparent 
CPE were found, even in cultures of brightest intensity of 
fluorescence and in those in which approximately 100# of the 
cells fluoresced. 
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In another experiment, after 6 cyclic passages had been 
accomplished, 4 subsequent serial passages in ERK-1 and in HaK 
cells were made without the alternate passage in susceptible 
cells. Results of immunofluorescence and viral titers as 
measured in primary EBK cells are given in Table 3 for NADL-PK23 
and C24V viruses passaged 4 additional times in HaK and ERK-1 
cells. The intensities and percentages of fluorescence occur­
ring in this series of infected cells remained at about the 
same level as those occurring after a corresponding amount of 
cyclic passages. The titers of free virus produced in these 
cells were very low and no virus could be detected in cell 
supernatant fluid after the 2nd passage, although the virus was 
certainly present as shown by the presence of specific fluo­
rescence in cells inoculated with these supernatant fluids. 
Passage of C24V virus in PK-15 cells 
Adaptation of the C24V strain of BVD virus to the PK-15 
cell line was followed by immunofluorescence and by production 
of CPE in both EBK and PK-I5 cells. No CPE were produced in 
PK-I5 cells until the 6th passage, although cell infectivity 
was shown by immunofluorescence; with each subsequent passage, 
CPE progressively increased. From the 6th to the l6th PK-I5 
passage, no CPE were produced in EBK cells when the "adapted" 
virus was assayed in these cells, although the EBK cells were 
infected as determined by immunofluorescence. Photographic 
results of this adaptation are shown in Figures 9 and 10. 
Table 3* Fluorescence and titers of NADL-PK23 C24V viruses in HaK and ERK-1 
cells after 6 cyclic passages, then 4 serial passages in HaK or ERK-1 cells 
Cell Cell Average intensity Percentage of Viral titer 
line passage of fluorescence cells fluorescing (CCID^o/ml) 
NADL-PK23 C24V NADL-PK23 C24V NADL-PK23 C24V 
HaK 1 ++ ++ 50-60 50-60 102 102 
2 +++ +++ 70-80 75-85 loi 10^ 
3 +++ +++ 90-100 95-100 <10^ 10^ 
4 +++ ++++ 90-100 95-100 <10^ <10^ 
ERK-1 1 ++ ++ 40-50 50-60 10^ 10^ 
2 ++ ++ 50-60 80-90 10^ <10^ 
3 +++ +++ 70-80 90-100 <10^ <10^ 
4 +++ +++ 90-100 90-100 <10^ <10^ 
Figure 9« Three stages in the adaptation of the C24V virus to 
PK-15 cells showing specific fluorescence and CPE 
by phase contrast in EBK cells (X400) 
A. Fluorescence exhibited after 0 to 5 
passages—++++ 
B. CPE after 0 to 5 passages—vacuoles 
C. Fluorescence after 6 passages—+++ 
D. CPE after 6 passages—slight 
E. Fluorescence after 7 to 16 passages—++ 
F. CPE after 7 to 16 passages—none 
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Figure 10. Three stages in the adaptation of the C24V virus to 
PK-15 cells showing specific fluorescence and CPE 
by phase contrast in PK-15 cells (X400) 
A. Fluorescence after 0 to 5 passages—++ 
B. CPE after 0 to 5 passages—none 
C. Fluorescence after 6 passages—+++ 
D. CPE after 6 passages—extensive 
E. Fluorescence after 7 to 16 passages—++++ 
F. CPE after 7 to I6 passages—extensive 
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Attempts to produce a chronically-infected cell line ty 
serially transferring C24V-infected PK-I5 cells in which the 
virus had been passaged from 1 to I6 times, yielded some unex-
plainable results. Growth of cells was slow when infected with 
C24V virus passaged from 1 to 10 times. Virus passaged from 
1 to 9 times completely destroyed their host cells by the 9th 
transfer (T) of these infected cells. Viruses passaged between 
10 and 19 times produced chronically-infected cells as measured 
by immunofluorescence; they also produced CPE in both EBK and 
PK-I5 cells. However, the CPE in EBK cells no longer resembled 
the vacuolization type of CPE characteristic of that of the 
original C24V, but was identical with the CPE produced by the 
NADL strain. Several of these viruses consisting of CZ^V-PK^--
13th T, C24V-PK q^—13th T, C24V-PKi2--l4th T, and C24V-PKi2--
17th T, were pooled and saved to be tested serologically to 
determine if a change in CPE type produced a corresponding 
change in the serological type. This pool will be referred to 
later as the C^kV-PK^ virus. From the 20th to 27th transfers, 
cell cultures died out one by one, commencing with the lowest 
passaged virus, until by the 28th transfer, the l6th passaged 
C24V virus had completely killed its host cells. Chronically 
infected PK-I5 cells were not produced successfully with the 
C24V virus. An attempt was made to get the C2W-PK-passaged 
virus to revert back to the original vacuolating type of CPE 
characteristic of the C24V virus. To accomplish this, l8th, 
19th and 20th passages of C24V in PK-15 cells were serially 
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passaged In EBK cells. No CPE whatsoever was produced, but 
cells were infected as measured by the FA and viral interfer­
ence titration tests. The adapted viruses resembled noncyto-
pathogenic BVD viruses, so a C24V-PE2^-EBK^ passaged culture 
was saved to test its serological properties as a noncytopatho-
genic virus. 
Interactions of BVD Viruses 
and In Vivo Host Cells 
Bovine host cells 
Positive or negative fluorescence with anti-BVD conjugates 
and recovery of infectious BVD virus from selected tissues of 
11 calves given the NADL strain and of 3 uninoculated control 
animals are given in Table 4. A further breakdown of the 
results of examinations of organs and tissues is presented in 
Table 5» Results of FA tests and viral cultures from control 
animals were all negative, so they are not included. A close 
inspection of these results indicates that rectum, spleen, 
lung, and submaxillary lymph nodes were the organs and tissues 
most often found to be positive by both the FA test and the 
viral assay method; heart, kidney and intestine contained 
infectious virus less frequently, and heart tissue was FA-nega-
tive; lymph nodes other than submaxillary all had a fairly high 
percentage of fluorescence, but seldom contained infectious 
virus. Additional isolations of virus from some of these 
animals in buffy coat samples, and rectal and nasal swabs are 
reported by Lambert (108), and by Lambert and Fernelius (109). 
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Table 4. Results of PA test and viral culture of selected 
tissue samples from BVD-infected cattle 
Calf designation BVD viral exposure Day of Results 
KADL 
no. 
Reference 
no.& Route 
Animal 
age (days) 
death 
pib FA Culture 
5469 4 Oral 1 D-2 + + 
5470 9 11 D-2 + + 
5480 19 Nasal n D-13 + + 
4961c 6 Oral tt 8-222 + -
0099 8 Oral 2 8-113 + -
5494 20 Nasal 1 8-211 + -
5496 21 II M 8-217 + -
5575 15 Oral It D—5 + + 
5592 18 tt II D-11 + + 
5394 (Oral 
(Nasal 
(IV 
513 8-554 + — 
5412 M 281 8-295 + _ 
% animals positive 100 45 
5397 None-control 8-553 - -
5666 26 II 8-50 - -
5667 27 M 8-48 __ 
% animals positive 0 0 
*Por further details, see Lambert and Fernelius (109). 
^ = animal died, S = animal sacrificed, control animals 
were sacrificed on day corresponding with animal age. 
Table 5* Presence of fluorescence and recovery of BVD virus from selected 
tissues of infected bovine hosts 
Tissue examined 
Heart Spleen Intestine Kidney Lung Rectum 
Calf no. FA Virus FA Virus FA Virus FA Virus FA Virus FA Virus 
4^69*^  + "" + — — + " + + 
3^ 7^  ^ 4"  ^ 4" — 4" 4" 
5^ 80* — + — + — 4- — 4- — 4- 4 - 4 -
ifçélc — —' — » + — 4" — » «« 
0099 4" ^ — m m  ^  •*.«. 
— —' — ' 
3573^ " 4" "" + — 4" — 4" — 4" — 
5^ 9^  — • — 
3392^ " 4" 4" tm — + -• 4" 4" 
^^94^ •• «w-f*-» — — ^ " — 4" — 
% positive 0 15 55 27 18 18 36 9 56 11 70 40 
^*Indicates animals that died from BVD. 
Table 5* (Continued) 
Tissue examined^ 
MLN RPLN SMLN PSIN AtLN BrLN PFLN 
Calf no, FA Virus FA Virus FA Virus FA Virus FA Virus FA Virus FA Virus 
3^ 69* — — + — 
5470* + + 
5^80* + — + — 
346I0 4" — —' — 
— — — — — — — — *4" — «— 
•«* « •» M M + 
+ — + — + *•* 4* — — + — — + 
^ — — — — "f" —• — — — — — 
^^ 2^* — — + «. — « — 
539^ - - - -
3^12 *4*" «»•« "4" — ^ mm — —' —. — — 
% positive 56 0 57 0 50 17 25 0 0 13 50 0 30 0 
^LN = lymph node: M = mesenteric, RP = retropharyngeal, SM = submaxillary, 
PS = prescapular. At = atlantal, Br = bronchial, PF = prefamoral. 
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A non-SPF calf, #0099, was given a rabbit-passaged NADL 
strain of BVD virus (R-lOa in Figure l6), This calf exhibited 
signs similar to those of the mild form of BVD disease; mod­
erate temperature rise, mild diarrhea, leukopenia, etc. Virus 
causing typical NADL-type of CPE in EBK cells was isolated 
early and up to approximately 50 days from buffy coat prepara­
tions, and from nasal and rectal swabs. Serological response 
was typical of animals receiving the NADL strain which had not 
been rabbit passaged. 
Illustrations of FA-positive smear impressions from some 
of the tissues and organs of BVD-infected calves are presented 
in Figure 11. Relationships of individual fluorescing infected 
cells with other cells of tissues and organs are illustrated by 
FA staining followed by MGG staining of the identical areas in 
Figures 12 and 13. These tissue sections were cut on a cryo­
stat from fresh frozen tissues of BVD-infected animals. Orien­
tations of infected cells with uninfected cells can be clearly 
seen from these figures, also, the types of cells involved in 
the infection can be determined. It is quite obvious where 
ducts or vessels are present in these sections, that the cells 
in immediate contact with the lumens of these ducts are the 
infected cells. 
Phase fluorescent studies 
Phase fluorescence photographs of FA-stained spleen and 
rectal tissues from calf #5^80 are shown in Figure 14. 
Figure 11. Specific fluorescence of smear impressions of 
certain tissues removed from BVD viral infected 
calves at necropsy 
A. Spleen of calf #0099 (XIOOO) 
B. Intestine of calf #5^80 (Xl600) 
C. Kidney of calf #496lC (XIOOO) 
D. Lung of calf #496lC (XIOOO) 
E. RPLN of calf #5^70 (Xl600) 
F. SMLN of calf #5575 (XIOOO) 
G. Bone marrow of calf #5480 (XIOOO) 
H. Pancreas of calf #5^70 (XIOOO) 
I. Ovary of calf #496lC (XIOOO) 
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Figure 12. Frozen tissue sections of spleen and rectum of BVD 
viral infected calves which died 
A. Spleen of calf #5^69 stained with fluorescent 
antibody (XIOOO) 
B. Same field as A, but re-stained with MGG 
(X1200) 
C. Rectum of calf #5^80 stained by FA method 
(XIOOO) 
D. Same field as C, but re-stained with MGG 
(X1200) 
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Figure 13. Frozen tissue sections of lymph nodes of 2 calves 
which died of BVD 
A. Mesenteric lymph node of calf #5^70 stained 
by the FA method (XIOOO) 
B. Same field as A, but re-stained with MGG 
(X1200) 
C. Retropharyngeal lymph node of calf #5^80 
stained by FA method (XIOOO) 
D. Same field as C, but re-stained with MGG 
(X1600) 
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Figure 14. Frozen sections of spleen and rectum of calf #5^80 
which died from BVD (all are X400) 
A. Spleen section stained by FA method and photo­
graphed by the usual ultraviolet illumination 
procedure 
B. Same field as A, but photographed by the phase-
fluorescence method 
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Figure l4. (Continued) 
C. Rectal section stained by FA method and photo­
graphed by the usual ultraviolet illumination 
procedure 
D. Same field as C, but photographed by the 
phase-fluorescence method 
Ill 
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Frames A and C are spleen and rectal tissues, respectively, 
shown with UV illumination only. Frames B and D are the same 
sections photographed after the addition of phase illumination. 
This tool, phase fluorescence, enables one to see the orienta­
tion of the fluorescing cells with respect to other cells in 
the tissue or organ. This technique has the advantage of a 
single operation over the laborious procedure of double stain­
ing and relocating the same areas of tissues described for 
Figures 12 and 13 above. Infected epithelial cells (green) 
surrounding a duct or vessel are clearly seen as contrasted 
with the surrounding uninfected cells (red), 
Rabbit host cells 
Partial results of passaging BVD viruses in neonatal and 
adult rabbits are given in Figures 15 and 16 and additional 
results are presented in Table 6. Briefly stated, data in 
these figures and table show that BVD viruses were successfully 
propagated by alternate passages in susceptible cultures and 
rabbits. Criteria of successful passage were positive assays 
for the presence of the virus expressed by the appearance of 
CPE and/or immunofluorescence in susceptible cell cultures. 
Two NADL viruses, 1 a splenic isolant from an infected calf 
and the other an isolant adapted to ERK-1 cells by 8 cyclic 
passages, were successfully passaged through 2 neonatal rabbits, 
then an additional 4 adult rabbits for a total of 6 rabbit 
passages. The splenic isolant and an Oregon C24V strain of BVD 
Figure 15. Flow chart showing IP passage of BVD viruses in neonatal 
rabbits and IV passage in adults. Results of passage of 
tissue homogenates from inoculated rabbits are given by 
EBK culture and the FA test 
* signifies the NADL-type of CPE 
- is negative for recoverable virus 
+ means tissues showed specific fluorescence with 
conjugated antiserum 
R-1, etc. are adult does 
R-la, etc. are neonatal rabbits 
^NADL 
R-la, 
1 j^lag f Y lb 
E-N-VIII-
Pooled 
spleens 
R-3a 
EBK cell 
passages 
Blood* 
Spleen* 
Liver* 
Pool 
• 
R-U 
EBK cell 
passages 
Liver* 
Intestine* 
Pc^l 
R-3 
EBK cell 
pasBEtges 
All cultures 
negative 
FA 
Spleen + 
Liver + 
-*-EBK cell 
cultures 
Blood* 
Spleen* 
Liver * 
Intestine(-) 
Pooled 
spleens 
R-3b 
EBK cell 
passages 
All cultures 
negative 
f 
R-lc 
E-C-VIII 
1 
R-lc^ 
EBK cell 
cultures 
Blood V* 
Spleen (-) 
Liver (-) 
Intestine^-) 
Pooled 
spleens 
R-3c 
"EBK cell 
cultures 
Blood (-) 
Spleen (-) 
Liver C-) 
Intestlne(-) 
EBK cell 
passages 
All cultures 
negative 
Figure 15• (Continued) 
V indicates a vacuolating CPE resembling that 
characteristic of the C24V virus 
V* signifies a type of CPE intermediate between that 
resembling the NADL-type and the C24V-type 
NADL 
R-2a 
Spleen 
R-ltd 
EBK cell 
passages 
Blood* 
Spleen* 
Intestine* 
Pool 
4 
R-2 
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Spleen 
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' r 
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I 
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Spleen V* 
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Intestine V* 
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•EBK cell 
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negative 
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passages 
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R-12 
R-5 
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Blood V 
Intestine V 
R-11 
EBK cell 
passages 
Spleen* 
R-10 
EBK cell 
passages 
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EBK cell 
passages 
Blood V 
Spleen V 
Intestine V 
R-9 
I 
EBK cell 
passages 
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Blood (,-) f 
Spleen(-) R-Ug 
Hver(-) j 
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passages 
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Figure 16. Flow chart showing oral passage of BVD viruses in neonatal 
rabbits and IV passage in adults; tissue homogenates from 
inoculated rabbits were cycled through intermediate EBK 
cell passages. Results are given for cytopathology in 
culture and FA tests 
* indicates the NADL-type of CPE 
V signifies the C24V-type of CPE 
*V represents an intermediate type of CPE 
+IF is a positive assay by the interference test for 
noncytopathogenic viruses 
+ under FA shows specific fluorescence of smear 
impressions of the indicated tissues 
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Table 6. Summary of results of passage of BVD viruses in rabbits 
Rabbit number(s) 
BVD strain 
originally 
Inoculated 
Tlssue(s) 
of viral 
isolation 
No. of No. of EBK 
rabbit cell 
passages passages 
Type of 
CPE in EBK 
cells 
a-1 
H—la^,R-la2 
(Pooled) 
R—Ib^,R—lb2,R-2b, 
R-4e (Pooled) 
R-2 
R-2a, R-4d (Pooled) 
R-2d, R-4g (Pooled) 
R-3 
R-4 
R-5 
R-5a 
NADL (E-N-VIII) Intestine 
NADL 
NADL 
(E-N-VIII) 
NADL 
NADL 
C24V 
C24V 
NADL 
Spleen 
(Blood 
(intestine 
Pooled 
Blood & spleen 
intestine 
Blood & intes­
tine, liver & 
intestine 
Spleen 
Pooled 
NADL (E-N-VIII) Pooled 
3 
1 
3 
1 .  2  
1 .  2  
3 
3 
4 
3 
3 
3 
2 
2 
3 
3 
6 
V*' 
* 
V* 
a 
NADL Liver 
intestine 
V* 
V 
V 
* 
V 
* 
^ = vacuolation CPE typical of C24V strain in EBK cells» 
* = destructive CPE typical of NADL strain in EBK cells. 
V* = combination of both types of CPE in EBK cells. 
Table 6. (Continued) 
BVD strain Tissue(s) 
originally of viral 
Rabbit number(s) Inoculated Isolation 
R-5b C24V Blood spleen 
R-5c NADL (E-N-X) Intestine 
R-5d C24V (E-C-B-X) Blood spleen 
R-6 NADL Pooled 
R-7 C24V All negative 
R-8 NADL All negative 
R-9 NADL (E-N-VIII) All negative 
R-10 NADL All negative 
R-lOa NADL Blood 
R-lOb C24V Pooled 
R-lOc NADL (E-N-P-X) Pooled 
R-lOd C24V (E-C-B-X) Pooled 
R-11 NADL (E-N-VIII) Blood 
intestines 
= contaminated. 
No. of No. of EBK Type of 
rabbit cell CPE in EBK 
passages passages cells 
1 
1 
1 
4 
4 
4 
6 
6 
2 
2 
2 
2 
5 
V 
* 
V 
V 
Neg. 
Neg. 
Neg. 
Neg. 
« 
V 
V 
C^ 
V* 
3 
3 
3 
6 
1 
1 
2 
2 
6 
6 
1 
1 
4 
Table 6. (Continued) 
BVD strain Tissue(s) No, of No, of EBK Type of 
originally of viral rabbit cell CPE in EBK 
Rabbit number(s) inoculated isolation passages passages cells 
R-lla NADL Pooled 3 3 * 
R-llb C24V Pooled 3 3 Y 
R-12 NADL Pooled 5 3 V 
R-13 NADL All negative k 3 Neg 
R-14 C24V All negative 4 3 Neg 
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were passaged through 3 neonatal rabbits, then through an 
adult rabbit for a total of 4 rabbit passages. Significant 
observations made during these rabbit passages were that 
(a) the type of CPE of the NADL strain changed, as a result of 
rabbit passages, from typical rounding and pyknosis of cells, 
to extreme vacuolization of infected cells resembling the type 
of CPE caused by the C24V strain of BW virus; (b) Infections 
of cells were frequently expressed by immunofluorescence, but 
infective viral particles were not recovered from these cells 
(Table 7). Rabbit blood was the best source for isolating 
infectious virus, spleen and liver were more often FA-positive 
than virus-positive, and intestinal tissue yielded rather 
unreliable results by both techniques. The order of occurrence 
of positive results from the same tissue specimen by both tech­
niques as shown by the bottom line of Table 7 was blood, 
spleen, liver, and intestine. 
Immunofluorescence of selected rabbit tissue smear impres­
sions is shown in Figure 17. Photographs of CPE produced by 
rabbit passaged virus isolants are shown in Figure 18: A is 
the C24V virus showing typical C24V CPE, B is the NADL type of 
CPE intermediate between that typical of NADL and C24V viruses, 
and D is the CPE exhibited by the rabbit-adapted NADL virus 
which has converted to the C24V-type of CPE. A pool of these 
rabbit-adapted NADL viruses was made from rabbits E-5, R-6, 
R-lOc, and R-12 and will be referred to as the NADL-HA virus 
in future experiments. 
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Table ?. A comparison of fluorescence and recovery of BVD 
viruses from blood, spleen, liver and intestinal 
tissues of infected rabbit hosts 
Rabbit Blood Spleen Liver Intestine 
no. FA Virus FA Virus FA Virus FA Virus 
R-5 - + + - + - - + 
R-6 + + + - - - + -
R-7 + - - - - - + -
a-8 - - + - + - - -
E-11 + + + + + - - + 
R-12 
R-13* 
-
+ + 
— 
— 
— 
R-lOa - + + - -
-
- -
R-lOb - + + - + + - -
R-lOc - + + - + - + -
B-lOd - + + + - + -
-
R-lOe - - + - - - - -
R-lOf - - - - + - - -
R-lla - - - + + -
-
+ 
R-llb + + - + + - - + 
% positive 29 57 64 36 64 14 21 29 
% positive 
by both tests 21 14 7 0 
^Noninfected control rabbit. 
Figure 1?. Smear impressions of BVD viral infected rabbit 
tissues stained by the FA method (all are XIOOO) 
A. Blood from R-llb 
B. Spleen from R-8 
C. Liver from R-lOc 
D. Spleen from R-5 
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Figure 18. Cytopathology of EBK cells inoculated with rabbit 
passaged BVD viruses (X125) 
A. A 2nd rabbit-passaged C24V virus from R-lOo 
showing typical C24V-type of CPE (V) 
B. A 3rd rabbit-passaged NADL virus from R-4 
exhibiting the typical NADL-type of CPE (*) 
C. A 3rd rabbit-passaged NADL virus with the 
intermediate type of CPE (*V) 
D. A 5th rabbit-passaged NADL virus showing 
"changed" CPE resembling that of the C24V 
virus (V) 
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Guinea pig host cells 
No BVD virus was isolated from any tissue or organ of 
guinea pigs, even from animals sacrificed as early as 2 days 
PI, Likewise, no fluorescence was present in any tissue by 
the smear impression technique as used on bovine and rabbit 
tissues and organs. It is therefore concluded that guinea pigs 
are completely resistant to infection by BVD viruses, and that 
these viruses do not propagate in cells, tissues, or organs of 
living guinea pig hosts. These results confirm those of Baker 
et al. (51) who used susceptible calves to show that the NY-1 
strain of BVD virus could not be transferred to guinea pigs. 
Serological and Immunological Interactions 
Cross-neutralization tests among BVD strains 
Cross-serological reactions of sera from animals receiving 
C24V and NADL strains of BVD virus are shown in Table 8. Ani­
mal #5501 was given NADL virus at 0 and 6 weeks and the heter­
ologous booster virus at 26 weeks. Animal #5506 was given the 
C24V virus at 0 and 5 weeks and the heterologous NADL virus at 
15 weeks. 
These reciprocal cross-neutralization tests show serologi­
cal differences between CZkV and NADL strains of BVD viruses. 
Similar results were reported by Gutekunst (18) with the NADL 
and CG-1220 virus strains, and by Fernelius (14) with the 
NADL, C24V, NY-1, IND-46, SAN, MEB, and CG-1220 strains. 
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Table 8, Cross-neutralization of anti-NADL and antl-C24V sera 
with their homologous and heterologous antigens 
Reciprocal of serum 
Antiserum dilution neutralizing 
and Virus Weeks 100 CCID q^ of; 
calf no. administered PI NADL virus C24V virus 
NADL NADL 
(5501) 
C24V ("booster) 
C24V C24V 
(5506) 
NADL (booster) 
0 and 6 
16 4,096 512 
22 8,192 1,024 
26 
30 16,384 2,048 
33 32.768 2,048 
0 and 5 
7 256 256 
11 1,024 2,048 
14 1,024 4.096 
15 
4.096 19 8,192 
24 8.192 16.384 
30 1.024 65,536 
Additionally, these results indicate that challenge with 
the heterologous antigen does not reverse the trend of forma­
tion of antibodies to the earlier antigen once the antibody-
producing trend is started. These data further confirm that 
BVD viruses are serologically distinct and suggest that perhaps 
a typing scheme can be worked out for epizootiological and 
diagnostic purposes. 
Results of cross-neutralizations with other BVD strains 
and their homologous and heterologous antisera are presented 
in Table 9. From these serological cross-reactions, it can be 
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Table 9» Cross-neutralization of several strains of BVD 
viruses with their homologous and heterologous sera 
Antiserum 
and Weeks 
Reciprocal of serum dilution neutral­
izing 100 CCIDcn of BVD virus; 
calf no. PI NADL C24V CG-1220 SAN WV-313 
NADL 
(5095) 
4 
8 
13 
4,096 
8,192 
16,384 
256 
256 
256 
128 
1,024 
128 
128 
256 128 
NADL-SA 
(5132) 
5 4,096 256 4,096 2,048 16,384 
C24V 
(5506) 
10 
30 
512 
1,024 
2,048 
65,536 
1,024 
16,384 
512 
4,096 
1,024 
32,768 
CG-1220 
(5131) 
7 
20 
8,192 
2,048 
8,192 
4,096 
32,768 
65,536 
16,384 
32,768 
65,536 
65,536 
CG-1220 
(5400) 
2 
3 
10 
16 
64 
1,024 1,024 
128 
2,048 
32,768 8,192 32,768 
SAN 
(5409) 
2 
3 
10 
8 
128 
4.096 128 32.768 
32 
1.024 
65.536 16,384 
WV-313 
(205) 
6 2,048 4,096 32,768 16,384 
Colfax 
(Pooled) 
? 512 256 8,192 2,048 
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deduced that each strain of BVD tested, is a separate and 
distinct serotype. Three classes or groups of virus serotypes 
can be named; (a) NADL, (b) C24V, and (c) noncytopathogenlc 
viruses (CG-1220, WV-313 and SAN). These 3 groups have dis­
tinctly different types of cytopathology in EBK cell cultures 
as well as distinct serotypes. Note that the antiserum pro­
duced against the soluble antigen of NADL virus (NADL-SA) 
presents a different neutralization pattern than the NADL viral 
antiserum. This could be due to production of different 
amounts of soluble antigen in cultures of different strains of 
BVD virus. 
Cross-neutralization of 3 strains of BVD viruses 
compared with those of "changed" CPE type 
The rabbit-passaged NADL strain (NADL-RA) assumed the 
C2^V-type of CPE; the pooled C24V strain passaged in PK-15 
cells (C24V-PKx) assumed the NADL-type of CPE; and the PK-15-
EBK-passaged strain of C24V (C24V-PK2^-EBK^) assumed charac­
teristics of noncytopathogenlc BVD viruses. Therefore, 
neutralization tests were performed to determine whether these 
"changed" viruses had assumed serological characteristics of 
their new type as expressed by CPE, or if they retained the 
serological characteristics of their strain of origin. The 
results of these neutralization tests in Table 10 show that 
these "changed" viruses have indeed changed their serological 
characteristics as well as their CPE-type. Neutralization 
titers of NADL-RA virus are comparable with those of the C24V 
Table 10. Cross-neutralization of 3 strains of BVD viruses compared with those of 
"changed" CPE-type with sera, homologous and heterologous to strain 
of origin 
Reciprocal of neutralization titer with 
100 CCIDi^o of BVD virus; 
Antiserum Weeks C24V- NADL- CÊ^-V-PKpg 
and calf no. PI NADL PK^ C24V RA CG-1220 EB% 
NADL (5501) 14 8,192 16,384 512 512 256 256 
NADL (5095) 13 8,192 16,384 512 256 1,024 2,048 
C24V (5506) 14 1,024 2,048 4,096 4,096 1,024 1,024 
CG-1220 (5400) 10 1,024 1,024 1,024 1,024 32.768 16,384 
CG-1220 (5131) 7 8,192 4.096 8,192 8,192 32,768 16,384 
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virus, titers of C24V-PKg. virus compare favorably with those 
of NADL virus, and the C24Vvirus neutralizes anti-
BVD sera similarly to the CG-1220 virus. 
Cross-precipitation of soluble antigens from 
various BVD strains in agar double diffusion systems 
Anti-BVD sera produced in calves against BVD viruses: 
NADL, C24V, CG-1220 and SAN formed precipitin lines in a^r gel 
double diffusion systems with homologous and heterologous SA 
as shown in Figure 19» Precipitin lines formed between the 
same antisera of bovine origin and SA produced from strains of 
"changed" CPE-type: NADL-HA, C24V-PK^ and C2^V-FK2^-BBKjf. are 
shown in Figure 20. Most bovine antiserum-BVD-SA systems 
exhibited single precipitin lines, however, some lines were 
more pronounced than others. The "strength" of the precipitin 
reaction seemed to vary more according to the antiserum used, 
than with the viral strain used to produce the SA for this 
immunological reaction. Precipitin lines between bovine anti­
viral sera and the "changed" CPE-type viruses (Figure 20) were 
much fainter than those between antisera and unmodified 
viruses (Figure 19). This was true for reactions with both 
homologous and heterologous antisera. 
Precipitin lines formed between SA and rabbit antisera 
produced against strains of BVD viruses: NADL, C24V, CG-1220, 
SAN, NADL-EA, CZkV-PKj., and C24V-PK2^-EBI% are shown in 
Figure 21. Single, double, and multiple lines developed in 
the rabbit systems, and are enumerated in Table 11. Lines 
Figure 19. Lines of precipitation formed between bovine anti-
BVD viral sera and homologous and heterologous 
soluble antigens produced in infected EBK cell 
cultures 
Virus SA Antiserum 
NADL I a 
C24V II b 
CG-1220 III c 
SAN IV d 
W 
Figure 20. Lines of precipitation formed between bovine anti-
BVD viral sera and SA from "changed" viruses 
grown in EBK cell cultures 
SA 
NADL-RA V 
C2^V-PKx VI 
C24V-PK24" VII 
EB% 
Antiserum 
NADL (5501) a 
C24V (5506) b 
CG-1220 (3500) c 
SAN (5509) d 
o 
o2o 
® o ®  
OXn 
ogS 
$ ' .©£c 
«:Se 
oSo 
Figure 21. Lines of precipitation formed between homologous 
and heterologous systems of 4 strains of BVD and 
3 "changed" viruses 
SA Virus Antiserum 
I NADL 1 
II C24V 2 
III CG-1220 3 
IV SAN 4 
V NADL-RA 5 
VI C24V-PKx 6 
VII C24V-PK2^-EB% ? 
All unmarked holes were filled with the 
SA indicated in the lower left-hand corner of 
each frame. 
137a 
137b 
Figure 21. (Continued) 
Table 11. Tabulation of the number of precipitin lines formed between various 
soluble antigens of BVD viral systems and homologous and heterologous 
antisera produced in rabbits 
Antibody and no. of lines in system 
Soluble 
antigen 
1 .  
NADL 
2.  
C24V 
3. 
CG-1220 
4. 
SAN 
5. 
NADL-RA 
6 .  
C24V-
PK^ 
, 7. 
C24V-PK25-
EB% 
I NADL 
II C24V 
III CG-1220 
IV SAN 
V NADL-RA 
VI C24V-PKx 
VII C24V-PK25-
EB% 
1' 
1 
1 
1 
1 
1 
1 
3 
3 
3 
4-
3 
3 
2 
2 
1 
4 
3 
2 
2 
2 
4 
5 
4 
7 
5 
k 
3 
4 
5 
4 
5 
5 
5 
3 
4 
4 
4 
6 
4 
6 
4 
3 
2 
3 
4 
4 
4 
5 
^Homologous systems are underlined. 
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formed by homologous and heterologous systems can be studied 
in this figure and table, however, reasons for the variations 
in the numbers of lines formed in these systems are not readily 
apparent. Reactions between SA and BVD antisera of rabbit 
origin were much stronger than those between SÂ and BVD anti-
sera of bovine origin. Again, as with studies on other pre­
cipitin systems described earlier, the ability of the system to 
form pronounced lines, or multiple lines seems to be more a 
property of the antiserum than of the antigen. This is appar­
ent from comparisons of homologous and heterologous systems, 
however, specific interactions of antigens and antisera are 
shown in most homologous systems by the existence of more lines 
than appear in heterologous systems. This is shown by the 
greater number of lines in the underscored diagonal values of 
Table 11 as compared with other values both horizontally and 
vertically. 
Interactions of anti-cell sera with various viruses 
Neutralization reactions Antisera produced in rabbits 
against whole and sonically disintegrated EBK and PK-15 cells 
neutralized BVD viruses grown in EBK or PK-15 cells as shown 
in Table 12. Both anti-EBK sera diluted as much as 1:512 com­
pletely neutralized the NADL strain grown in either EBK (II) 
or PK-15 (III, IV) cells. The C24V strain grown in EBK cells 
(I) was neutralized to a greater degree by the anti-EBK sera 
than was the NADL strain (II), but the noncytopathogenic 
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Table 12. Neutralization of BVD viruses with anti-cell sera 
produced in rabbits 
Reciprocal serum dilution 
neutralized with 100 CCID_$o of the 
Indicated viruses with the following antisera; 
1 2 3 4 
BVD viral Anti-EBK Anti-EBK Anti-PK-15 Anti-PK-15 
strain cells fraction cells fraction 
I. C24V 1,024 2,048 0 0 
II. NADL 512 512 0 0 
III. NADL-PK22 512 512 0 0 
IV. NADL-PK24 256 1,024 0 0 
V. CG-1220 256 256 0 0 
VI. SAN 128 128 0 0 
VII. NADL-RA 128 256 0 0 
VIII. C2ifV-PKx 0 128 0 0 
IX. C24V-PK25-
EBK4 0 128 0 0 
strains CG-1220 (V) and SAN (VI) were neutralized to a somewhat 
lesser degree than the NADL or C24V strains. Viruses of 
"changed" CPE were also neutralized to a lesser degree by anti-
EBK sera; the NADL-BA (VII) was neutralized by both anti-whole 
cell and anti-cell fraction sera, but the C24V-PKy (VIII) and 
C24V-PK2^-EBKi^ (IX) viruses only by the anti-EBK fraction sera. 
Neither of the anti-PK-15 sera neutralized the NADL virus grown 
in EBK (II) or PK-15 (III, IV) cells, nor did they neutralize 
any other BVD virus. 
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Serum 2 (Table 12) was absorbed for 1 hr at 37 C with a 
monolayer of EBK cells in a 1-liter Blake culture bottle, then 
titrated for neutralizing antibodies. Both NADL and C24V 
viruses were neutralized to exactly the same dilution titer as 
those obtained from serum 2 before absorption. The cell mono­
layer on which serum 2 was absorbed was challenged with NADL 
virus, with the result that complete CPE occurred in 4 days. 
This shows that no neutralizing antibody was removed by 
absorption on the cell monolayer, and no measurable degree of 
protection was given to the monolayer of cells by the anti-
cell sera. 
All anti-cell sera failed to neutralize the Colorado 
strain of IBR virus and Indiana strain of VS virus grown in 
either EBK or PK-15 cells; 3 strains of ECBO virus or vaccinia 
virus grown in EBK cells also were not neutralized. 
Anti-cell sera also did not have any hemagglutination 
inhibition titers against parainfluenza-3 virus, SF-4 strain. 
Precipitin reactions Anti-cell sera would be expected 
to form precipitin lines with soluble antigens extracted from 
homologous cell preparations. This was not the case with 
either anti-EBK or anti-PK-15 sera as shown in Figure 22 
(antigens VIII and IX, and antisera f, g, h and i). Both the 
EBK and PK-15 cell-sonicated antigens (VIII and IX), however, 
did react with all 4 anti-BVD viral sera (b, c, d, and e) as 
shown in Figure 22. These findings were quite unexpected 
inasmuch as cell sorlcrtes of both EBK and PK-15 cells failed 
22. Precipitation reactions of SA from 4 BVD strains 
and 2 cell sonicates with normal serum, anti-BVD 
viral serum, and anti-BVD "changed" viral serum 
SA^ Rabbit serum 
I NADL a N ormal 
II C24V b Anti-NADL 
III CG-1220 c Anti-C24V 
IV SAN d Anti-CG-1220 
VIII EBK cell sonicate e Anti-SAN 
IX PK-15 cell f Anti-EBK whole cells 
sonicate 
g Anti-EBK cell sonicates 
h Anti-PK-15 whole cells 
i Anti-PK-15 cell soni­
cates 
^•Unmarked holes were filled with the SA desig­
nated in the upper left-hand corner of each frame. 
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Figure 22. (Continued) 
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to react with their homologous antisera. Note that all 4 
anti-viral sera (b, c, d and e) also cross-reacted with heter­
ologous and homologous soluble antigens (I, II, III, and IV). 
Fluorescent antibody tests Results of FA tests of 
anti-cell sera with viral-infected and non-infected cells are 
given in Table 13 and Figure 23. In this indirect FA test, 
anti-EBK sera reacted with both BVD viral-infected and non-
infected EBK cells; likewise, anti-PK-15 sera reacted with both 
infected and non-infected PK-15 cells. There were, however, no 
cross-reactions between anti-EBK sera and PK-15 cells, or 
between anti-PK-15 sera and EBK cells unless anti-viral sera 
and cells infected with a BVD virus were involved. The only 
exception to these straight-forward reactions was the ++ fluo­
rescence of non-infected EBK cells (column of Table 13) and 
anti-NADL (rabbit) + anti-rabbit conjugate (line 1 of Table 13). 
These anti-NADL sera from rabbits were produced from virus 
originally cultured in EBK cells which could account for the 
++ reaction with EBK cells in this FA test. The FA test seems 
to be fairly cell-type specific or viral specific, whereas 
both precipitin tests and neutralization tests are not. 
Heterogeneity of BVD Viral Antibodies 
Agar double diffusion precipitin tests 
Results of the Ouchterlony Plate Test are given in 
Column 2 of Table 14 and a typical example is shown in Fig­
ure 24. Lines of precipitation developed between the BVD 
1^5 
Table 13. Indirect FA tests of rabbit anti-EBK and anti-PK-15 
sera with infected and non-infected EBK and PK-15 
cells 
Anti-serum Cell system and virus 
system EBK EBK + NADL PK-15 PK-15 + NADL-PK23 
Anti-NADL (rabbit) 
+ ++ ++++ - +++ 
Anti-rabbit conJ. 
Anti-EBK (rabbit) 
+ ++++ ++++ — — 
Anti-rabbit conj. 
Anti-rabbit conj. 
only 
Anti-PK-15 (rabbit) 
+ — — ++++ ++++ 
Anti-rabbit conj. 
Anti-NADL (bovine) 
conjugate = direct - ++++ - +++ 
method 
soluble antigen and all of the whole sera from immunized 
animals except serum #1. Gamma-globulin fractions of all sera 
tested were precipitin-positive against the NADL-SA, as were 
all 19 S fractions except for the #5 sample. 
The 19 S fraction from the same animal at 13 weeks gave a 
weakly positive precipitin line. All 7 S fractions were nega­
tive for precipitins against the SA except serum #1; the pre­
cipitin reaction from this serum fraction, however, was only 
weakly positive. Serum samples taken from all animals prior 
to immunization or infection were precipitin-negative. 
Figure 23. Specific fluorescence of non-infected and viral-
infected EBK and PK-I5 cells employing an 
indirect FA test (X500) 
A. Direct FA control--NADL in EBK cells + anti-
NADL conjugate (++++) 
B. NADL in EBK cells + anti-NADL rabbit serum + 
anti-rabbit conjugate (++++) 
C. EBK cells + anti-EBK rabbit serum + anti-
rabbit conjugate (++++) 
D. EBK cells + anti-rabbit conjugate (-) 
E. PK-I5 cells + anti-PK-15 rabbit + anti-
rabbit conjugate (++++) 
F. PK-I5 cells + anti-rabbit conjugate (-) 
w 
y 
j* J ' . # 
Table 14. Resiilts of agar double diffusion précipitation, Immunofluorescent and 
neutralization tests 
Reciprocal of 
Serum or serum Precipitation Immunofluorescence neutralization 
fraction designation with NADL-SA Intensity ^Cells titer 
1 NADL-MD-SA 5 week - ++ 1-5 2,048 
Y1 NADL Y-glob fraction + +++ 10-20 1,024 
la NADL T-glob-7 S fraction + ++++ 10-20 32 
lb NADL Y-glob-19 S " + ++++ 20-30 1,024 
2 NADL-MD-SA 20 week + ++++ 50 2,048 
r z  NADL Y-glob fraction + ++++ 30-40 1,024 
2a NADL T-glob-7 S fraction — ++++ 40-50 128 
2b NADL Y-glob-19 S " + ++++ 80 4,096 
3 NADL-MD 4 week + ++++ 40-50 1,024 
NADL Y-glob fraction + ++++ 50-60 512 
3a NADL Y-glob-7 S fraction - ++++ 50 64 
3b NADL T-glob-19 S " + ++++ 80-90 2,048 
4 NADL-MD 13 week + +++ 50 4.096 
Yif NADL T-glob fraction + ++++ 90-100 2,048 
4a NADL Y-glob-7 S fraction - ++++ 90-100 512 
4b NADLY-glob-19 S " + ++++ 40-50 16,384 
5 NADL-MD 5 week + ++++ 80-90 8.192 
Y5 NADL y-glob fraction + ++++ 70-80 2,048 
5a NADLT-glob-7 S fraction - ++++ 5-10 256 
5b NADL Y-glob-19 S " - ++++ 90-100 4,096 
Table 14. (Continued) 
Reciprocal of 
Serum or serum Precipitation Immunofluorescence neutralization 
fraction designation with NADL-SA Intensity /SCells titer 
6 NADL-MD 13 week 4- ++++ 50-60 8,192 
y6 NADL Y-glob fraction + ++++ 70-80 48 
6a NADL Y-glob-7 S fraction - ++++ 80-90 512 
6b NADL Y-glob-19 S " + ++++ 40-50 8,192 
7 CG-1220 7 week + +++ 5-10 2,048 
Y7 CG-1220 Y-glob fraction + ++++ 40-50 1,024 
7a " Y " -7 8 fraction - ++++ 90-100 128 
7b M T » -19 s " + ++++ 100 4,096 
8 CG-1220 18 week + ++++ 100 4,096 
Y8 " Y-glob fraction + ++++ 100 1,024 
8a " Y " -7 S fraction — — 0 128 
8b » Y " -19 s " + ++++ 100 4,096 
Figure 24. Pr'ectpitation lines of NADL-SA reacted with serum 
w serum fractions. Numbers in wells correspond 
VFl-th serum or serum fraction numbers (Table 14) : 
3» and 4 are whole sera, 3a and 4a are albumin 
rr-acti-ons, 3b and 4b are pre-inoculation whole 
sierra, Jc and 4c are gamma-globulin fractions, 3^-
a-riid 4d are 7 S fractions, and Je and 4e are 19 S 
rr*actions 
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Immunofluorescence 
Sera from all animals, both early and late, combined with 
antigen produced in PK-15 cell cultures in the indirect FA 
test, except the 7 S fraction of serum from the l8-week-sample 
from the calf inoculated with the noncytopathogenic BVD virus, 
CG-1220 (Column 3» Table 14). This FA test is qualitative 
rather than quantitative, but because infected cultures employed 
as test-antigens were all treated alike, the percentages of 
PK-15 cells infected (Column k. Table Ik), as well as the 
intensity of fluorescence gives a rough quantitation of the com­
bining powers of the test sera. This criterion indicates that 
sera 1, Vl, 4 and 7 reacted with viral antigen to a lesser 
degree than did the other sera under test. 
Neutralization tests 
Neutralization titers of sera and serum fractions are 
given as reciprocals of serum dilutions in column 5. Table 14. 
All BVD antisera possessed some degree of neutralizing power 
against virulent NADL virus. The range of titers went from a 
low of 1:32 to a high of 1:16,384. In general, the low 
neutralization titers were associated with the 7 S fractions 
which also elicited no precipitation lines in the Ouchterlony 
test, Preinoculation sera from all 6 animals possessed no 
neutralizing capacity against the challenge virus. 
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Sequential Development of Viral Antigen 
Within Infected Cells 
Results of a study of sequential development of fluores­
cing viral antigen within infected EBK cells (Table 15) show 
that the viral antigen probably originates in the nucleus of 
the host cell, moves through the nuclear membrane, possibly to 
the Golgi apparatus (juxtanuclear position in the cell), exists 
for a time in the cytoplasm, moves to the periphery of the 
cell, then disappears. 
The time of disappearance of fluorescence from infected 
cells depends largely upon the infecting dose of virus. When 
low multiplicities of virus are used as inocula, fluorescence 
persists in the culture probably due to repetitive cycles of 
infection from cell to cell. With high multiplicities of 
infecting virus, fluorescence disappears from infected cells 
much earlier (it is almost totally gone at 72 hr in some 
cases). Different antisera, i.e., anti-NADL, anti-NADL-SA, and 
anti-CG-1220 (Table 15), employed in detecting viral antigen 
appeared to gi'Ç-e slightly different results, but not enough 
work has been done in these systems to draw any conclusions as 
to the exact effect of antiserum on immunofluorescence and its 
sequential development in BVD-infected cells. 
Sequential development of fluorescent 
antigen in EBK cells 
The series of photomicrographs in Figure 25 show that 
nuclear fluorescence develops at 6 hr after cells are inoculated 
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Table 15. Sequential development of viral antigen within EBK 
cells as measured by immunofluorescence with 3 dif­
ferent antiserum preparations and 2 cytopathogenic 
viruses, NADL and C24V 
C24V virus + 
Sampling 
time, Anti-NADL Anti-NADL 
hr post globulin SA Anti-CG-1220 
infection conjugate conjugate conjugate 
12 
24 
48 
72 
96 
++++ 
Nuclear, peri­
nuclear and 
juxtanuclear 
++++ 
Perinuclear 
++++ 
Perinuclear 
and 
juxtanuclear 
++++ 
50-60^ cells 
with 
cytoplasmic 
+++ 
Very granular 
cytoplasmic 
++ 
Very few cells 
have cytoplasmic 
++++ 
Nuclear only 
+++ 
Nuclear and 
perinuclear 
++ 
Cytoplasmic 
only 
++ 
Periphery of 
cytoplasm 
Periphery of 
cytoplasm 
++++ 
Granules 
within nucleus 
++++ 
Nuclear and 
perinuclear 
+++ 
Perinuclear 
and 
juxtanuclear 
Cytoplasmic 
only 
Cytoplasmic 
only 
^Intensity of fluorescence and its location within the 
cell. 
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Table 15. (Continued) 
SamplIng 
time, 
hr post 
infection 
Anti-NADL 
conjugate 
NADL virus + 
Anti-NADL 
SA 
conjugate 
Anti-CG-1220 
conjugate 
++++ 
Nuclear only 
+++ 
Nuclear only 
12 ++++ 
Perinuclear 
and 
juxtanuclear 
++++ 
Nuclear and 
cytoplasmic 
24 ++++ 
Juxtanuclear 
and 
cytoplasmic 
++ 
Cytoplasmic 
only 
Cytoplasmic 
only 
48 +++ 
Cytoplasmic 
only 
Cytoplasmic 
only 
72 ++ 
Cytoplasmic 
only 
No 
sample Cytoplasmic 
only 
96 
Periphery of 
cytoplasm 
No 
sample Periphery of 
cytoplasm 
Figure 25. Sequentially FA-stained EBK cells infected with 
the NADL strain of BVD virus: 
A. 6 hr (XIOOO), B. 6 hr (Xl600), C. 12 hr 
(1000), D. 24 hr (XlOOO). E. 36 hr (XIOOO), 
F. 48 hr (XIOOO), G. 54 hr (XIOOO) H. 71 hr 
(XIOOO) 
157 
158 
with infecting NADL virus (A and B). After 12 hr, no nuclear 
fluorescence is present in the cells shown (C), but fluorescing 
antigen is located paranuclearly, probably in the region of the 
Golgi body of the cell. At the end of 18 hr, both faint 
nuclear fluorescence and brighter cytoplasmic fluorescence has 
appeared (D). At 24 hr, fluorescence is all cytoplasmic (E) 
and at 36 hr, perinuclear halos are seen around the cells shown 
(?). Granular cytoplasmic fluorescence and cellular breakup 
due to the CPE of the virus are seen at 5^ hr (G), Fluores­
cence at 48 hr has dimmed considerably and cellular disorgani­
zation due to CPE is more prevalent (H), 
Sequential development of fluorescent 
antigen in PK-16 cells 
Photomicrographs showing the development of fluorescence 
in PK-15 cells infected with the modified BVD virus (NADL-PKg^) 
were essentially identical to those for EBK cells described 
above. One minor difference was that time periods required for 
the appearance of fluorescing antigen in the various cell sites 
were slightly longer than those required for a similar fluores­
cing "cycle" in primary EBK cells. The sequential appearance 
of fluorescing antigen which coupled with fluorescein isothio-
cyanate-labeled antibody specific for the BVD virus is indi­
cated in Figure 26. The time period when the brightest 
cytoplasmic fluorescence appeared was 36-60 hr (F-H). Cellular 
destruction by the virus was quite marked at 60 hr (H), granu­
lar cytoplasmic fluorescence appeared at 72 hr, but extensive 
Figure 26. Sequentially FA-stained PK-I5 cells infected with 
the NADL-PK23 strain of BVD virus, all frames are 
(XIOOO): A. 6 hr, B. 12 hr. C. 18 hr. D. 24 hr. 
E. 30 hr, F. 36 hr, G. 40 hr, H. 60 hr, I. 72 hr, 
J. 96 hr 

I6l 
loss of fluorescence due to cell destruction did not appear 
until about 96 hr (J). The fluorescence in the nuclei was 
probably due to the entrance of labeled anti-BVD serum into 
the cell itself. This is commonly seen at terminal CPE of 
cells. Also, note the presence of very large and very small 
nuclei in Figure 26 (J), probably due to the CPE of the infect­
ing virus. 
Physical and Chemical Properties 
of BVD Viruses 
Size determinations of 
BVD viruses by ultrafiltration 
Titers of various strains of BVD after passage through 
Millipore filters of 10, 50» 100 and 220 my in Filterfuge tubes 
are given in Table 16. 
Inspection of the results leads one to speculate that 
these BVD viruses are either highly heterogeneous as to size, 
the filters are not well standardized, some factor such as 
highly variable electrostatic forces are causing the infectious 
particles to adsorb to the filters, or there is some other 
unexplained reason for these variable results. After the first 
few runs had been made, and the C24V virus in run #5 seemed to 
pass a 10 mp filter and the NADL virus in run #1 passed a 50 my 
filter; it was speculated that perhaps the frozen-storage 
periods were responsible for changes in the physical properties 
of the viruses. This led to freeze-thaw treatments which 
appeared to change the filterability of sample #9, but had no 
no 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
l6. Ultrafiltration of several strains of BVD viruses through Millipore 
filters in Filterfuge tubes 
BVD strain Treatment or storage time 
CCID50 after filtration through the 
indicated pore-size Millipore filter 
None 220 m)i 100 mju 50 10 
NADL 
C24V 
tl 
SAN 
NY-1 
IND-46 
MER 
CG-1220 
NADL-PK24 
Stored 1/2 yr at -75 C 
Stored 1 yr at -75 C 
Cone by pressure dialysis, 
stored 1 yr at -75 C 
Freshly grown, 4 days 
Stored 3i yr at -75 C 
Freshly grown, 5 days 
Same culture, but frozen-
thawed (FT) 3 times 
Fresh culture, but 
given 3 FT cycles 
Stored 3 yr at -75 C 
Freshly grown 
Freshly grown 
Stored 1 yr at -75 C 
Freshly grown, 3 days 
10^.5 
105.3 
10 4.0 
10 
10 
6.3 
6 . 2  
lo5.0 
lO^.O 
10 4.0 
10^*® 
106. 3  
lo5.3 
10^-3 
4.0 10 
10 
lo5.6 
10^.3 
10^ .0 
io5.3 
106.0 
lo4.0 
102.0 
10^*3 
lo5.8 
10^-3 
lo5.3 
lo4'3 
10 2 . 2  
lo4.8 
io2.3 
103.3 
ioO-3 
106. 0  
0 
0 
0 
lo4,8 
100. 7  
lo2.7 
lo2.0 
10 1 .0  
103.3 
0 
0 
0 
lo5.8 
0 
0 
0 
6*8 io5«8 io5"0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
io3.o 
0 
0 
0 
0 
0 
0 
0 
0 
0 
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effect on sample #8. Sonication of viral preparations at 
20,000 cps in a Model 75 Branson Bonifier for 10 min, also, 
did not change the filtration properties of NADL or C24V 
viruses (these data are not shown in Table l6). Freshly grown 
Sanders virus was largely retained by the 220 m)i filter until 
it was frozen and thawed 3 times, and then readily passed the 
100 mji pore-sized filter. 
Buoyant densities of BVD viruses as 
determined by ultracentrifugation 
Sedimentation rate curves Preliminary measurements of 
physical properties of the NADL strain by sedimentation rate 
curves provided basic data on which to base more definitive 
centrifugation experiments. A plot of the rates at which BVD 
virus particles, infective for cell cultures, passed the mid­
point of centrifuge tubes in an 8W-391 rotor at 40,000 rpm 
(105t000 g) is given in Figure 2?. Curve A is a plot of a 
pre-clarification run of NADL virus at 25,000 rpm for 30 min. 
Curve B is a plot of NADL virus centrifuged and sampled at 
time periods up to $60 min and assayed for infectivity in EBK 
cells. Curve C was plotted from titrations of NADL-PK23 virus 
similarly centrifuged and assayed in PK-15 cells. 
Rate zonal centrifugation A potassium tartrate den­
sity-gradient centrifugation of a concentrated NADL viral 
preparation at 39,000 rpm was carried out in the SW-39L rotor 
for 4 hr. Titrations of O.5 ml samples of the gradient, which 
ranged from 15^  at the top to 55^  at the bottom, located the 
Figure 2?. Sedimentation rate curves of BVD virus 
A. Pre-clarification run 
B. NADL virus assayed in EBK cells 
C. NADL-PK23 virus assayed in PK-I5 cells 
LOG OF CONCENTRATION OF VIRUS 
ôo ô_ 5^  5, 5, 5, 5^  5^  
Ol 
ro 
S O oy 
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infectious particles. Viral activity in EBK cells was largely 
located in two "bands, one at 30^  and the second at concen­
trations of KT. Examinations of these fractions by electron 
microscopy showed that most of the small particles were in the 
upper 30% band and the larger particles were in the lower 
band. Almost no viral activity was found in the lowest 55% 
fraction. No particles resembling known viruses as identified 
by their internal or external structures were seen. 
All early preliminary density gradients were formed with 
weight-volume percentages of chemicals. The 30% band repre­
sents an approximate density of l.l6 g/ml and the 40% band, 
1,20 g/ml. 
Results of preliminary rate zonal centrifugations of BVD 
viruses in sucrose pre-formed gradients agreed with results 
obtained with potassium tartrate gradients, i.e., bands were 
formed just above the 55% sucrose and in the upper portion of 
38% sucrose. These concentrations were also weight-volume 
percentages, and the approximate densities of the regions of 
banding were 1.16 g/ml and 1.20 g/ml respectively. Assays for 
infectivity of fractions collected from these regions showed 
approximately 10^  CCID^ o/ml for EBK cells in the lower band, 
and 10^  CCID^ o/ml in the upper band. 
The preliminary centrifugations with potassium tartrate 
and sucrose gradients indicated a buoyant density of the NADL 
strain of BVD virus to be approximately I.I6 g/ml. 
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Several rate zonal centrifugation runs with NADL, C24V 
and CG-1220 strains of BVD viruses were made with sucrose, 
potassium tartrate, and cesium chloride gradients. These 
gradients were all formed from weight/weight preparations which 
correspond with data given in chemical handbooks. Results of 
these runs were calculated from the standard curves given in 
Figures 3»  ^and 5* Results of a typical experiment, using the 
SW 25.3 rotor and centrifuging the NADL strain for 24 hr at 
25,000 rpm (113.000 g) are presented in Table 17. An illustra­
tion of banding occurring at the 1,15 g/ml density level in a 
sucrose gradient is presented in Figure 28. The results of 
these runs confirmed the earlier results that the apparent 
buoyant density of the infective particle of BVD viruses is in 
the range of 1.14 to I.16 g/ml. The CsCl gradient gave a 
sharper peak than did either the sucrose or potassium tartrate 
gradients. 
Isodensity or isopyknic equilibrium centrifugation 
Three cups of the SW 25.3 rotor, in the same run reported for 
the rate-zonal method above, were used for an isodensity 
centrifugation employing the 3 solutions: sucrose, potassium 
tartrate, and cesium chloride. Cellulose acetate tubes were 
filled with these solutions mixed with a concentrated prepa­
ration of NADL virus to give an approximate density of I.15 
g/ml. After centrifugation at 25.000 rpm for 70 hr in the 
SW 25.3 rotor, the results given in Table 18 were obtained. 
Here again, the CsCl gradient gave a much sharper banding than 
Table 1?. Results of rate zonal ultracentrifugation of NADL virus in an SW-25.3 
rotor at 25.000 rpm for 24 hr in sucrose, potassium tartrate, and cesium 
chloride gradients 
Potassium Cesium 
Sucrose gradient tartrate gradient chloride gradient 
Infectivity Infectivity Infectivity 
Fraction Density for EBK cells Density for EBK cells Density for EBK cells 
number g/ml CCID^ o/ml g/ml CCID^ o/ial g/ml CCID^ o/ml 
1.213 5.2^  1.215 5.2 1.240 2.2 
2 1.181 5.2 1.189 4.2 1,190 3.2 
3 1.165 5.2 1.167 4.2 1.155 4.2 
4 1.143 7.2 1.147 7.5 1.140 7.2 
5 1.108 6.2 1.115 5.2 1.117 4.2 
6 1.097 5.2 1.085 4.2 1.109 4.2 
7 1.043 5.2 1.045 3.5 1.055 3.2 
8 1.010 4.2 1.007 3.5 1.035 3.0 
S^ampled from bottom of tube. 
L^og of infectivity calculated by method of Reed and Muench (10?). 
Figure 28. Banding seen in sucrose rate zonal density-
gradient ultracentrifugation runs with BVD virus 
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Table 
Fract 
numb 
1 
2 
3 
4 
5 
6 
7 
8 
Results of isodensity ultracentrlfugation of NADL virus in the SW-25»3 
rotor at 25,000 rpm for 70 hr in sucrose, potassium tartrate, and cesium 
chloride gradients 
Potassium Cesium 
Sucrose gradient tartrate gradient chloride gradient 
Infectivlty Infectivity Infectlvity 
Density for EBK cells Density for EBK cells Density for EBK cells 
g/ml CCID^ o/ml g/ml CCID^ o/ml g/ml CCID^ o/ml 
1.168 2.7 
1.160 4.2 
1.154 6.2 
1.151 8.2 
1.149 7.5 
1.148 7.0 
1.140 6.5 
1.091 4.0 
1.200 2.5 
1.185 3.2 
1.166 3.2 
1.154 5.2 
1.153 6.2 
1.139 5.0 
1.125 4.3 
1.111 3.0 
1.240 4.0 
1.192 4.5 
1.165 5.2 
1.154 8.5 
1.140 6.7 
1.125 4.7 
1.113 3.2 
1.079 2.2 
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did either the sucrose of potassium tartrate gradients, and 
the buoyant densities obtained for NADL virus were again approz-
imately the same as those obtained by the rate zonal centrifu-
gatlon method. 
Concentration and purification of BVD virus 
Ultracentrlfugatlon Both concentration and purifica­
tion of viral preparations are desirable for examination in the 
electron microscope. Various concentration methods have been 
outlined In the materials and methods section. Results of the 
method employing 525 ml of crude virus preliminarily concen­
trated by pressure dialysis, then centrifuged in the Spinco 
centrifuge as described earlier were as follows: Cell culture 
titrations of the resulting concentrate showed that the 
virulence of the concentrate had increased approximately 2 logs 
or from lO?'^  CCID^ o/ml to lO^ 'l CClD^ j/ml. Examination of 
these preparations negatively-stained with PTA showed that k 
types of particles were present in the tissue culture fluids: 
(1) rectangular shaped "snow-flakes" approximately 15 X 20 m)i 
in size which were often surrounded by a large membranous sac­
like structure, which could be part of the cellular endoplasmic 
reticulum; (2) 45-50 myi particles; (3) 80 mji particles; (4) 100 
to 120 m)i particles. Examination of these various particles at 
magnifications ranging up to 500,000 diameters have not revealed 
any typical internal structure or external morphological fea­
tures which could be used for virus identification and/or 
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classification, or which corresponds to structures of any known 
viral agents. 
Results of other centrifugation methods, i.e., rate zonal 
and isodensity equilibrium were given in the section on buoyant 
densities of BVD viruses. These methods were also employed as 
concentration and purification methods and results will be pre­
sented in the electron microscope section. 
Purification by agar gel filtration Results of filtra­
tion of the NADL strain of BVD virus through 3^  agarose beads 
and chips are given in Figure 29. Notice that 2 peaks were 
present in eluates from both bead and chip columns, indicating 
that 2 sizes of infective particles were present in the 
original BVD preparation, and these 2 sizes were separated by 
the hold-up qualities of the agarose preparations. It is also 
apparent that the agarose beads gave sharper peaks and, thus, 
better separation of infectious particles than did the chips. 
This finding is contrary to that of Steere (see footnote on 
page ?8). Electron microscopic examination of concentrated 
preparations from this column separation showed that more work 
was needed to purify the BVD virus so that cell fragments and 
media constituents could be eliminated. The objective of 
"purification" of the BVD virus by agar gel filtration had not 
yet been accomplished so that the viral particle could be 
identified in the electron microscope. These results were 
merely preliminary or exploratory-type experiments. 
Figure 29. Titers of the NADL strain of BVD virus in EBK 
cells after elutlon of fractions from 3^  agarose 
columns consisting of beads and chips 
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Purification by Genetron treatment Plots of infec-
tivity of NADL virus in EBK cells after mixing in a Servall 
Omnimix homogenizer for time periods ranging from 0 to l6 min 
are shown in Figure 30. For each doubling time of treatment, 
a 1-log decrease in titer occurred. The results of this experi­
ment preclude the use of Genetron treatment as a useful method 
to purify cultures of BVD virus. 
Size and structure of BVD viruses 
as determined by electron microscopy 
Ultrafiltration results (Table l6) indicated that a 
majority of infectious BVD particles will pass through a filter 
with 100 ny, pores, but will not pass through 50 m^  pores. 
There were certain exceptions when infectious particles appeared 
to have passed through 50 and even 10 pore-sized filters. 
Preliminary electron microscopic examinations of concentrated 
and partially purified BVD viral preparations revealed a range 
of particle sizes which could be grouped roughly into 4 size-
classifications. These size ranges were stated in an earlier 
section, and the following results confirm these earlier obser­
vations. 
Electron microscopy of density-gradient purified concen­
trates of BVD virus Particles shown in Figure 31 are 
thought to represent the virions of BVD, NADL strain. All 
markers on the electron micrographs are 0.1 jx (100 m^ ) unless 
otherwise indicated. The size of the intact spherical par­
ticle in frame A is approximately 100 m^ , and the other 
Figure 30. The effect of Genetron on the viability of the 
NADL strain of BVD virus after doubling time 
periods of homogenization in a Servall Omnimix 
(CCI  D 50/ml ) 
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Figure 31• Disintegration of BVD virions due to concentra­
tion and purification procedures 
A. The intact virion. Preparation purified by 
a 2.5^  agarose column filtration (X330,000) 
B. Slight erosion of the particle (X296,000) 
C. Further degeneration (X4l3,000) 
D. Rupture and spilling out of internal con­
tents. (Note the presence of subunits). 
(X270,000) 
E. and F. Further stages of particle break-down 
(X272,000 and 350,000) 
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particles shown range between 90 and 100 mji, taking into 
account the spreading-out of the contents of the ruptured par­
ticles, The ease with which BVD viruses disintegrate may be 
one of the principal factors responsible for the difficulties 
of many workers in finding and identifying the causative agent 
of BVD. Micrographs A to F of Figure 31 demonstrate what is 
thought to represent progressive stages of disintegration of 
BVD virions. 
Because the BVD viruses are sensitive to lipid solvents, 
it can be speculated that they possess a lipid or lipo-protein 
envelope. Evidence for such an envelope is presented in 
Figure 32, which shows various stages of envelope loss by BVD 
viruses. In frame A there are 2 such particles, in B the 
envelope seems to be separating from the inner core in two 
parts. In C, the envelope is almost separated from the par­
ticle, and in D, envelope and virus are completely separated 
and appear as 2 separate particles. Eolling-up of envelope 
material could be one of the factors contributing to the 
presence of different sized and structured particles in BVD 
preparations as seen through the electron microscope. 
Certain myxovirus-like characteristics of BVD virions are 
shown in Figure 33* Note the hairlike projections on the sur­
face of particles shown in frames A and B. These projections 
are not seen on most of the particles from BVD viral prepara­
tions and it is believed that they are easily removed by 
purification and concentration procedures. Another myxovirus-
Figure 32. Loss of envelope material from BVD virions 
A. Two particles losing their envelopes (X390.000) 
B. Envelope appears to be separating from core in 
two segments (X435.000) 
C. Envelope almost completely separated, also, 
note 30-40 m)i fragment above marker (X380,000) 
D. Envelope (above) and core separated (X390.000) 
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Figure 33. Myxovirus-like characteristics of BVD virions 
A. 80-90 mji particle with hair-like projections 
showing a ball on the end as described by 
Dut ta et Réf. (21) (X280,000) 
B. Fragmenting virion with hair-like projections 
(320,000) 
C. Particle showing envelope (E), fragmentation 
(F) and SA (S) (X300,000) 
D. Cluster of 30-40 mji fragments purified by 
2,5^  agarose column (XI69.OOO) 
E. Virion (V) with fragment (F) forming (X400,000) 
F. Clump of virions and fragments (X217.000) 
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like property of BVD viruses is the formation of internal sub-
unit particles similar to the Internal rosettes so clearly 
demonstrated by Ritchie and Stone (129) with Newcastle disease 
virus. Formation of these internal fragments (?) are shown in 
frames B and C of Figure 33» the body of the virus from which 
these fragments are derived is indicated by (V). Blebs which 
are probably the beginnings of fragmentation of viruses (V) 
in frames A and E are indicated by the arrows and letters (F). 
A group of fragments are shown in frame D. In frame F, several 
fragments and 2 or 3 whole virions are shown. The letters (S) 
and (E) in frame C are thought to be a soluble antigen particle 
and a rolled-up envelope respectively. The black arrow in 
frame E points to what is probably a free envelope rather than 
a viral fragment or subunit. 
Particles in the size range 15 to 20 m}i have been observed 
in electron micrographs of negatively stained preparations of 
BVD viruses from the first preliminary experiments. These 
particles are thought to be viral precursor units, or "soluble 
antigen" which has been described for numerous viral systems. 
The membranous structure in Figure 3^. A is believed to be a 
portion of the infected cell, and probably represents a portion 
of a viral "factory". Soluble antigen particles appear to be 
on the inside of this membranous sac. Likewise, in frames 
B, C, and D, SA particles are believed to be on the inside of 
the larger structure. In frame D a group of free SA particles 
are seen, as well as particles which appear attached to a 
Figure 34. Soluble antigen or precursor subunits of BVD 
viruses 
A. Membranous structure containing 15-20 mu 
particles (XIOO.OOO) 
B. Cellular fragment containing SA particles 
{X380,000) 
C. Same as B (X275,000) 
D. Same, but with free SA particles also 
(X390,000) 
E. A string of SA particles (X430,000) 
F. SA particles showing 2-3 m)i subunits 
(X750,000) 
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cellular fragment. Inside this fragment can be seen faint 
dark outlines of what appear to be particles of the same size 
as those attached to the outside and free from the structure. 
Groups of free SA particles are shown in frames E and F. The 
magnification of the particles in F is 750»000 diameters, and 
subunits almost at the molecular level can be seen to comprise 
the larger SA particle. Rough measurements of these subunits 
of the SA particles indicate that they are approximately 20 to 
25 Angstrom units in diameter. 
Immuno-electron microscopy of BVD viral particles 
Following incubation with antibody, aggregated clumps of par­
ticles were seen in the electron microscope. The intact 
particles in Figure 35^ , considered to be the virions of BVD 
seem to be somewhat free of antibody coating. In frame B, 
2 smaller particles which are probably fragmented subunits of 
the virion appear to be fairly well coated with antibody. 
Another cluster of smaller particles bound together with anti­
body appears in C, while in D an apparently ruptured particle 
is literally covered with antibody. In E various fragments 
and pieces which appear to be envelope fragments as well as 
internal fragments are heavily coated with antibody. Massive 
clumps of viral fragments appear to be tightly held together 
with BVD viral antibody in Figure 36. A fairly spherical frag­
ment with distinctive subunits can be seen at (f) in Frame A. 
Frames B and C represent massive clumping of fairly small 
particles, while frame D contains particles of 90 to 95 mp in 
Figure 35* Immuno-electron microscopy of BVD viral 
preparations 
A. Virions of BVD without antibody coating 
(X200,000) 
B. BVD viral fragments with antibody between 
them (X350,000) 
C. Antibody-clumped particles (X265.000) 
D. A ruptured particle completely coated with 
antibody (X270,000) 
E. Fragments and pieces coated with antibody 
(X137.0OO) 
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Figure 36. dumping of fragments and particles with BVD 
viral antibody 
A. Disintegrating virion with spherical fragment 
(f) showing subunits (X320,000) 
B. Massive clump of 30-40 m)i particles (X117,000) 
C. A clump of particles similar to B (X177»000) 
D. A clump of mixed sizes of particles (X177,000) 
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addition to smaller units. These larger particles are con­
sidered to represent the size of the BVD virion. 
Clusters of SA-sized particles (15-20 mji) are shown in 
Figure 37 at 3 different magnifications. The top frame, A, is 
magnified 72,000 X, B is l6l,000 X, and C is 406,000 X, These 
subunit particles are considered to be viral precursors, unless 
they represent completely broken-down or disintegrated viral 
units. The specificity for antibody would probably be the same 
in either case. 
Cell-virus interactions seen in ultra-thin 
sections by the electron microscope 
One of the most striking features of BVD viral infection 
of EBK cells as seen In the electron microscope is the devel­
opment of what is interpreted to be SA in the cytoplasm of the 
infected cell. Vast amounts of this SA appear between 6 and 
24 hr PI. These 15-20 n^ i particles have been observed in cell 
cultures infected with NADL, CG-1220 and C24V strains of BVD 
virus. A massive collection of these positively stained par­
ticles Is shown in Figure 38 which is an electron micrograph of 
an ultra-thin section of an EBK cell Infected with NADL virus, 
after approximately 12 hr PI. This is a magnification of 
103,000 diameters. No other structures or organelles are 
recognizable in this micrograph except perhaps some smooth endo­
plasmic reticulum. A higher magnification of similar particles 
(131.000 X) is shown in Figure 39« Note the enmassed mito­
chondria indicating that very active synthesis requiring a 
Figure 37 • Clusters of 15-20 mji particles reacted with BVD 
antibody 
A. (X72,000), 3. (Xl6l,000), C. (X406,000) 
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Figure 38. Ultra-thin section of a BVD viral infected EBK 
cell, at 12 hr ?I, showing masses of ribosome-
like particles (XIO3.OOO) 
Figure 39. Cell section at 12 hr PI with 15-20 mji particles 
among the enmassed mitochondria (XI31.OOO) 
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great deal of energy is probably taking place in the region of 
the cell where these SA particles appear, A higher magnifi­
cation (210,000 X) of this same area is shown in Figure 40. 
Close examination of these positively stained particles and 
comparisons of the negatively stained particles in Figure 37 
leads one to speculate that they are the same structures. 
The structure labeled (AA) in Figure 4l might well be an 
assembly area for completed virions. The grey slightly rounded 
bodies labeled (SU) could be viral subunits. These particles 
are in the size range of 30-50 mji. Particles labeled (V) could 
be completed virions of BVD emerging from this "factory" or 
"assembly area". These (V) particles are all within the size 
range (90-100 mfi) considered to be the approximate size of the 
BVD virus from filtration data and from negatively stained 
electron micrographs. 
Studies on Nucleic Acid of BVD Virus 
Type of nucleic acid 
All the strains of BVD virus tested with BUDR and lUDR 
possess SNA as the nucleic acid in their chemical composition. 
The results of these tests are shown in Table 19 which also 
gives the results of the growth of control DNA and RNA viruses 
in these chemicals. The response of the control viruses 
attests to the validity of the results. 
Figure 40. Ultra-thin section of the 12 hr PI BVD viral 
infected cell shown in Figure 39t but at a 
higher magnification (X210,000) 
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Fit'r-tre 4l. Ultra-thin section of a BVD viral infected cell 
24 hr PI. Interpretation of visible structures 
is: cell membrane (CM), vacuoles (VAC), viral 
Assembly area (AA), viral subunits (SU), BVD 
virions in the cytoplasm of the cell (V) 
(X153.000) 
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Table 19, Titers of BVD. vaccinia, herpes, ECBO, and VS 
viruses as controls and after addition of 
50 jig/ml of lUDR and BUDR in EBK cell cultures 
Virus Controls BUDR lUDR 
C24V 10?.0 106.7 106.5 
NADL 106.7 106.5 lo6'3 
WV-313 105'5 105'5 105'3 
CG-1220 IQS.O 10^.7 io5.o 
SAN io5.3 lO^'S lO^'S 
NY-1 106.0 106.0 io5.5 
MER 106.0 io5.3 io5.5 
IND-46 lo5.3 lo5.3 lo5.5 
Vaccinia 10^.0 lO^'S iqI.O 
IBR 10?.5 io2.5 io2.o 
ECBO 10^.3 108.5 108.3 
VSV 106.7 106.0 106.0 
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Assays of Infectlvity of BVD nucleic acid 
The results of a number of attempts to extract infectious 
RNA from the NADL-PK22 strain of BVD by the cold phenol method 
described by Bachrach (128) turned out completely negative. 
Results of the treatment conditions are tabulated below; 
Preparation 
a, RNA phenol extract 
b, RNA phenol extract + DEAE dextran 
c, RNA phenol extract + RNAse (1.0 /ig/ml) 
d, Intact NADL-PK22 virus + RNAse 
(1.0 Mg/ml) 
e, Intact NADL-PE22 virus only-
Contrary to the report of Diderholm and Dinter (23) that 
BVD viruses contain phenol-extractable infectious RNA, no evi­
dence was found to support this conclusion from the results of 
these experiments. 
CCIDjo/ml 
noninfective 
noninfective 
noninfective 
10^ .3 
106.7 
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DISCUSSION 
Adaptation of BVD viruses to infect cells other than 
"natural host" cellë has provided an opportunity for studying 
certain aspects of virus-host cell interactions which are not 
readily apparent from studies of these viruses either in intact 
animals or in primary cells of bovine origin. Infection may be 
expressed by replication of infectious virus or by production 
of viral material in affected cells. 
Strains of BVD viruses were adapted to grow in cells of 
hamster (HaK) and in cells of human (ERK-1) origin with no 
production of CPE and with very little, if any, shedding of 
"free" or measurable virus as titrated in susceptible EBK cells. 
However, the presence of specific FA-staining substances in 
these cells indicated that viral mediated synthesis was occur­
ring with or without the production of infectious virus. These 
results support, in part, the conclusions of Kniazeff (130)» 
that transmissible BVD viruses infect not only cells of bovine 
origin, but will propagate in ovine, porcine, caprine, HeLa, 
Chang's human liver, and Henle's human intestinal cells without 
the expression of cytopathogenicity. 
It is possible that such adapted viruses have become 
"defective" by loss of a mechanism of release from these cells, 
thus creating a chronic intracellular infection such as has 
been postulated for the adenoviruses which have no mechanism 
for release and tend to be retained by the cell (131). 
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The C24V virus passaged in PK-15 cells, progressively 
lost its ability to produce CPE in EBK cells, developed the 
ability to produce CPE in PK-15 cells but no CPE in EBK cells, 
produced CPE in both EBK and PK-15 cells, then after further 
passages in EBK cells, failed to produce CPE in either EBK or 
PK-15 cells. The latter "changed" virus behaved as a typical 
noncytopathogenic BVD virus. Reasons for the ability of the 
C24V virus to produce different kinds of CPE in different 
cells upon passages remain obscure, but it is possible that an 
exchange of genetic material between the infecting virus and 
the infected cell could account for the expressed interactions 
between virus and cell. The basic concepts underlying success­
ful viral infections of susceptible cells are that viral 
genomes supersede the cellular genomes and therefore code for 
the type of nucleic acid and protein required for replication 
of the virus at the expense of the metabolism of the affected 
cell. Apparently the degree to which this viral "takeover" 
occurs is variable and can be altered by passages of viruses 
in various host cells. The effects of this basic principle 
were recognized by Pasteur et (I32) in their early work in 
modifying the rabies virus by passage through an "unnatural" 
host, even though viral agent properties as understood today 
were largely unknown in Pasteur's day. 
Among the theories as to causes of viral CPE in suscep­
tible cells is one postulated by Wolff and Bubel (133) who 
demonstrated an association between the release of lysosomal 
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enzymes and the appearance of a characteristic cytopathology 
of poliovirus-infected cells. 
Roizman (13^ ) studied a strain of herpes simplex virus 
which produced plaques in HEp-2 cells but not in dog kidney 
cells. He postulated that the virus "aborts" in the latter 
cells because one or more proteins specified by the virus are 
nonfunctional. An early viral enzyme, thymidine Kinase was not 
produced. The infected cells survive and carry the genome of 
the virus. The progeny of these dog kidney cells carried the 
virus in an inapparent form for 6 weeks, but ultimately, 
mutants capable of multiplying in these cells destroyed the 
survivors. 
Attempts to develop a chronically-infected PK-15 cell line 
with the C24V strain of virus ended in failure, even though the 
passaged virus did not exhibit any CPE in the cells at the time 
serial transfers of cells were commenced. Apparently, upon 
transfer, the C24V virus regained the ability to produce CPE 
and destroyed the host cells so that they could no longer be 
transferred from culture to culture. This appears to be a tem­
porarily "masked" or "abortive" infection in which the virus 
eventually recovered its cell-destructive properties. 
Another example of an abortive infection of a cell line 
by a virus is the work of Eodriquez et al. (135) who passed 
chick embryo-adapted Newcastle disease virus in L cells. After 
numerous passages, the NDV ceased to produce CPE in the L cells 
and they became abortively infected, however, the cultures 
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survived as viral carriers. These workers attributed the 
aborted infectious process to interferon-inducing components 
which may have represented inactive or incomplete viral par­
ticles. They theorized that NDV populations are virulent in 
the absence of the interferon-inducing components. The cita­
tion of this work with NDV and interferon as the possible 
abortive principle does not imply that interferon is involved 
in the inapparent or "abortive" Infections seen in certain cell 
lines infected with BVD viruses. Earlier work (58) is sugges­
tive that interferon probably is not involved in BVD viral 
infections. 
The loss or gain of cytopathogenicity of the C24V virus 
for PK-15 and EBK cells upon cell passage as well as the 
production of different types of CPE, or no CPE as exemplified 
by the C24V-PKj, NADL-EA, and C24V-PK25-EBK4 viruses could all 
be explained on the basis of loss, gain, or exchange of genetic 
material in the infected cell. These experimentally induced 
changes in the characteristics of the BVD family of viruses 
point out possible reasons as to why strains of differing cyto­
pathogenicity, virulence, and serological characteristics also 
occur in field isolates. 
Cytopathogenic properties of other BVD viruses have been 
seen to change during routine cell passage and maintenance. 
The CG-1220 virus was once a noncytopathogenic virus, but has 
developed the ability to destroy certain lots of EBK cells, and 
is therefore, considered to be a BVD virus of intermediate 
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virulence for bovine primary cell cultures. Other BVB field 
strains possessing an intermediate virulence for cell cultures 
are Auburn and Hubbard strains. 
Evidence of BVD viral infection from tissues of 11 necrop-
sied cattle by the FA smear impression technique was 100# 
(Table 4), but recovery of infectious virus from these same 
animals was only In no instance was virus recovered from 
an PA-negative animal (Table 4), although there were 7 instances 
out of 108 tissues tested where infectious virus was recovered 
from FA-negative tissues (Table 5)» It is noteworthy that all 
of these virus-positive, FA-negative tissues were from animals 
that succumbed to the BVD infection. Furthermore, no infec­
tious virus was isolated from any animal which recovered from 
the initial infection and was sacrificed, even though these 
same animals were 100# FA-positive, some in excess of 200 days 
PI. These findings denote that either the selected FA-positive 
cells continued to code for FA-reactive antigen without the 
production of recoverable infectious virus, or a low-grade 
"carrier state" existed in these animals within certain infected 
cells, and the viruses produced were neutralized outside the 
cellular environment by circulating humoral antibodies which 
do not penetrate the confines of these "infected" cells. 
Gutekunst (18) showed that "normal" cattle may be "carriers" of 
the virus without showing clinical signs of disease. Other 
investigators (11, 108, 136) have shown that some BVD-infected 
animals do not develop detectable humoral antibodies for 
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considerable lengths of time, and shed infectious viruses for 
equally long periods of time. 
The high percentage of FA-positive samples from lung 
tissues (56^ ) in Table 5 confirm that respiratory infection 
occurs along with enteric infection. High percentages of 
FA-positive samples from spleen and lymph nodes reaffirm the 
concept that BVD viruses have a high affinity for lymphoid 
tissues (Table 5 and Figures-11_, 12, 13. 14). 
Baker et al, (51) modified the NY-1 strain of BVD virus by 
cyclic passages in calves and rabbits to the extent that a 75th 
passage produced little or no symptoms in susceptible calves. 
On the other hand, early rabbit-passaged virus had no effect on 
rabbits, but in later passages, a slightly increased tempera­
ture was noticed 2 to 3 days after inoculation. The NY-1 
strain is noncytopathogenic for EBK cell cultures, so probably 
the 2 mentioned changes were the only discernible ones. 
In the present study, the changes in the type of CPE pro­
duced by the rabbit-adapted NADL strain of BVD virus are the 
significant expressions of modification of the viral agent in 
the rabbit host. When the vacuole-type CPE, which are charac­
teristic of the C24V virus, were first seen in EBK cells 
inoculated with blood from the neonatal rabbit, H-5c (Figure 16), 
which was inoculated with a virus producing the NADL-type of 
CPE, mislabeling or contamination of the culture was suspected. 
However, resampling of original tissue from rabbit R-5c dis­
closed that samples had not been mixed. Cross contamination 
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was considered because all viruses were administered by the 
oral route, and all the neonatal rabbits were nursing the same 
mother (R-5)• When the same phenomenon appeared in an adult 
rabbit, R-5. (Figure 15) which was also inoculated with a virus 
exhibiting NADL-type of CPE, and caged and necropsied sepa­
rately, it was realized that the NADL virus had been modified 
so that it now produced a vacuolating C24V-type of CPE in EBK 
cells (Figure 18). Subcultures of material from all rabbits 
showed that some KADL viruses had not been modified by rabbit 
passage, and still produced the typical NADL-type of CPE in 
EBK cells; some NADL viruses produced a sort of "hybrid" CPE 
intermediate between those of NADL and C24V viruses; and some 
had converted entirely to a C24V-type of CPE in EBK cells 
(Figures 15, l6 and Table 6). None of the rabbit-passaged 
C24V viruses were modified in any observable way, but all pro­
duced the vacuolated CPE typical of that strain. 
Later work in passaging the C24V strain through PK-15 
cells revealed that the expression of this virus could also be 
changed to one emulating the NADL type of CPE (exemplified by 
the pooled CZ^ V-PK^  virus) and furthermore, that noncytopatho-
genic viruses could be developed (typified by the CZ^ V-PK#^ -
EB% virus). 
Whatever genetic changes occurred in these rabbit- and 
cell line-modified viruses which resulted in a different pheno-
typic or genotypic expression (CPE), also resulted in a sero-
typic change as measured by neutralization tests (Table 10). 
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These concomitant changes seem to indicate that gene loci 
responsible for each may be adjacent on the genetic material. 
The loss or gain of the gene locus responsible for CPE-type 
seems to affect the locus for serotype when viral or cellular 
genomes are exchanged in the adaptive process. These "genetic 
markers" could be "linked" in the inheritance patterns of these 
viruses. No observable changes in FA or agar double diffusion 
results could be discerned, except that all 3 of the above 
modified viruses produced more lines of precipitation against 
their homologous sera than did the NADL, C24V, or CG-1220 
strains (Table 11). 
Another aspect of BVD virus-host cell interactions worthy 
of discussion is the apparent immunological paradox shown in 
Table 8. These 2 calves, 5501 and 5506, hyperimmunized with 
NADL and C24V viruses respectively, were cross-injected with 
the heterologous strains at 26 and 15 weeks PI respectively. 
A rise in neutralization titers against the heterologous 
viruses was expected, but instead, only an additional rise in 
titers against the original immunizing viral strains occurred. 
It appears that the heterologous antigens (those not cross-
reacting in neutralization or other immunological reactions) 
do not reverse the trend of formation of antibodies to the 
earlier administered antigen once the antibody-producing trend 
is started. 
Reasons for the above phenomenon are not readily apparent, 
and lie in a highly controversial area of immunology. 
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According to Feldman and Mekori (137): 
"The question whether each immune competent cell within 
one organism is genetically determined to form a single 
specific antibody, or whether it is a priori pluri-
potential, capable of forming antibodies to any given 
antigen, presents a crucial and as yet unsolved problem." 
The clonal selection theory of Burnet (I38) implies 1 antibody 
per immunologically competent cell. The state of pluripoten-
tiality may imply either an instructive mechanism, or a con­
dition where multiple antibodies may be coded by an entire 
spectrum of genes located within the genome of each competent 
cell (139). Makela and Nossal (140) immunized isolated cells 
with Z different Salmonella antigens and found that each cell 
produced antibodies to only 1 antigen at a time. 
Failure of the antibody-producing cells, in the 2 calves 
studied, to produce measurable quantities of antibody specific 
for the later administered heterologous antigen, does not 
imply that clonal selection is the antibody-producing mecha­
nism. It is possible that pluripotential cells, once activated 
by a particular antigen, could become unresponsive to other 
antigenic determinants. Besides, it should be kept in mind 
that the C24V and NADL viruses are not completely different 
antigenically, but they possess common antigens which cross-
neutralize (14, 100), cross-fluoresce (14, 34), cross-precipi­
tate (35) and cross-fix complement (18). The common antigens 
between these 2 strains of virus may be potent enough to over­
ride production of possibly minor antigens not possessed in 
common by both strains. 
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Whatever mechanism is involved in antibody production, the 
genetic coding principle is most assuredly part of that mecha­
nism. As evidence of this, a change in the phenotypic or 
genotypic expression of CPE by "changed" BVD viruses resulted 
in a corresponding genotypic change in serotypic expression as 
shown by neutralization tests (Table 10). 
Anticellular sera have been reported to inhibit the CPE 
of viruses and/or to suppress viral multiplication in cell 
cultures and chicken embryos. Viruses so affected are avian 
sarcoma and leukosis, vaccinia, poliomyelitis, ECHO, coxsackie, 
influenza, Newcastle disease and certain herpesviruses (l4l). 
Theories concerning the mechanism of the inhibiting effect of 
anticellular sera vary. Some investigators say the sera act 
on the susceptible cell and possibly block attachment or 
entrance sites (142, 143). Others explain this phenomenon as 
a direct effect of anticellular sera on the viral particle as 
a result of antigenic similarity of viruses and host cells, 
perhaps because of the host cell origin of the viral envelope 
(l4l, 144, 145). 
The reason for neutralization of all strains of BVD virus 
by anti-EBK sera and failure of anti-PK-15 sera to neutralize 
any strains, even those cultured by 22 and 24 passages in 
PK-15 cells, is unknown (Table 12). Reasons for the wide 
variability in titers of the anti-EBK cell sera when reacted 
with the different strains of virus are also a mystery. The 
theory proposed by Quersin-Thiry (142) and by Habel et al. 
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(143) that anti-cell sera block attachment sites on susceptible 
cells was disproven by the experiment where anti-EBK cell serum 
was absorbed to an EBK cell monolayer with neither a resultant 
reduction of neutralizing power of the serum for BVD viruses, 
nor any inhibition of viral infection of the treated monolayer 
upon challenge. These results favor the theory of neutraliza­
tion of the virus by the anti-cell sera which was postulated 
as early as 1931 by Gye and Purdy (146) and in 1939 by Amies 
and Carr (14?). Both groups showed that antiserum to normal 
chick tissues neutralized the Rous sarcoma virus by some type 
of action on the virus itself. These findings also agree with 
those of Kosyakov et al. (141), Wildy and Watson (l44), and 
Laver and Webster (145). 
Reasons for failure of all anti-cell sera to neutralize 
IBR, VS. ECBO, and vaccinia viruses grown in EBK or PK-15 cells 
are unknown. 
While there can be no doubt that anti-cell sera contain 
antibodies, as expressed by indirect FA tests (Table 13 and 
Figure 23) and neutralization tests (Table 12), there seems to 
be some sort of "new" cellular antibody produced in animals as 
a result of injection of antigen from viral infected cells. 
This is shown by the following brief summary of agar double 
diffusion tests; 
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Antigen Antiserum Results 
(a) Cell sonicates + anti-cell — no precipitation lines 
(b) Cell sonicates + anti-viral — 1 to several precipitation 
lines 
(c) SA from viral 
infected cells + anti-cell — no precipitation lines 
(d) SA from viral 
infected cells + anti-viral — 1 to several precipitation 
lines 
It is difficult to explain why soluble cell components 
from cell sonicates did not react in the agar double diffusion 
precipitation system (Figure 22). 
One possible explanation for the lack of lines of precipi­
tation in system (a) is that the cell sonicates may have been 
poor antigens which did not stimulate production of antibodies 
which would precipitate when reacted with the original antigen. 
This could be possibly due to formation of monovalent or block­
ing-type of antibodies only. Anti-viral sera in system (b) 
contained complete or bivalent antibodies which gave visible 
reactions to the antigens in cell sonicates. This theory would 
also account for the lack of a visible reaction in system (c) 
which contained a highly reactive antigen, but also the mono­
valent antibody which again prevented precipitation in the test 
system. System (d) contained complete antigens and antibodies 
and thus gave a positive reaction expressed by the formation 
of lines of precipitation. 
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Another possible explanation for the above phenomenon is 
that cellular protein incorporated into the coat of the BVD 
virion may have an adjuvant effect on the production of serum. 
Lines of precipitation are formed by serum from such combina­
tions of viral and cellular materials, even with cell sonicates, 
which by themselves do not stimulate formation of precipitat­
ing antibodies. 
Bovine neutralizing antibodies to the BVD agent reported 
in Table 14 for calves described in Table 1 are plotted graphi­
cally in Figure 42. The 19 S antibody predominated regardless 
of the treatment condition for the animal involved. Kabat 
(148) studied antipneumococcal serum systems and concluded that 
antibodies from sera of various animals fall into 2 groups on 
the basis of molecular weight; in 1 group are the cow, horse 
and pig with 19 S sized antibodies: in the other group are 
human, rabbit and monkey with 7 S antibodies. Many workers 
have since shown that 19 S immunoglobulins are also found in 
the serum of rabbits, guinea pigs, chickens, humans and mice 
as well as in the sera of ungulates (l49). 
The size of antigen dose (5 X 10^  CCID^ g given to calf #1 
compared to ?, X 10^  CCID^ q Siven to calf #2) had no apparent 
effect on the size-class of antibodies produced. This is con­
trary to results of Uhr (6l, 150) obtained with the bacterial 
virus fi X 174 - guinea pig system and of Svehag and Mandel 
(151) with a poliovirus system; both groups established dose-
dependency for the type of antibody produced. 
Figure 42. Neutralization of BVD virus by ? 8 and 19 S 
fractions and whole serum from BVD viral-
immunized calves 
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Classical secondary responses, i.e., predominance of pro­
duction of 7 S antibodies to "booster* injections were also 
not exhibited in animals #3 and #4. Coupled with this lack of 
response, calves did not show the classical "early-19 8--
late-7 S" responses reported for other immunological systems 
(62, 63). In the present study with the BVD agent in calves, 
the production of 19 S antibodies persisted for as long as 20 
weeks PI, whereas production of 7 S antibodies did not increase 
markedly with the passing of time or upon secondary stimulation 
of animals. This persistence of I9 S antibodies resembles the 
human-typhoid "O" antigen system, which according to LoSpalluto 
et al, (152) elicits only 19 S antibodies in convalescent 
patients, even after many years. 
Viral agent-host cell interactions are further demonstrated 
in these studies by the exhibition of further heterogeneity of 
antibodies, even to the same antigen, by the lack of correlation 
of neutralization, FA, or double agar diffusion precipitation 
tests (Table 14), All of the 19 S fractions showed precipita­
tion lines in Ouchterlony plates, whereas 7 S fractions were 
all negative with the exception of sample la which had a 
neutralization titer of 1:32; other 7 S fractions with neutrali­
zation titers of 1:128, 1:256 and 1:512 yielded negative pre-
ciç itlîi results. This association of I9 S antiserum fractions 
hith liiiss of precipitation, and the lack of precipitins in the 
7 S fraction is contrary to the results of Shulman et al. (63), 
who reported the complete lack of precipitating antibody in gel 
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diffusion plates by the heavy antibody fraction of a human 
serum albumin-rabbit antiserum system. Other workers, however, 
have reported precipitins in the 19 S fraction expressed in 
agar double diffusion systems (61, 64). 
Fluorescent antibody staining of BVD viral infected cells 
is likely due to the formation of SA within the infected cell. 
So far, no antiserum specific for viral antigen (VA) as opposed 
to that specific for SA has been produced, Gutekunst and 
Malmquist (35) produced BVD antiserum to a crude preparation of 
SA, but it is likely that VA also was present in fairly high 
concentrations, even though the infectivity of the virus was 
destroyed by treatment with chloroform. Their criterion for 
SA as opposed to VA was complement fixing (CP) titers as 
opposed to serum neutralizing (SN) titers. 
In the present work, antiserum from the SPF calf receiving 
only crude SA (Table 1) was conjugated. Fluorescence appearing 
in BVD viral infected cells stained with conjugated SA anti­
serum could not be distinguished from that appearing in infected 
cells stained with conjugated whole viral antiserum, therefore, 
SA preparations will require further purification procedures 
before they will be free from VA. 
In a more recent publication, Gutekunst and Malmquist (101) 
reported a partial purification of the SA of a BVD virus by 
sedimentation in a sucrose density-gradient and by DEAE-cellu-
lose chromotography. These authors presented evidence by CF 
tests that SA associated with the BVD virus was present at 
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3 hr PI or earlier. A decline in intracellular SA after 12 hr 
PI, as measured by a CP technique, with a concomitant rise in 
cell-associated virus, suggested that some SA was incorporated 
into mature virus. They further showed that the release of 
infective virus into the extracellular fluid was concomitant 
with the release of SA. This timetable based on CP and cyto-
pathology of infected cells is substantiated by times of 
appearance of immunofluorescence in BVD viral infected cells. 
The initia: formation of CP antibodies corresponds approxi­
mately with the appearance of nuclear fluorescence. 
Nuclear fluorescence appears in so few cells in a FA 
system, that it is likely that only cracked or damaged cells 
caused by the fixing process in -60 C acetone allows the 
labeled antibodies to enter the cell and tag SA or some other 
viral precursor protein as it is being synthesized in the 
nucleus of the cell. This appearance of tagged antibodies 
inside of the cell is analogous to the appearance of ferritin-
conjugated antibodies in viral infected cells (153). Pailure 
to detect nuclear immunofluorescence could also be due to 
occurrence of the classical viral eclipse phase where viral 
nucleic acids are dissembled and cellular synthesis of viral 
antigen has not yet proceeded to a detectable level within the 
infected cell. Roane and Roizman (15^ ) devised an ingenious 
method of detecting specific nuclear fluorescence caused by the 
herpes simplex virus in HEp-2 cells. They showed that other 
workers had been confused by antiserum produced against 
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cellular debris and had not recognized early-staining nuclear 
antigen. They overcame this in 2 ways: by repeated absorp­
tions of conjugated serum globulins with homogenized uninfected 
HEp-2 cells, and by boiling infected cells prior to rabbit 
immunization to denature cellular protein and produce a viral-
specific antiserum. These authors maintain that their treat­
ments of cells and sera help to explain much of the controversy 
over nuclear versus cytoplasmic staining of viral antigens 
within infected cells. Howe ed. (155) showed a picture of 
a cell with a large bright nuclear area of fluorescence such 
as is shown in Figures 25 and 26, frames A, B and A respec­
tively. They explained the cell and its nuclear fluorescence 
as follows: "... a large cytoplasmic focus of fluorescence 
overlies the nucleus, which itself shows no specific fluores­
cence." Future work is planned to examine FA stained cells to 
ascertain if these large fluorescing bodies are indeed within 
the nucleus, or merely overlying the nucleus as postulated by 
Howe ^  al. 
A reduction of fluorescing material from the cytoplasm of 
viral infected cells corresponds approximately to the appear­
ance of mature infectious viral particles in the fluid phase of 
the cell culture system unless the cell is destroyed first by 
viral CPE as often happens when high multiplicities of infect­
ing virus are employed in cell culture systems. 
Ishizaki et aJL, (76) in studying the development of VA and 
SA in horse kidney cells infected with equine rhinopneumonitis 
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virus, suggested that SA is synthesized in the nucleus, fol­
lowed by the synthesis of VA in the cytoplasm, and finally the 
mature virus particle is completed in the cytoplasm by assembly 
of both antigenic materials. The SA represents nucleic acid-
protein constituting the viral core and VA constitutes the 
virus particle surface of protein nature. The sequential 
appearance of fluorescence in the BVD viral infected cell sys­
tems studied by FA could be parallel to the sequential events 
postulated by these Japanese workers. 
Before the problem of sequential development of BVD 
viruses in cell culture systems can be completely resolved, it 
will be necessary to purify SA and VA by available techniques 
so that antisera specific for these respective antigens can be 
produced. Perhaps procedures similar to those employed by 
Roane and Hoizman (154) would be helpful to resolve these prob­
lems. Sequential time studies of infected cells by electron 
microscopy is another tool which should help to elucidate the 
intracellular synthesis of viruses and viral products which 
contribute to the appearance of the immunofluorescence reported 
in this dissertation. 
Approximate size ranges of BVD viruses have been reported 
variously as 15O-25O m;i (22), 75-85 W (21), 40 mp. (17), and 
35-55 mp (20) by electron microscopic examination. Filtration 
data have suggested sizes of less than 50 (17), and 50-100 
mp. (18, 19). Examination of filtration data in Table I6 leads 
to the speculation that the BVD viruses are highly heterogeneous 
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as to size, filters are not well standardized, or viral par­
ticles may be adhering to either cellular debris or are elec­
trostatically bound to the filters. Additional aliquots of 
NADL and C24V viral preparations used in runs 1 and 5 were 
filtered 2 additional times through the same series of filters 
shown in this table. Both preparations contained infectious 
units that passed a 50 filter, but not a 10 myi filter, thus 
confirming the original results that very small infectious 
particles can be present in certain preparations. 
The wide variety of sizes of particles seen in electron 
micrographs of crude, partially purified, and more extensively 
purified BVD viral preparations, led to the speculation that 
these viruses actually do exist in several size ranges. 
Immuno-electron microscopy confirms the premise that most of 
these particles are either BVD viruses, precursor units, or 
disintegration products. Figure 33 showing the stages of 
theorized break-down of what is considered to be intact BVD 
virions has a range of particles from approximately 30 to 100 
mji. The 15 to 20 mji particle appearing in several micrographs 
is considered to be the precursor material from which the com­
plete virion is assembled. From data obtained from these 
electron microscopic studies, it is believed that the complete 
virion which is encased in a lipid or lipo-protein envelope is 
in the size range of 80-100 mp. Infectious subunits which may 
be formed as such in the infected cell, or may be products of 
disintegration, probably carry portions of the lipid membrane 
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parainfluenza-3 virus to pass. These viruses are also 150-250 
mp. in size (Karstad, 1964, personal communication to Ditch-
field) . 
Almeida et al. (159) published pictures of break-down 
units of African swine fever (ASF) and tipula iridescent (TI) 
viruses. These viruses resembled BVD viruses in that they do 
not survive purification procedures particularly well, but seem 
to break-up into subunits, especially in the absence of a con­
fining membrane. They suggested that ASF and TI viruses are of 
the compound cubic type. Inasmuch as no helices have been seen 
either inside or outside of BVD viruses, it is hereby suggested 
that BVD viruses may also have compound cubic symmetry, rather 
than the compound helical symmetry postulated by Ditchfield and 
Doane. There are, however, certain of the myxoviruses which 
also break-up so that helical structures are not seen unless 
certain careful handling procedures are observed. Such a myxo-
virus is the parainfluenza virus, SV-5 described by Compans and 
Choppin (l60). 
The possibility that contaminating viruses could be present 
in BVD viral preparations and contribute to the various types 
of CPE seen in cell cultures has been considered. Such con­
taminating viruses have been reported in cultures of hog cholera 
virus, A recent publication by Horzinek ^  al. (l6l) has 
pointed out the existence of a picodnavirus and an adenovirus 
contaminating a HCV preparation. These viruses were separated 
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on the basis of different buoyant densities by ultracentrifu-
gation. In several ultracentrifugation runs with both the 
cytopathogenic strains of BVD virus, NADL and C24V, the cyto-
pathogenic virus was found in density bands between I.l4 and 
1.16 g/ml in both rate zonal and isodensity centrifugation runs 
(Tables 1? and I8). Densities above and below these bands were 
also titrated by the interference method to determine the 
possible presence of a noncytopathogenic virus, which could be 
the true BVD virus if the CPE were hypothetically considered to 
be due to a contaminating virus. No such interfering virus was 
found in any preparation, so the assumption was made that the 
CPE seen in cell cultures are caused by the BVD virus. No 
evidence for any other viral agent has been seen in the elec­
tron microscope other than the variable-sized particles dis­
cussed earlier. 
Cell cultures infected with NADL, CG-1220 and C24V strains 
of virus were thin-sectioned and examined in the electron 
microscope. At time periods between 6 and 12 hr after infec­
tion, the endoplasmic reticulum of infected cells became 
literally loaded with 15-20 mji ribosome-like particles (Figures 
38» 39i 40). Kerr et al. (l62) reported similar particles in 
Krebs ascites cells infected with the encephalomyelocarditis 
(EMC) virus at 6-9 hr PI. The appearance of these particles 
was coincident in time with a large turnover of cytoplasmic 
RNA. These particles in BVD viral infected cells are most 
likely the soluble antigen and may be viral subunits. Their 
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appearance coincides with the appearance of antigen which 
stains with fluorescent antibodies and fixes complement. These 
ribosome-like particles largely disappeared from infected cells 
between 24 and 48 hr PI and the cytoplasm of the cell became 
filled with vacuoles. 
The ultrathin section of an EBK cell, 24 hr PI (Figure 41), 
is thought to contain an assembly area or viral "factory" where 
subunits are assembled into completed virions. This stage in 
viral production is the period of vacuole formation, especially 
in the case of cell Infection with cytopathogenic BVD viruses. 
The presence of nuclear fluorescence during the early stages of 
viral infection (3-12 hr PI), and the appearance of large 
amounts of SA (6-12 hr PI), then appearance of assembly or fac­
tory sites (24-48 hr) preceding cell destruction or death con­
stitutes the sum of our knowledge concerning the sequence of 
events in the infection of host cells by BVD viruses. Mecha­
nisms of viral entry or penetration and of release of mature 
viruses from infected cells remain unknown. No electron micro­
scopic evidence for these events was obtained in the present 
studies. 
231 
SUMMARY 
Some of the interactions of bovine viral diarrhea (BVD) 
viruses with infected host cells were studied. 
Two strains, NADL and Oregon C24V, were adapted to cell 
lines other than "bovine—HaK, ERK-1, and PK-I5. In those 
cells, the viruses either produced an abortive infection, 
detectable only by means of fluorescent antibodies (FA) , or 
changed their biotype as expressed by the kind of cytopathic 
effect (CPE) produced. 
Passage of BVD viruses in rabbits, as well as in cell 
lines "changed" the type of CPE of certain strains to resemble 
those of other strains. Expression of CPE-type (biotype) 
seemed to be genetically linked to the strain serotype as 
measured by neutralization tests. 
Tissues from necropsied cattle infected with the NADL 
strain of BVD virus were tested for the presence of infectious 
virus by inoculation of tissue homogenates into susceptible 
embryonic bovine kidney (EBK) cells, and by specific reactions 
with fluorescent antibody (FA). Of 11 infected cattle, 100^  
were FA-positive, but recovery of infectious virus from these 
animals was possible in only Some of the tissues were 
FA-positive in excess of 200 days postinfection, and there were 
only 7 instances out of 108 tissues tested where infectious 
virus was recovered from FA-negative tissues—all from animals 
that succumbed to BVD. The tissues most often found to be 
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positive by both FA and viral assay methods were rectum, spleen, 
lung, and submaxillary lymph nodes. Heart, kidney and intes­
tine contained infectious virus less frequently, and heart 
tissues were completely negative for fluorescing cells. Lymph 
nodes, other than submaxillary, all had a fairly high percent­
age of fluorescence but seldom contained infectious virus. 
Anti-EBK cell sera produced in rabbits neutralized a 
number of strains of BVD virus. Serum dilutions as high as 
1:2048 neutralized 100 CCID^ q (cell culture infective doses) of 
virus. These anti-cell sera failed to neutralize the following 
viruses: infectious bovine rhinotracheitis, vesicular stoma­
titis, bovine enteroviruses (ECBO), vaccinia, and parainflu-
enza-3. 
Heterogeneity studies of BVD antibody and its fractions 
showed that the 19 S gamma globulin predominated in the bovine 
sera studied. Restimulation of animals with antigen did not 
produce a secondary effect and the "early-19 S—late-7 S" 
responses were not present in this immunological system. 
From sequential time studies of development of fluores­
cence in BVD-infected cells, it appears that BVD-viral-induced 
fluorescing antigens originate in the nucleus, move to a para­
nuclear position, then diffuse throughout the cytoplasm before 
fading or disappearing from the cell. The time-sequential 
development and disappearance of fluorescing antigen correlates 
approximately with the appearance of mature infectious par­
ticles in cell culture systems. 
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Ultrafiltration of BVD viral preparations indicated a 
size range of infective particles between 50 and 100 mji. The 
buoyant density of these particles was between 1.14 and l,l6 
g/ml. 
Electron and immuno-electron microscopic studies of 
partially purified BVD viral preparations showed the presence 
of 3 sizes of characteristic particles: (1) 15-20 m}i, con­
sidered to represent soluble antigen, either precursor or 
break-down material; (2) 30-^ 0 mpi, probably fragments of disin­
tegrated virus; (3) 80-100 mji, thought to represent the virion 
of BVD. Intact particles are believed to have an enveloping 
membrane which is easily lost in purification and concentration 
procedures. Also fragmentation of the virion occurs from these 
treatments. Certain myxovirus-like characteristics were 
observed, but others were absent in BVD viral preparations. 
Studies of thin sections of infected cells in the electron 
microscope revealed the presence of vast amounts of 15-20 mji 
particles in the cytoplasm. These particles are thought to be 
SA and viral precursors. Viral factories or assembly areas 
were seen in 24-hr infected cells, as well as particles in the 
size range of BVD virions. 
All strains of BVD viruses tested were ENA viruses, and 
none were shown to possess phenol-extractable infectious RNA. 
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